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Abbreviations  
 
ADP   adenosine diphosphate 
AIF   apoptosis-inducing factor 
ANT   adenine nucleotide translocator 
Apaf-1   apoptotic protease activating factor 1 
ATP   adenosine triphosphate 
AV(s)   autophagic vacuole(s) 
Baf A1   bafilomycin A1 
Bax   Bcl-2 associated X protein 
Bcl-2   B-cell leukemia/lymphoma 2 
BD   binding domain 
BH3   Bcl-2 homology domain 3 
Bid   Bcl-2 interacting domain 
Bnip3   Bcl-2/adenovirus E1B 19 kDa interacting protein 
CFP   cyan fluorescent protein 
Ca2+   calcium 
CsA   cyclosporin A 
DCF   2',7'-dichlorofluorescein 
CM-DCFH2-DA chloromethyl dichlorodihydrofluorescein diacetate 
DNA   deoxyribonucleic acid 
∆Ψm   mitochondrial transmembrane potential 
EDTA   ethylene diamine tetraacetic acid 
ETC   electron transport chain 
FADD   Fas-associated death domain 
FADH2  1,5-dihydroflavin adenine dinucleotide 
4D   four-dimensional (X/Y/Z/time) 
FRET   fluorescence resonance energy transfer 
GFP   green fluorescent protein 
GDP   guanosine diphosphate 
GTP   guanosine triphosphate 
H+   proton 
IAPs   inhibitor of apoptosis proteins 
I/R   ischemia/reperfusion 
kDa   kilo Dalton 
KH   Krebs-Henseleit 
Lamp2   lysosomal-associated membrane protein 2 
LC3   microtubule-associated protein light chain 3 
LSCM   laser scanning confocal microscopy 
LTR   LysoTracker Red 
MAPK   mitogen-activated protein kinase 
MCS   multiple cloning site 
µM   micro-molar (µmol/L) 
mM   mill-molar (mmol/L) 
MPT(P)  mitochondrial permeability transition (pore) 
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mRNA   messenger ribonucleic acid 
mTOR   mammalian target of rapamycin 
N.A.   numerical apertur 
NADH   nicotinamide adenine dinucleotide  
ORF   open reading frame 
PBS   phosphate buffered saline 
PCD   programmed cell death 
PE   phosphatidylethanolamine 
PI3-K   phosphatidylinositol 3-kinase 
PI3-P   phosphatidylinositol 3-phosphate 
RFP   red fluorescent protein 
RIRR   ROS-induced ROS release 
RNA   ribonucleic acid 
RNAi   RNA interference 
ROS   reactive oxygen species 
SDS-PAGE  sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
S/ER   sarco/endoplasmic reticulum 
SERCA  sarco/endoplasmic reticulum calcium ATPase 
sI/R   simulated ischemia/reperfusion 
tBid   truncated Bid 
TM   transmembrane 
TMRM  tetramethylrhodamine methyl ester 
TNF-α   tumor necrosis factor-α 
TRADD  TNF-α-associated death domain 
3D   3-dimensional (X/Y/Z) 
3-MA   3-methyladenine 
v-ATPase  vacuolar ATPase 
VDAC   voltage dependent anion channel 
YFP   yellow fluorescent protein 
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I-1 Heart disease 
The heart is a muscular pump which is responsible for circulating blood throughout the 
body, in order to deliver cells with nutrients and oxygen, the substrate permitting aerobic 
metabolism, as well as to carry away their waste products.  The human heart begins 
beating at approximately 4-5 weeks following conception and continues, hopefully 
uninterrupted, until death, beating around 3 billion times.   
Despite its central importance, the working conditions of the average heart are 
worsening.  Approximately one third of all deaths in the Western industrialized world are 
caused by the effects of acute or chronic limitations to coronary blood flow (Thom et al., 
2006).  Many of these deaths are attributable to modifiable risk factors, such as obesity, 
hypertension, and smoking (Ellsworth et al., 1999; Poulter, 2003), which are prevalent 
and increasing throughout the world.  Thus, in all likelihood heart disease will remain the 
leading cause of death for generations to come. 
 A crucial event in the development of heart disease is the hardening and 
narrowing of the blood-supplying arteries (atherosclerosis, coronary heart disease).  Key 
to the pathogenesis is the abundance of cholesterol (Huxley et al., 2002), a component of 
cell membranes which serves to regulate membrane fluidity and permeability.  High 
levels of low-density-lipoprotein (LDL)-cholesterol lead to the gradual build-up of 
plaques, which in severe conditions results in reduced blood supply and thus, insufficient 
oxygenation of myocardial tissues.  As a consequence, the heart loses its ability to 
properly circulate blood throughout the body, the condition referred to as congestive 
heart failure.   
 A myocardial infarction, or heart attack, occurs when a coronary artery supplying 
oxygen-rich blood to a region of the heart is blocked (e.g. due to coronary obstruction, 
surgical clamp, heart transplantation).  The resulting condition of low oxygen and 
nutrient supply is termed ischemia (from Greek: ‘ischo’, to hold back, and ‘haima’, 
blood), and is accompanied by decreased intracellular availability of ATP, and low pH, 
partly due to increased lactate concentrations.  Following a bout of ischemia, reperfusion 
(e.g. via vasodilator pharmaceuticals, angioplasty) must be achieved in order to prevent 
the irreversible destruction of affected tissues.  Paradoxically, reperfusion itself causes 
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damage and subsequent cell death.  This condition is referred to as ischemia/reperfusion 
(I/R) injury.   
Mitochondria, the ‘powerhouses’ of the cell, are key integrators and controllers of 
the pathways mediating I/R injury.  Depending on the magnitude of the insult, 
mitochondria either promote cellular survival (Oldenburg et al., 2002) or transform into 
lethal entities, executing cell death (Gustafsson and Gottlieb, 2003; Crow et al., 2004).  
The mitochondrial response is in part controlled by the interplay between pro-life and 
pro-death Bcl-2 family members which decides the prevalence of survival or death 
signals.  Understanding the events leading to and stemming from mitochondrial 
dysfunction is crucial for the ultimate goal of treating heart disease and preventing I/R-
activated cell death. 
 
I-2 The heart and its working units 
The heart is divided into two upper chambers, the atria, and two lower chambers, the 
ventricles.  Contraction of the right ventricle pumps blood from the Vena cava inferior 
and superior via the Aorta pulmonalis through the lungs.  Simultaneous contraction of the 
more powerful left ventricle pumps the oxygenated blood through the aorta into the body.  
Pumping of the blood is accomplished via the rhythmic sequence of contraction (systole) 
and relaxation (diastole).  The blood supply of the body (~five liters in an adult) is 
circulated once per minute.  This astonishing pumping action is generated through highly 
coordinated contraction of a mesh of billions of heart muscle cells, known as cardiac 
myocytes or cardiomyocytes, which are interconnected via gap junctions (Severs, 2000).  
Cardiac myocytes are a terminally differentiated cell type, i.e. they do not divide and thus 
are of limited number.  There is a recent debate whether cardiac myocytes are 
regenerated within the heart (Anversa et al., 2006); however, any innate regenerative 
capability can not be sufficient to recover from most pathologies. 
Cardiac myocytes have a high energy expenditure and accordingly 30% of the 
cardiac cellular volume is accounted for by mitochondria (Page et al., 1971), which are 
responsible for almost all the supply of ATP.  ATP is the free-energy carrier fuelling 
most cellular energy-dependent operations; in the cardiac myocyte approximately 30% of 
ATP is used to maintain calcium homeostasis and 60% is used to power contraction 
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(Opie, 1998).  Mitochondria generate ATP through a process termed oxidative 
phosphorylation.  Electrons originating from nutrients are carried to the electron transport 
chain by NADH and FADH2 and then transferred along a series of carrier molecules in 
the inner mitochondrial membrane, driving the extrusion of protons (H+) from the matrix 
across the inner mitochondrial membrane into the mitochondrial intermembrane space to 
form the protonmotive force (∆µH+).  ∆µH+ describes the electrochemical potential 
difference for H+ across the inner mitochondrial membrane, which represents the net 
electric potential difference (∆Ψm) and the difference in pH (∆pH).  The free energy 
contained within ∆µH+ can be used to drive H+ back through the F1F0 ATPase into the 
matrix whereby ADP is phosphorylated to generate ATP (Saraste, 1999b).  Cardiac 
myocytes must continually replenish their supply of ATP, which would be exhausted 
within seconds in the absence of resynthesis: In a 70 kg individual, ATP turnover of the 
human heart exceeds 6 kg per day, yet total ATP content in the heart amounts to about 
3.5 grams (Ingwall, 2002).  
 
I-3 Myocardial cell death during I/R injury   
As discussed above, I/R injury is a major cause of cell death, leading to extensive loss of 
myocardial tissue and consequently reduced myocardial function.  It has been established 
that cell death occurs via both necrosis and apoptosis (Kajstura et al., 1996), two distinct 
modes of death.  Necrosis (Greek for: death, causing to die) is a degenerative process in 
which cellular integrity is lost and the release of cytosolic contents provokes an 
inflammatory response (Searle et al., 1982).   Ischemia induces necrosis in a certain 
subset of cells, whereby the extent of necrotic cell loss is a function of the duration of the 
ischemic insult.  Necrotic cells are mainly found in the central zone of the infarct (infarct 
= region of dead tissue).   
In contrast, apoptosis (from Greek: ‘falling off’, figurative for the falling of 
leaves; also termed programmed cell death (PCD) type I) is a highly-regulated, 
genetically-determined mechanism that does not provoke an inflammatory response 
(Saraste, 1999a).  Moreover, apoptosis requires energy in form of ATP for its successful 
completion.  Apoptosis plays a role in pathophysiological conditions but is also essential 
in normal tissue homeostasis, allowing the organ or tissue to rid itself of cells which are 
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dysfunctional or no longer needed.  Apoptotic cell death is characterized by cell 
shrinkage, membrane blebbing, and nuclear condensation and degradation.  The cell is 
eventually broken into small membrane-enclosed pieces (apoptotic bodies), which in vivo 
are removed by macrophages, or taken up by neighboring cells.  This prevents the release 
of cellular compounds and thus ensures that an inflammatory response is not provoked.  
In I/R injury, apoptotic cell loss manifests itself during the reperfusion period due to the 
slowly orchestrated execution of the apoptotic cell death program, and is more apparent 
at the marginal zone of the infarct.  In addition to its contribution to I/R injury, apoptosis 
has been implicated in the pathogenesis of several cardiovascular diseases including 
nonischemic dilated cardiomyopathy (Schoppet et al., 2005) and congestive heart failure 
(Narula et al., 1996; Olivetti et al., 1997).   
Recently, a second mode of programmed cell death (PCD type II), termed 
autophagic cell death, has been discovered which is characterized morphologically by the 
presence of numerous autophagic vacuoles (Bursch, 2001).  Autophagy is a vital process 
by which macromolecules and organelles are being delivered to lysosomal degradation 
(see I.4).  Uncontrolled or excessive autophagy is thought to cause cell death via the 
extensive degradation of cytoplasmic constituents.  Under these conditions 
pharmacological or molecular inhibition of the components of the autophagic pathway 
prevents cell death.  Autophagic cell death has been implicated in heart failure (Knaapen 
et al., 2001; Shimomura et al., 2001; Miyata et al., 2006) and myocardial hibernation 
(Elsasser et al., 2004).  However, the data used in the support of this hypothesis is 
correlative or relies on the use of nonspecific inhibitors.  To date there is no direct 
evidence implicating autophagic cell death as a contributor to I/R injury.    
I-3.1 Pathways and executers of apoptosis (PCD type I) 
PCD presents a target for reducing the size of the infarct, and thus preserving myocardial 
function following I/R injury.  In the heart, apoptosis is mediated by two central 
pathways, the receptor-mediated (extrinsic) and the mitochondrial (intrinsic) pathway 
(Crow et al., 2004) both of which are depicted in Fig. 1.  So-called caspases, a family of 
cysteine aspartate proteases, are the main effectors of, and allow for crosstalk between, 
both pathways (Thornberry and Lazebnik, 1998; Stennicke and Salvesen, 2000).  
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Caspases are synthesized as inactive precursors and generally activated by proteolytic 
cleavage of the procaspase form to the catalytically active heterotetramer (Shi, 2002).   
I-3.1.1 Receptor-mediated death pathway 
The receptor-mediated (extrinsic) pathway is initiated by the binding of a death ligand 
(e.g. CD95 /Fas ligand, TNF-α) to its cognate cell surface death receptor (e.g. CD95/Fas, 
TNF-α receptor) (Ashkenazi and Dixit, 1998; Schmitz et al., 2000).  Consequently, death 
adapter molecules such as FADD (Fas-associated death domain) and TRADD (TNF 
receptor-accociated death domain) form homotrimers which are recruited to the 
cytoplasmic tail of the death receptor through interactions between “death domains” 
present in both proteins (Tartaglia and Goeddel, 1992; Chinnaiyan et al., 1995; Hsu et al., 
1995).  Subsequently, procaspase 8 is recruited to the complex resulting in increased 
proximity of the molecules which forces autocatalytic homooligomerization and 
processing (Muzio et al., 1998).  Once activated, caspase 8 initiates the apoptotic cascade 
via processing of downstream effector caspases such as caspase 3 (Nicholson et al., 1995; 
Tewari et al., 1995) and pro-apoptotic Bcl-2 family member Bid (Li et al., 1998), leading 
to the death of the cell.   
Recently, the receptor-mediated death pathway was linked to the progression of 
heart disease: mice lacking functional Fas exhibited smaller infarcts following a model of 
in vivo I/R injury (Lee et al., 2003), while increased levels of Fas ligand are present in 
congestive heart failure (Schumann et al., 1997; Yamaguchi et al., 1999) and were 
associated with I/R-induced apoptosis of cardiac myocytes (Kajstura et al., 1996).  
Likewise, increased TNF-α production was reported to occur during myocardial I/R 
injury and linked to mitochondrial damage (Lefer et al., 1990; Kimura et al., 2006).   
I-3.1.2 Mitochondrial death pathway 
Under pathophysiological conditions (e.g. enhanced oxidative stress and/or calcium 
overload) mitochondria participate in the apoptotic pathway (Green and Reed, 1998; 
Desagher and Martinou, 2000).  Death signals transmitted to the mitochondria lead to the 
release of pro-apoptotic proteins from the mitochondrial intermembrane space to the 
cytosol, through pathways which are still subject to much debate and investigation.  The 
majority of studies focused on the release of cytochrome c, which normally functions as 
                                                                                                                                  INTRODUCTION
          
I
 
 
 8 
part of the mitochondrial electron transport chain.  Two main models have been proposed 
to describe the mechanism(s) of cytochrome c release to the cytosol (Bernardi et al., 
1999; Lim et al., 2002).  The first model describes a non-specific mode of release in 
which opening of the mitochondrial permeability transition pore (MPTP, I-3.2.1) leads to 
the swelling of mitochondria due to the osmotic influx of water into the protein- and 
metabolite-dense mitochondrial matrix.  The highly convoluted inner mitochondrial 
membrane is able to expand while the outer mitochondrial membrane ruptures, releasing 
cytochrome c into the cytosol.  The second model describes specific modes of release, 
where Bcl-2 family proteins (I-3.3) either form pores directly via oligomerization, 
regulate the pore size of pre-existing pores, or induce the formation of lipidic pores by 
causing membrane instability.   
In the cytosol, cytochrome c binds to Apaf1 (apoptotic protease activating factor 
1) and, in the presence of dATP, procaspase 9 is recruited to the complex, now termed 
the apoptosome, leading to the activation of procaspase 9 (Rodriguez and Lazebnik, 
1999; Acehan et al., 2002).  Activated caspase 9 can activate downstream effector 
caspases, and thus determine the cell to death.  Cytochrome c-dependent activation of 
caspase 9 is supported by Smac/DIABLO which is likewise released from the 
mitochondrial intermembrane space and removes the anti-apoptotic activity of IAPs 
(inhibitor of apoptosis proteins) (Du et al., 2000; Verhagen et al., 2000).   In addition, 
mitochondria release endonuclease G and AIF (apoptosis-inducing factor) which 
translocate to the nucleus and promote chromatin condensation and large-scale DNA 
fragmentation (Sharpe et al., 2004).  
The mitochondrial death pathway appears to play an important role in the 
execution of apoptosis in cardiac myocytes (Gottlieb and Engler, 1999; Gustafsson and 
Gottlieb, 2003; Crow et al., 2004).  Caspase-dependent cytochrome c release has been 
reported in isolated chick cardiac myocytes subjected to simulated I/R (Qin et al., 2004) 
and several parameters of mitochondrial-mediated apoptosis were demonstrated during 
myocardial I/R injury in vivo (Lundberg and Szweda, 2004) and in vitro (Chen et al., 
2001).  Furthermore, preservation of mitochondrial integrity via inhibition of the MPTP 
(Halestrap et al., 2004) or counterbalancing of pro-apoptotic Bcl-2 protein activity 
(Brocheriou et al., 2000; Gustafsson et al., 2002) proved cardioprotective in I/R injury.   
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FIG. 1. Comprehensive schema of signaling pathways implicated in apoptosis (PCD type I) 
of cardiac myocytes.  Depending on the stimuli apoptosis may be initiated extrinsically via the 
engagement of cell surface death receptors or intrinsically via the mitochondrial pathway.  The 
receptor-mediated death pathway is initiated by binding of a death ligand (e.g. CD95L/FasL) to its 
cognate receptor (e.g. CD95/Fas) in the plasma membrane.  The cytoplasmic tail of the death 
receptor then engages death adaptor molecules (e.g. FADD), resulting in the recruitment and 
activation of Procaspase 8.  Caspase 8 activates downstream effector caspases such as caspase 
3, resulting in the execution of apoptosis.  Caspase 8 also activates Bid, thereby linking the two 
death pathways.  The mitochondrial death pathway is regulated by the Bcl-2 family of proteins 
(see I.3.3).  Cellular stresses are communicated to the mitochondria by pro-apoptotic Bcl-2 family 
members (e.g. Bid, Bax), leading to the release of pro-apoptotic molecules (e.g. cytochrome c, 
EndoG, AIF, Smac/DIABLO) from the mitochondrial intermembrane space into the cytosol where 
they initiate the apoptotic cascade.  Anti-apoptotic Bcl-2 family members (e.g. Bcl-2 and Bcl-xL) 
oppose these actions.    
 
 
I-3.2 Death signaling at the mitochondria 
Mitochondria form a point of convergence and integration of both survival and death 
signaling pathways.  Mitochondria communicate death signals between mitochondria and 
to other organelles such as the sarco-/endoplasmic reticulum and the nucleus.  The pro-
death capabilities of the mitochondrion are controlled by three main factors: MPTP 
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activity, increased reactive oxygen species (ROS) production, and impaired calcium 
homeostasis. 
I-3.2.1 Mitochondrial permeability transition 
The mitochondrial permeability transition (MPT) is a pathophysiological relevant 
mechanism that leads to increased permeability of the mitochondrial membranes and 
participates in both necrotic and apoptotic cell death (Kim et al., 2003).  The onset of 
MPT is initiated by the opening of the nonspecific large-conductance MPTP, whereby the 
inner mitochondrial membrane is permeabilized to solutes of up to 1.5 kDa, causing the 
collapse of ∆Ψm.  It is generally thought that a minimal MPTP is composed of VDAC 
(voltage dependent anion channel in the outer mitochondrial membrane), ANT (adenine 
nucleotide translocator in the inner mitochondrial membrane) and cyclophilin D (a prolyl 
isomerase located in the matrix) (Crompton, 2000).  Under normal conditions, both 
VDAC and the ANT are involved in the delivery of ATP from the mitochondrial matrix 
to the cytosol.  The function of the prolyl isomerase cyclophilin D in the mitochondrial 
matrix is still subject to investigation.  However, under certain pathophysiological 
conditions (e.g. high mitochondrial matrix calcium levels and/or enhanced oxidative 
stress) these three proteins appear to be altered into forming the MPTP.    
 Interestingly, MPTP activation has been shown to occur upstream of Bax-
mediated cytochrome c release (De Giorgi et al., 2002; Precht et al., 2005).  MPTP 
activation may also amplify any cellular energetic crisis, as mitochondria become ATP 
consumers, via ATP hydrolysis and reverse proton pumping by H+-ATPase (Leyssens et 
al., 1996).  In the heart, the MPTP has been implicated as an important factor mediating 
I/R injury (Weiss et al., 2003). Both cyclosporin A (CsA) and sanglifehrin-A, inhibitors 
of the MPTP, have been shown to prevent cardiac myocyte death caused by I/R in 
perfused hearts (Borutaite et al., 2003; Hausenloy et al., 2003). Recently, in vivo studies 
in cyclophilin D-null mice have confirmed the MPTP, or at least cyclophilin D, as a 
mediator of I/R injury in the heart (Baines et al., 2005).  
I-3.2.2 Mitochondrial ROS generation 
Intimately linked to the mitochondrial role in PCD is their capability to generate ROS.  In 
the cardiac myocyte about 1-3% of the O2 that is normally reduced to H2O is converted to 
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the superoxide anion (O2-˙), the upstream source of most ROS (Boveris et al., 1972).  O2-˙ 
production occurs by the constant slow transfer of electrons onto O2 at Complex I 
(Turrens and Boveris, 1980) and the semiquinone radical of Complex III of the 
mitochondrial electron transport chain (Turrens et al., 1985).   
During I/R injury the return of oxygen to ischemic tissues is accompanied by an 
increased production of ROS.  Studies on whole hearts and isolated cells have shown that 
a burst of ROS generation occurs during the first minutes after hypoxic and ischemic 
tissues are reoxygenated (Zweier et al., 1987), due to the reactivation of mitochondrial 
respiration (Ambrosio et al., 1993).  ROS generation results in tissue lipid and protein 
oxidation (Levraut et al., 2003) (Vanden Hoek et al., 1998).  Antioxidant scavenging of 
ROS blunts or eliminates I/R injury in vivo and in vitro (Vanden Hoek et al., 1997; 
Calvillo et al., 2003; Adlam et al., 2005) and enhanced catalase expression via adenoviral 
gene transfer decreased injury (Zhu et al., 2000), demonstrating that ROS play a 
causative role in myocardial I/R injury.   
I-3.2.3 Mitochondrial calcium handling 
The cardiac myocyte requires an efficient supply and delivery of ATP from the 
mitochondria to perform work and maintain ionic homeostasis.  Calcium (Ca2+), which is 
stored in the sarcoplasmic reticulum (SR, specialized endoplasmic reticulum of muscle 
cells) serves as a second messenger to couple mitochondrial ATP production to demand:  
Ca2+-release during the action potential (ionic exchanges at the plasma membrane which 
mediate the contraction cycle) stimulates both actino-myosin ATPase activity 
(contraction) and mitochondrial oxidative phosphorylation (Duchen, 2000) through 
activation of the tricarboxylic acid cycle (Rizzuto et al., 2000).  During the action 
potential, a small amount of Ca2+ enters the cardiac myocyte through L-type channels in 
the plasma membrane, triggering the large-scale release of sarcoplasmic reticulum Ca2+ 
stores into the cytosol (Bers, 2000).  The ATP-dependent sarco/endoplasmic reticulum 
calcium ATPase (SERCA), is then responsible for pumping Ca2+ from the cytosol back 
into the SR during the relaxation phase (Dremina et al., 2004).   
Decreased ATP production due to mitochondrial dysfunction during I/R results in 
decreased SERCA activity: less Ca2+ is pumped back into the SR, leading to increased 
cytosolic Ca2+ levels. The increased cytosolic Ca2+ levels may activate the Ca2+-
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dependent calpain protease, which can activate the pro-apoptotic Bcl-2 family member 
Bid (Chen et al., 2001).  Furthermore, elevated cytosolic Ca2+ levels have been suggested 
to lead to mitochondrial Ca2+ overload, which in turn would be causative in MPTP 
opening and subsequent activation of apoptosis (Bagchi et al., 1997; Halestrap, 2006).  
However, during simulated I/R in isolated adult cardiac myocytes, mitochondrial Ca2+ 
overload was found to be the consequence, rather than cause, of MPTP activation (Kim et 
al., 2006), underscoring the importance of elucidating the events leading to mitochondrial 
dysfunction.  
I-3.3 Regulation of mitochondrial integrity by Bcl-2 family members 
At the level of the single mitochondrion, both MPTP activity and the release of pro-
apoptotic proteins from the mitochondrial intermembrane space are regulated by two 
opposing classes of the Bcl-2 (B-cell leukemia/lymphoma 2) family of death-regulating 
proteins (Fig. 1).  Members of the Bcl-2 protein family have either anti- or pro-apoptotic 
functions (Reed et al., 1998) (Cory and Adams, 2002).  Cellular stresses leading to the 
execution of cell death pathways are perceived by Bcl-2 family proteins and 
communicated to the mitochondria by regulated targeting of these proteins to the outer 
mitochondrial membrane where they modulate the release of pro-apoptotic molecules 
such as cytochrome c through interaction with other Bcl-2 family proteins.  Bcl-2 family 
proteins exert different activities as a function of their intracellular localization.  Bcl-2 
family members have also been shown to target membranes of the sarco-endoplasmatic 
reticulum (S/ER), and the nuclear envelope where they excert additional/alternate pro- or 
anti-apoptotic functions in part by regulating organelle calcium content and trafficking 
events (Marin et al., 1996; Beham et al., 1997; Breckenridge et al., 2003; Xu et al., 
2005). 
A common characteristic for all Bcl-2 family members is the presence of at least 
one, and up to four, Bcl-2 homology (BH) domains (Fig. 2) which allow for the 
formation of homo- or heterodimers between Bcl-2 proteins (Oltvai et al., 1993; Kelekar 
and Thompson, 1998).  The majority of Bcl-2 proteins furthermore possess a C-terminal 
hydrophobic transmembrane (TM) domain for targeting to intracellular membranes, with 
the exception of some BH3-only proteins.   
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FIG. 2.  Bcl-2 homology domains. Bcl-2 homology domains are a short stretch of sequences 
shared by the anti-apoptotic and pro-apoptotic Bcl-2 family of proteins.  The anti-apoptotic Bcl-2 
family members contain four Bcl-2 homology domains (BH1-BH4; e.g. Bcl-2, Bcl-xL). The pro-
apoptotic Bcl-2 family can be further subdivided into the multidomain subfamily containing three 
Bcl-2 homology domains (BH1-BH3; e.g. Bak, Bax) and the BH3-only subfamily (BH3; e.g. Bid, 
Bnip3).  In addition, most Bcl-2 proteins have a C-terminal hydrophobic transmembrane (TM) 
domain for targeting to intracellular membranes. Exceptions are found in the BH3-only subfamily 
(e.g. Bid). 
 
I-3.3.1 Anti-apoptotic Bcl-2 family members 
The anti-apoptotic members, including Bcl-2 and Bcl-xL, posses four Bcl-2 homology 
domains (BH1-BH4) and potently inhibit apoptosis in various settings through the 
sequestration of pro-apoptotic Bcl-2 family members via heterodimerization (Antonsson, 
2004).  Bcl-2 is always associated with intracellular membranes (i.e. the outer 
mitochondrial membrane, S/ER and nuclear envelope) (Krajewski et al., 1993).  Bcl-xL is 
found in association with intracellular membranes and in addition exists in a soluble form 
in the cytosol which translocates to the mitochondria during apoptosis (Wolter et al., 
1997).  At the mitochondria both Bcl-2 and Bcl-xL have also been shown to stabilize the 
MPTP and block the release of mitochondrial apoptogenic factors following cell death 
stimuli (Susin et al., 1996).  At the S/ER, Bcl-2 and Bcl-xL increase the permeability of 
the S/ER to calcium, minimizing the Ca2+ signaling component of apoptosis (Chami et 
al., 2004).   
Anti-apoptotic Bcl-2 proteins have potent cardioprotective effects.  Both Bcl-2 
and Bcl-xL have been shown to protect against I/R injury in vivo (Brocheriou et al., 2000; 
Imahashi et al., 2004; Huang et al., 2005).  Gene transfer of Bcl-xL reduced cardiac cell 
apoptosis following cold preservation and warm reperfusion of rat cardiac transplants 
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(Huang et al., 2005).  Furthermore, elevated Bcl-2 protein levels were reported to 
coincide with the onset of protection during myocardial stunning (Depre et al., 2004). 
I-3.3.2 Pro-apoptotic Bcl-2 family members 
The pro-apoptotic members either contain three Bcl-2 homology domains (BH1-BH3; 
e.g. Bax and Bak) or a single BH3 domain (‘BH3-only’; e.g. Bid and Bnip3).  Bax and 
Bid reside largely in the cytosol (or loosely bound to the mitochondria) and translocate to 
the mitochondria following a pro-death stimulus (Wolter et al., 1997; Gross et al., 2004).  
Once activated, Bax (Bcl-2 associated X protein) undergoes a conformational change, 
allowing for its C-terminal end to be inserted into the mitochondrial outer membrane 
(Goping et al., 1998; Nechushtan et al., 1999).  Membrane insertion is followed by 
oligomerization, an event thought to precede cytochrome c release  (Shimizu et al., 1999; 
Saito et al., 2000).  It has been proposed that Bax, together with activated Bid, forms 
channels directly via its oligomerization (Lim et al., 2002), regulate the pore size of the 
VDAC to allow cytochrome c translocation (Shimizu et al., 1999) or cause membrane 
instability to open lipidic channels (Degli Esposti, 2002).  
The ‘BH3-only’ family member Bid (Bcl-2 interacting domain) lies within the 
extrinsic death receptor pathway, and upon its activation serves to bridge the intrinsic and 
extrinsic pathways.  Following TNF-α or Fas treatment, Bid is cleaved by caspase 8 
generating the C-terminal product tBid (truncated Bid), which is myristoylated and 
translocates to the mitochondria (Zha et al., 2000).  Bid can also be activated during 
reperfusion by calpain cleavage (Chen et al., 2001). Bid has been proposed to both 
directly participate in the mitochondrial outer membrane permeabilization event  (Yuan 
et al., 2003), as well as amplify the pro-apoptotic signaling of Bax either through direct 
interaction with Bax/Bak (Saito et al., 2000; Wei et al., 2000), or through scavenging of 
anti-apoptotic Bcl-2 and Bcl-xL, which oppose Bax activity (Wang et al., 1996; Cheng et 
al., 2001).  During I/R injury Bid and Bax play crucial roles in the commitment to cell 
death, as demonstrated in both Bid (Peng et al., 2001) and Bax (Hochhauser et al., 2003) 
knockout mice, where infarcts following I/R in the isolated heart were largely reduced.   
 Bnip3 (Bcl-2/adenovirus E1B 19 kDa interacting protein) is another member of 
the ‘BH3-only’ Bcl-2 subfamily which has been described to induce apoptotic (Kubasiak 
et al., 2002), necrotic (Vande Velde et al., 2000), and autophagic (Daido et al., 2004; 
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Kanzawa et al., 2005) cell death.  Bnip3 possesses a C-terminal transmembrane (TM) 
domain which is required for its pro-apoptotic function, including targeting to the 
mitochondria (Chen et al., 1997; Yasuda et al., 1998).  Elevated Bnip3 protein levels 
have been observed in vivo in an animal model of chronic heart failure (Regula et al., 
2002).  Moreover, Bnip3 expression has been reported to be upregulated in neonatal 
myocytes subjected to hypoxia, resulting in mitochondrial dysfunction and subsequent 
cell death (Bruick, 2000; Kubasiak et al., 2002; Regula et al., 2002).  Recently, our lab 
has shown that Bnip3 contributes to I/R injury in the ex vivo heart via disruption of 
mitochondrial integrity, leading to enhanced superoxide production and the release of 
pro-apoptotic factors such as cytochrome c and AIF (Hamacher-Brady et al., 2006).   
 
 
I-4 Autophagy – at the interface between death and survival 
Autophagy (Greek for: ‘self-digestion’), is under normal conditions a process for the 
turnover and recycling of long-lived macromolecules and organelles via the lysosomal 
degradative pathway, involved in maintaining cellular homeostasis, differentiation, and 
tissue remodeling.  Paradoxically, under pathophysiological conditions, autophagy may 
serve a protective role or contribute to cell damage.  For example, nutrient depletion 
classically induces autophagy in order to provide amino acids for the synthesis of 
essential proteins, thus prolonging cell survival (Klionsky and Emr, 2000).  Moreover, 
autophagy may up to a certain threshold counteract apoptosis (PCD type I) (Boya et al., 
2005; Ravikumar et al., 2006).  Other studies, however, have shown that autophagy can 
act as a second type of programmed cell death, termed PCD type II (Yu et al., 2004; 
Canu et al., 2005).  Interestingly, autophagy shares common molecular regulators with 
apoptosis, such as anti-apoptotic members of the Bcl-2 family proteins (Liang et al., 
1998; Shimizu et al., 2004), indicating a possible crosstalk between the two pathways. 
I-4.1 Molecular mechanism of autophagy 
Three main pathways lead to the lysosome via autophagy: macroautophagy, 
microautophagy, and chaperone-mediated autophagy (Klionsky and Emr, 2000; Cuervo, 
2004).  During chaperone-mediated autophagy, proteins are delivered to the lysosome via 
the chaperone Hsc73 (heat shock cognate protein 73) (Cuervo and Dice, 1996).  
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Microautophagy describes the process whereby proteins are locally taken up by the 
lysosome.  Macroautophagy (hereafter referred to as autophagy), the most active form of 
autophagy and a focus of this thesis, is a specific mode of autophagy in which isolation 
membranes envelope a portion of the cytosol, containing non-specific cytosolic 
components, selectively targeted toxic protein aggregates (Ravikumar et al., 2004), 
intracellular pathogens (Gutierrez et al., 2004a), or organelles such as mitochondria (Xue 
et al., 2001; Priault et al., 2005).  The autophagosomes undergo a series of maturation 
steps via fusion with endosomal vesicles and are then delivered to the lysosome, forming 
the autophagolysosome, for subsequent degradation of their contents by lysosomal 
proteases (Fig. 3).   
 
Autophagosome
Lysosome
AutophagolysosomePhagophore
(1) (2) (3)
 
FIG. 3.  Macroautophagy is a three-step process.  (1) Macroautophagy first involves the 
sequestration of a region of the cytosol, containing proteins and/or organelles, which are engulfed 
by a newly formed double-membrane organelle, the autophagosomes.  (2) To accomplish 
degradation of the autophagosomes and its cargo (●), the autophagosomes mature via fusion 
with endosomal vesicles and, subsequently, with the acidic lysosome, generating the 
autophagolysosome.  (3) Within the autophagolysosome lysosomal proteases (▲) degrade the 
inner autophagosomal membrane and cargo.    
 
I-4.1.1 Autophagosome formation  
The autophagic process is initiated by the formation of an isolation membrane (or 
phagophore), possibly derived from the S/ER (Juhasz and Neufeld, 2006), which engulfs 
portions of the cytoplasm to generate a closed, double-membrane structure, the 
autophagosome.  Two ubiquitin-like conjugation systems which are well conserved 
among eukaryotes are required for the formation of the autophagosome. One involves the 
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attachment of Atg12 to Atg5 and the other the conjugation of phosphatidylethanolamine 
to LC3/Atg8 (Fig. 4).   
Atg12 is a modifier protein which is irreversibly conjugated to Atg5, independent 
of autophagy induction (Mizushima et al., 1998a; Mizushima et al., 1998b).  Atg7 (an 
ubiquitin-activating E1-like enzyme) activates Atg12 in an ATP-dependent manner, by 
binding to its C-terminal glycine.  Subsequently, the C-terminal glycine of Atg12 is 
transferred to Atg10 (an ubiquitin-conjugation E2-like enzyme).  Atg10 in turn activates 
the conjugation of Atg12 C-terminal glycine to Atg5 lysine 130.  Atg16 dimerizes and 
forms a complex with a pair of Atg12-Atg5 and this complex evenly associates with the 
crescent shaped phagophore.  Curvature is thought to be introduced via subsequent 
asymmetrical redistribution of the Atg12-Atg5.Atg16 complex mainly to the convex 
surface of the phagophore.  Upon completion of autophagosomes formation, Atg12-
Atg5.Atg16 complexes dissociate from the membrane (George et al., 2000) and are not 
present in the mature autophagosome.  Atg12-Atg5 conjugation is indispensable for the 
involvement of Atg5 in the elongation of the initial phagophore (Mizushima et al., 2001).   
The development of the phagophore into the autophagosome requires the 
cooperation of microtubule-associated protein light chain 3 (LC3/Atg8) (Tanida et al., 
2004).  LC3 is synthesized as a cytosolic full-length precursor protein which is converted 
into LC3-I via cleavage by the cysteine protease Atg4, exposing its C-terminal glycine 
residue (Kirisako et al., 2000). The glycine residue is then activated by Atg7 (E1-like) in 
an ATP-dependent manner, transferred to Atg3 (E2-like), and finally conjugated to the 
phospholipid phosphatidylethanolamine (PE) through an amide bond (Marino, Uria et al. 
2003).  LC3-PE (or LC3-II) is then recruited to the autophagosomal membrane in an 
Atg5-dependent manner (Mizushima et al., 2001; Kabeya et al., 2004), a process that is 
required for the execution of autophagy (Kirisako et al., 2000).  A lysine-130-arginine 
(K130R) mutation of Atg5 prevents binding of Atg12 without interfering with membrane 
targeting of Atg5 (Mizushima et al., 1998b; Pyo et al., 2005).  Importantly, Atg5(K130R) 
is unable to recruit LC3 and results in failed phagophore maturation.  As opposed to 
Atg12-Atg5, LC3-II is present in the early phagophores and matured autophagosomes 
where it ultimately is degraded by lysosomal proteases (Kirisako et al., 1999).  Atg4 can 
deconjugate PE from LC3-II located in the outer autophagosomal membrane, converting 
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it back to cytoplasmic LC3-I (Kabeya et al., 2004), although most LC3-II is degraded by 
the lysosome (Tanida et al., 2005).  The C-terminal end of LC3 is acting as an interface 
for interacting with autophagosomal membranes, while its amino-terminal end is required 
for its binding to tubulin and microtubules (Kouno et al., 2005).  Coupled to GFP, LC3 
serves as a specific and unique fluorescent marker for autophagosomal structures 
(Mizushima et al., 2004).   
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FIG. 4.  Two ubiquitin-like conjugation systems during autophagosome formation.  Atg12 
and LC3/Atg8 are ubiquitin-like proteins which during autophagosome formation are conjugated 
to Atg5 and PE, respectively.  Atg12 is activated and bound by E1-like Atg7, transferred to E2-like 
Atg10, and conjugated to Atg5.  Homodimers of Atg16 bind a pair of Atg12-Atg5 conjugates and 
this complex transiently associates with the forming autophagosomal membrane.  The 
membrane-bound Atg12-Atg5.Atg16 complex is a prerequisite for the recruitment of LC3-II, which 
is the product of the second ubiquitin-like conjugation.  Initially, the cysteine protease Atg4 
removes the C-terminal arginine residue of cytosolic LC3, generating LC3-I with a revealed 
glycine residue.  LC3-I is then activated by E1-like Atg7, transferred to E2-like Atg3, and 
conjugated to PE.  The resulting LC3-II is recruited into the forming autophagosomal membrane. 
After completion of autophagosomes formation, a second cleavage by Atg4 results in some 
removal of PE from LC3-II, reverting it back into LC3-I which is released from the membrane.  
The remaining membrane-attached LC3-II is degraded by lysosomal proteases. 
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I-4.1.2 Autophagosome maturation  
Following the completion of autophagic sequestration, the autophagosome undergoes a 
series of maturation steps prior to its fusion with the lysosome.  During the multi-step 
maturation process, autophagosomes fuse with endosomal vesicles and protease-
containing late endosomal compartments and finally, lysosomes (Gordon et al., 1992 
1992; Dunn, 1994).   
These fusion events are mediated in part by a family of Rab GTPases, known 
mediators of vesicular trafficking, whose functions include vesicle formation, motility, 
and tethering to their target compartment (Zerial and McBride, 2001).  Upon membrane 
fusion, Rab-bound GTP is hydrolyzed to GDP, and inactive Rab-GDP is bound by a Rab 
GDP-dissociation inhibitor (RabGDI), removing Rab to its original membrane 
compartment.  Rab7 is a key component in the regulation of autophagosomal maturation: 
overexpression of a dominant negative mutant of Rab7 has been shown to inhibit fusion 
between autophagosomes and the late endosome/lysosomal compartment (Gutierrez et 
al., 2004b; Jager et al., 2004).  Lysosomal receptor protein Lamp2 is involved in Rab7-
mediated fusion of autophagosomes and lysosomes as RNAi knockdown results in 
retarded recruitment of Rab7 to autophagosomal membranes (Jager et al., 2004), and the 
accumulation of autophagosomes (Eskelinen et al., 2004; Gonzalez-Polo et al., 2005b).  
 Also the cytoskeleton also regulates autophagosome formation as well as 
endosomal and lysosomal trafficking (Aplin et al., 1992).  Pharmacologic inhibition of 
microtubules with nocodazole blocks fusion between autophagosomes and lysosomes, 
evidencing its role in autophagosomal formation and delivery (Kochl et al., 2006).  
Autophagy is furthermore dependent on intermediate filaments (Blankson et al., 1995). 
I-4.1.3 Degradation within the autophagolysosome  
The autophagosome acquires the milieu and enzymes necessary for the degradation of its 
cargo through fusion with the lysosome.  The lysosome is a membrane-bound organelle 
which contains a cocktail of predominantly hydrolytic enzymes that are maximally active 
at low pH (e.g. cathepsins B and D which degrade proteins, lipids, nucleic acids, and 
polysaccharides). Acidification of the lysosomal lumen is accomplished by the vacuolar 
H+-ATPase (v-ATPase), which hydrolyses cytosolic ATP to translocate H+ into the 
lysosomal lumen (Sun-Wada et al., 2003).  Lysosomal transport proteins such as 
                                                                                                                                  INTRODUCTION
          
I
 
 
 20 
cystinosin are thought to mediate the recycling of degraded products (amino acids, 
sugars, and nucleotides) from the lysosome back to the cytosol (Winchester, 2001), 
hereby completing the catabolic process.   
I-4.2 Regulation of autophagy  
Two pathways, which are conserved among eukaryotes, are involved in regulating 
autophagic activity at the level of induction: one involves class I phosphatidylinositol 3-
kinase (PI3-K), which suppresses autophagy, and the other activation of autophagy by 
class III PI3-K (Fig. 5).   
I-4.2.1 Negative regulation of autophagy 
Autophagy is suppressed by the class I PI3-K/Akt pathway (Petiot et al., 2000), which is 
involved in anabolic metabolism (Chang et al., 2004; Hanada et al., 2004).  Within this 
pathway mTOR (mammalian target of rapamycin) is a central downstream effector 
kinase which mediates the cellular response to nutrients, amino acids and mitogens 
(Schmelzle and Hall, 2000).  In the presence of amino acids and growth factors, mTOR 
activates the p70S6 kinase (p70S6K), which phosphorylates the ribosomal protein S6, 
resulting in the upregulation of the translational machinery.  In addition, mTOR 
phosphorylates and thereby deactivates the initiation factor 4E-BP1 (4E binding protein).  
Deactivated 4E-BP1 then dissociates from the initiation factor eIF4E which is the rate-
limiting step in protein synthesis.  Inhibiting mTOR activity with the immunosuppressant 
rapamycin (Blommaart et al., 1995) increases the catabolic process of autophagy, even in 
the presence of nutrients (Noda and Ohsumi, 1998).  The negative control of mTOR over 
autophagy is a generally accepted phenomenon (Shintani and Klionsky, 2004), however, 
the underlying mechanism is largely unknown.   
I-4.2.2 Positive regulation of autophagy 
Beclin1/Atg6, the first mammalian protein described to mediate autophagy (Liang et al., 
1999), is a coiled-coil, myosin-like Bcl-2-interacting protein which engages class III PI3-
K/Vps34 to positively regulate autophagy (Kihara et al., 2001a; Zeng et al., 2006).  
Beclin1 has been shown to colocalize with the S/ER, mitochondria (Liang et al., 2001), 
and Golgi (Kihara et al., 2001a).  Typically all Beclin1 forms a complex with Vps34, 
whereas ~50% of Vps34 is not associated with Beclin1 (Kihara et al., 2001a).  The 
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specific product of Vps34, phosphatidylinositol 3-phosphate (PI3-P), is a lipid second 
messenger which mediates the formation of autophagosomes (Schu et al., 1993; Petiot et 
al., 2000).  Furthermore, the yeast homologues of Beclin1 and Vps34 have been shown to 
mediate intracellular vesicle trafficking, including endosomes and transport of lysosomal 
proteases from the Golgi to the lysosome (Kihara et al., 2001b; Obara et al., 2006).  
However, in mammalian cells the role of Beclin1-Vps34 in trafficking and protein sorting 
remains controversial (Kihara et al., 2001a; Row et al., 2001; Obara et al., 2006). 
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FIG. 5.  Molecular mechanism and regulation of autophagy. (1) Induction of autophagy 
requires activity of Beclin1 and its interacting partner, class III PI3-K (Vps34), resulting in the 
generation of PI3-P; and it is negatively regulated by class I PI3-K through mTOR.  (2) Formation 
of the phagophore requires conjugation of Atg12 to lysine 130 of Atg5 as a prerequisite for 
recruiting LC3-II. (3) Sequestration of cytoplasmic material may be nonspecific or selective; 
mechanisms that may govern selectivity are incompletely understood. (4) Degradation of the 
autophagosomes and its cargo is accomplished after sequential fusion events with endosomes 
and finally lysosomes.  Transport and fusion events are mediated by Rab GTPases, with Rab7 
being a major player in autophagy.  Beclin1-Vps34 activity might further be involved in lysosomal 
protein sorting (not shown).   
 
I-4.3 Cross-talk of autophagy and apoptosis: Bcl-2 family members 
Interest in autophagy is at present increasing, due in part to the recognition of its 
involvement in caspase-independent PCD (PCD type II) and its interaction with 
components of the apoptotic death pathway (PCD type I) (Saeki et al., 2000; Yanagisawa 
et al., 2003; Shimizu et al., 2004).   
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I-4.3.1 Anti-apoptotic Bcl-2 family members 
Beclin1 was initially identified as a Bcl-2 interacting protein using a yeast two-hybrid 
screen (Liang et al., 1998).  Following, it was established that the Bcl-2 binding domain 
of Beclin1 serves as a point of crosstalk between the autophagic and apoptotic pathways, 
at the level of autophagy induction.  Interestingly, it seems that only anti- but not pro-
apoptotic Bcl-2 family members can interact with this domain (Liang et al., 1998).  Bcl-2 
downregulation has been shown to increase autophagy in HL60 cells (Saeki et al., 2000), 
while overexpression of Bcl-2 or Bcl-xL increased the autophagic response to etoposide 
treatment in MEF cells (Shimizu et al., 2004). Recently, Bcl-2 was shown to suppress the 
autophagic response to starvation (Pattingre et al., 2005). Clearly, the nature of the 
relationship is not yet fully understood and merits further investigation.  It is likely that 
the regulation of autophagy through Bcl-2 is a function of both cell type and stimulus.  
I-4.3.2 Pro-apoptotic Bcl-2 family members 
The BH3-only proteins Bid and Bnip3 also constitute a point of crosstalk between the 
apoptotic and autophagic pathways.  Bid can be activated by lysosomal cathepsin 
proteases which are released into the cytosol during some forms of PCD (Stoka et al., 
2001; Cirman et al., 2004).  Moreover, Bid itself has recently been shown to cause 
destabilization of lysosomes and release of cathepsin B (Werneburg et al., 2004; 
Guicciardi et al., 2005), forming an amplification event for mitochondrial apoptosis.  In 
MCF-7 cells exposed to camptothecin, RNAi silencing of Bid inhibited apoptosis and 
enhanced autophagy, suggesting that Bid may function as a ‘switch’ between the 
different modes of PCD (Lamparska-Przybysz et al., 2005).   
Upregulation of Bnip3 has been shown to correlate with ceramide-induced 
accumulation of autophagosomes in malignant glioma cells (Daido et al., 2004).  
Similarly, arsenic trioxide-induced PCD correlated with elevated levels of Bnip3 and 
enhanced presence of autophagosomal structures (Daido et al., ; Kanzawa et al., 2005).  
Furthermore, in these studies expression of the dominant-negative transmembrane 
domain deletion mutant of Bnip3 prevented the observed changes in autophagy, while 
overexpression of Bnip3 was sufficient to induce increased steady-state levels of 
autophagosomes in the absence of ceramide or arsenic trioxide.  The authors concluded 
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that ceramide- and arsenic trioxide-induced Bnip3-mediated PCD is autophagic, however 
a causative role of autophagy in cell death was not established.   
I-4.4 Autophagy in the heart 
Autophagy is a vital process in the heart, presumably participating in the removal of 
dysfunctional cytosolic components, and serving as a catabolic energy source during 
times of starvation.  For example, autophagy in cardiac myocytes has been suggested to 
provide a necessary source of energy between birth and suckling (Kuma et al., 2004), and 
in a GFP-LC3 transgenic mouse, cardiac myocytes from starved animals displayed high 
numbers of autophagosomes, some of which contained mitochondria (Mizushima et al., 
2004).   
Impaired autophagy may play a causative role in cardiac disease.  Incomplete 
autophagic turnover of ‘old’ mitochondria may be the source of lipofuscin, a toxic waste 
product which builds up during the lifespan (Brunk and Terman, 2002).  Danon disease, 
is caused by decreased levels of Lamp2 (Saftig et al., 2001; Horvath et al., 2003), a 
lysosomal receptor which mediates the fusion process between autophagosomes and 
lysosomes (Gonzalez-Polo et al., 2005a).  Recently it was shown that Danon disease-
related cardiomyopathy develops as a result of extensive vacuolization in cardiac 
myocytes and interference with the contractile function (Stypmann et al., 2006).  
Furthermore, disruption of the autophagic pathway may contribute to myocardial cell 
death under conditions where lysosomal integrity is lost and lysosomal proteases are 
released into the cytosol (Decker et al., 1980).   
Importantly, autophagy may serve as a protective response to myocardial I/R 
injury, as increased prevalence of autophagosomes has been documented in response to 
sub-lethal ischemia in the perfused heart (Decker et al., 1980).  Moreover, it was recently 
reported that in an in vivo model of myocardial stunning the onset of protection correlated 
with increased Beclin1 expression (Yan et al., 2005).  Controversially, other correlative 
studies indicate that autophagic cell death (PCD type II) occurs in the failing heart.  
Autophagosomes are widely reported to be increased in heart disease (Knaapen et al., 
2001; Shimomura et al., 2001; Saijo et al., 2004; Miyata et al., 2006), and in response to 
myocardial hibernation (Elsasser et al., 2004) and Diphtheria toxin-activated myocardial 
cell death (Akazawa et al., 2004).   
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I-5 Thesis objectives 
Enhancing survival of cardiac tissues following I/R is a crucial goal in cardiovascular 
research.  One characteristic of myocardial I/R injury is the prevalence of 
autophagosomes.  However, the role of autophagy in this pathophysiology is unclear.    
Two hypotheses are proposed here: 
(1) Autophagy functions as a cytoprotective mechanism to oppose I/R injury.   
(2) The protection exerted by autophagy is in part due to the degradation of  
     malfunctioning mitochondria.  
Thus, overall goal of this body of work was to quantify the relationship between 
I/R-activated mitochondrial death pathways and autophagy.  To do so we sought to 
systematically perturb the apoptotic and autophagic signaling pathways, in order to 
determine and quantify cause and effect.  High-resolution fluorescence imaging was 
employed as the main tool as it allows spatial and temporal detection of events in the 
single live cell.   
I-5.1 Cell culture model of I/R injury to the heart 
A cell-based model of I/R is a prerequisite for studies aimed at elucidating signaling 
pathways in myocardial I/R injury.  However, for our purposes to date no satisfactory 
model existed that combined high comparability to the in vivo situation with the high 
capacity for manipulation of cell culture models.  Thus, the goal of Chapter III was to 
develop a unique model for studying the multiple pathways during I/R injury.  Using the 
recently established cardiac cell line HL-1, which is novel in its high degree of molecular 
and physiological similarity to the adult cardiac myocyte, the spatio-temporal dynamics 
of mitochondrial dysfunction, and the activities pro-apoptotic Bcl-2 family members Bax 
and Bid were studied to establish quantifiable parameters of pro-death signaling leading 
to mitochondrial dysfunction in I/R.   
I-5.2 Elucidation of the regulation of Beclin1-mediated autophagy 
To date the nature of control of anti-apoptotic Bcl-2 family members over Beclin1-
mediated autophagy is unclear.  In part this is due to incorrect use of tools available for 
detecting the autophagic response.  The goal of Chapter IV was to develop a method for 
the specific and quantitative assessment of macroautophagic activity, and subsequently to 
                                                                                                  
INTRODUCTION
          
I
 
 
25 
determine how Beclin1-mediated autophagy is regulated by Bcl-2 in the HL-1 cardiac 
myocyte.   
I-5.3 Role of Beclin1-mediated autophagy in myocardial I/R injury 
To date studies on the role of autophagy in the heart are correlative and it remains to be 
determined if, and under which conditions, autophagy represents a protective or 
detrimental cellular mechanism.  Using the our established  model of I/R injury in HL-1 
cells together with the techniques developed for investigating autophagy, the goal of 
Chapter V was to elucidate the role of Beclin1-mediated autophagy in cardiac I/R injury.  
The goal of Chapter IV through pharmacologic and molecular approaches while 
monitoring the effect on cellular injury.  
I-5.4 Connection between mitochondrial dysfunction and autophagy 
Bnip3 is a pro-apoptotic Bcl-2 protein which contributes to myocardial I/R injury by 
causing mitochondrial dysfunction.  On the premise that mitochondrial dysfunction plays 
a key role in I/R injury and autophagy is capable of scavenging damaged mitochondria, 
we hypothesized that during I/R, Bnip3 promotes autophagy of malfunctioning 
mitochondria.  The goal of Chapter VI was to investigate the connection between I/R 
injury, Bnip3-induced mitochondrial dysfunction, and mitochondrial autophagy in the 
HL-1 cardiac myocyte.   
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II-1 Materials 
Reagents for the production of solutions, buffers, and media were purchased from Sigma-
Aldrich (St. Louis, MO, USA).  Materials for HL-1 cell culture were obtained from JRH 
Biosciences (Lenexa, KS, USA), BD Biosciences (San Jose, CA, USA), and Sigma-
Aldrich.   Pharmacologicals were purchased from EMD Biosciences (La Jolla, CA, 
USA).  Fluorescent dyes were obtained from Invitrogen (Carlsbad, CA, USA).  
Antibodies were obtained from Abcam (Cambridge, MA, USA), BD Biosciences - 
Clontech (Mountain View, CA, USA), Caltag (Burlingame, CA, USA), R&D Systems 
(Minneapolis, MN, USA), Santa Cruz (Santa Cruz, CA, USA), and Sigma-Aldrich.  
Materials for Western blotting were purchased from Bio-Rad (Hercules, CA, USA) and 
Pierce (Rockford, IL, USA).  Kits and enzymes for DNA techniques and transfection 
reagents were purchased from Qiagen (Valencia, CA, USA), New England Biolabs 
(Ipswich, MA, USA), Stratagene (La Jolla, CA, USA), and Invitrogen.  Consumables 
were bought via Fisher Scientific (Tustin, CA, USA) from the following suppliers: 
Corning (Corning, NY, USA), and BD Biosciences.  Pipet-tips were from Myriad (San 
Diego, CA, USA).  Glass-bottom microwell dishes were obtained from MatTek 
(Ashland, MA, USA). 
 
II-1.1 Antibodies 
II-1.1.1 Primary antibodies 
 
Antibody against Description Source 
Actin clone AC-40;   mouse monoclonal Sigma-Aldrich 
Atg5 3H2201;  chicken polyclonal Abcam 
Bcl-2 C-2;   mouse monoclonal Santa Cruz  
Bcl-xL H-5;   mouse monoclonal Santa Cruz  
Beclin1 D-18; goat polyclonal Santa Cruz  
Bid rat monoclonal R&D Systems 
Bnip3 mouse monoclonal Sigma-Aldrich 
Drp1 (= Dlp1) mouse monoclonal BD Biosciences 
Fluorescent Protein mouse monoclonal BD Biosciences 
RhoGDI mouse monoclonal BD Biosciences 
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II-1.1.2 Horseradish peroxidase-conjugated secondary antibodies 
 
Description Source 
Goat anti-mouse IgG (H+L) Caltag  
Goat anti-rabbit IgG (H+L) Caltag  
Swine anti-goat IgG (H+L) Caltag  
Goat anti-rat IgG (H+L) Caltag  
Rabbit anti-chicken IgY (H+L) Abcam 
 
II-2 Methods 
II-2.1 Cloning and plasmid construction 
The DNA sequences of interest were amplified from the indicated template via PCR 
(polymerase chain reaction) (Mullis et al., 1986) using primers (listed in the appendix: X-
2) containing restriction sites according to the MCS (multiple cloning site) of the vector 
(Scharf et al., 1986).  Primer design was done using the nucleic acid analysis and 
modeling tools of the web-based SDSC Biology Workbench 
(http://workbench.sdsc.edu/).  All primers where synthesized by Allele Biotech (San 
Diego, CA, USA). 
 
Standard PCR reaction mix1: 
5 ng Template 
0.5 µM each Oligonucleotides (‘primer’) 
250 µM Desoxynucleotides (dNTPs) 
1X Pfu DNA Polymerase Reaction Buffer 
1 µl PfuTurbo DNA Polymerase (Stratagene) 
1
 final volume: 40 µl per reaction, adjusted with MilliQ-H2O. 
 
Standard PCR program: 
Cycle Reaction Temperature Duration Loops 
1 (Lid heat) 110°C   
2 Denaturing 95°C 1:00 min 1 x 
3 Denaturing 95°C 1:00 min  
 Annealing 54°C 0:30 min 30 x (Cycle 3) 
 Synthesis 72°C 1:00 min  
4 “Fill-in” 72°C 10:00 min 1 x 
5 Reaction stop 4°C forever  
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Subcloning of PCR products into mammalian expression vectors was performed using 
standard methods of molecular biology (CPMB).  PCR products were purified by size-
separation on 1% (w/v) agarose gels and subsequent QIAEX II gel extraction (Qiagen).  
Following, both vector and PCR-products were digested with the appropriate restriction 
enzymes.  After gel purification, vector and PCR-products were ligated using T4 DNA 
ligase (Invitrogen).  The obtained plasmids were transformed into bacteria of the 
Escherichia coli strain DH5α (Invitrogen) for amplification.  Transformed bacteria were 
selected with the help of vector-encoded antibiotic resistance.  Plasmid DNA was 
purified from DH5α over-night cultures using the QIAprep Miniprep kit (Qiagen) and 
sequence verified (TSRI DNA core lab).  Vector maps were generated using pDraw32 
DNA analysis freeware (AcaClone software, http://www.acaclone.com/) and gathered in 
the appendix (X-6). 
II-2.1.1 pmCherry-C1 
mCherry was amplified from the pRSET-mCherry vector (Shaner et al., 2004), with the 
forward (5’-GTAACCGGTATGGTGAGCAAGGGCGAG-3’) and reverse (5’-
GTAAGATCTCTTG TACAGCTCGTCCATGC-3’) primers.  AgeI and BglII restriction 
sites (underlined) were added to 5’ and 3’ cDNA ends, respectively.  mCherry was 
swapped with EGFP of the vector pEGFP-C1, generating the pmCherry-C1 vector. 
II-2.1.2 mCherry-Bax  
Human Baxα was amplified from pEGFP-Bax (Wolter et al., 1997), with the forward (5’-
GTAAGATCTATGGACGGGTCCGGGGAG-3’) and reverse (5’- 
GTAGAATTCTCAGCCCACT TCTTCCAGATGGTG-3’) primers BglII and EcoRI 
restriction sites (underlined) were added to 5’ and 3’ cDNA ends, respectively.  Human 
Baxα was inserted into pmCherry-C1 at the BglII and EcoRI restriction sites. 
II-2.1.3 Mito-ECFP 
ECFP was excised from pECFP-N1 at restriction sites BamHI and NotI.  DsRed2 was 
removed from the mito-pDsRed2 vector (Clonetech) at restriction sites BamHI and NotI, 
and replaced with ECFP to generate the mito-ECFP vector. 
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II-2.1.4 YFP-Bid-CFP 
YFP-Bid-CFP was generated using the improved versions of YFP, Venus (Nagai et al., 
2002), and CFP, Cerulean (Rizzo et al., 2004). Human full-length Bid, Venus, and 
Cerulean were amplified by PCR using end primers containing the required restriction 
sites to generate (KpnI)YFP-(XhoI)-Bid-(SphI)-CFP(NotI). The obtained ligation product 
was subcloned into pcDNA3.1(+) using the KpnI and NotI sites.    
II-2.1.5 mCherry-Atg5  
Atg5 cDNA was amplified from mouse cDNA library (Invitrogen) with the forward (5’- 
GTACTCGAGGGATGACAGATGACAAAGATGTG-3’) and reverse (5’- 
GTAGGATCCATCTGTTGGCTGGGGGAC-3’) primers.  Primers were designed to 
remove the stop codon and add XhoI and BamHI restriction sites (underlined) to 5’ and 3’ 
ends, respectively. Atg5 was then ligated into pmCherry-C1 vector at the XhoI and 
BamHI restriction sites.   
II-2.2 Site-directed mutagenesis 
Site-directed mutagenesis was employed to investigate the role of specific proteins in 
autophagy and apoptosis.  The desired mutations were inserted into wild-type cDNA by 
PCR, using two complementary oligonucleotides containing the altered codon (Higuchi 
et al., 1988; Weiner et al., 1995).  Template cDNA encoding the gene of interest was 
amplified by PCR using the restriction site-containing primers used for the amplification 
and cloning of wild-type constructs (II-2.1).  To insert the mutation, two PCR reactions 
were performed, amplifying the 5’template end with the 5’Forward primer and 3’Reverse 
mutant primer, and amplifying the 3’template end with the 5’Forward mutant primer and 
3’Reverse primer.  The PCR products were separated on 1% (w/v) agarose gels and 
extracted using the QiaQuick Gel Extraction Kit (Qiagen).  Another PCR was performed 
on the purified 5’ and 3’ ends.  During PCR, the overlapping segments corresponding to 
the mutant primer sequences, anneal and the DNA polymerase extends the 3’ ends to 
generate full length cDNA.  The reaction was then spiked with template 5’Forward and 
3’Reverse primers to amplify the cDNA containing the desired mutation.   
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II-2.2.1 mCherry-BaxT182A 
The threonine 182 to alanine (T182A) point mutation within human Baxα was generated 
using site directed mutagenesis. The T182A mutation was inserted using the forward 
primer 5'-GGGAGTGCTCGCCGCCTCACTCACCATCTGG-3' and its complementary 
reverse primer 5'- CCAGATGGTGAGTGAGGCGGCGAGCACTCCC-3'.  The construct 
was inserted into the pmCherry-C1 vector.   
II-2.2.2 YFP-Bid∆casp8-CFP 
To generate YFP-Bid∆casp8-CFP, wild-type Bid in YFP-Bid-CFP was exchanged 
against Bid∆casp8 which had previously been obtained via site directed mutagenesis of 
the caspase 8 cleavage site generating a aspartic acid 60 to glutamic acid (D60E) point 
mutation using the forward primer 5’-GAGCTGCAGACTGAGGGCAACCGCAGC 
AGC-3’ and the complementary reverse primer 5’-GCTGCTGCGGTTGCCCTCAGTCT 
GCAGCTC-3’. 
II-2.2.3 mCherry- Atg5K130R 
The lysine 130 to arginine (K130R) point mutation within mour Atg5 was inserted using 
site directed mutagenesis as previously described (Mizushima et al., 2001), using the 
forward primer 5’-GTCGTGTATGAGAGAAGCTGATG-3’ and the complementary 
reverse primer 5’- CATCAGCTTCTCTCATACACGAC-3’.  Atg5K130R was then ligated 
into pmCherry-C1 vector at the XhoI and BamHI restriction sites.   
II-2.3 RNA interference  
Silencing of Bnip3 and Beclin1 was achieved using the vector-based RNAi system 
BLOCK-iT™ Pol II miR RNAi Expression Vector Kit (Invitrogen).  The vector 
pcDNA™6.2-GW/EmGFP-miR embeds a small hairpin RNA within a microRNA fold, 
which is then processed by the endogenous RNAi machinery (Amarzguioui et al., 2005).  
Sequences with 100% homology to regions within the ORF (open reading frame) of the 
gene of interest were generated using the BLOCK-iT™ RNAi Designer 
(https://rnaidesigner.invitrogen.com/rnaiexpress).  The obtained target sequences were 
checked for the absence of significant homology to other proteins within the respective 
species using BLAST analysis (Altschul et al., 1990). The sequence was used to generate 
homologous oligonucleotide pairs (Allele Biotech; San Diego, CA, USA), which were 
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inserted into the pcDNA™6.2-GW/EmGFP-miR, which has co-cistronic expression of 
EmGFP, allowing for determination of transfection efficiency by fluorescence 
microscopy.  The obtained vectors were sequence verified.  To control for non-specific 
RNAi effects, the construct pcDNA™6.2-GW/EmGFP-miR-LacZ (targeting beta 
galactosidase) was used as control.   
II-2.3.1 Bnip3 
The obtained target sequence for the ORF of mouse Bnip3 was 5’-
TCCAGCCTCCGTCTCTATTTA-3’ (78-98) and showed no significant homology to 
other mouse proteins.  The generated oligonucleotide pairs were used to generate 
pcDNA™6.2- GW/EmGFP- miR-Bnip3(78).  For silencing of Bnip3, HL-1 cells were 
transfected using Lipofectamine 2000.  Cell lysates were prepared 48 h after transfection 
and Bnip3 protein levels were assessed via Western blotting (II-2.14).  
II-2.3.2 Beclin1 
The obtained target sequences for the ORF of mouse Beclin1, 5’-
TGAAACTTCAGACCCATCTTA-3’ (a) and 5’-TAATGGAGCTGTGAGTTCCTG-3’ 
(b), showed no significant homology to other mouse proteins and were used to generate 
pcDNA™6.2-GW/EmGFP-miR-Beclin1(a) and –Beclin1(b).  Cells were co-transfected 
with both vectors using Lipofectamine 2000 to achieve maximal knock-down of Beclin1.  
96 h after transfection, Beclin1 protein levels were assessed via Western blotting.   
II-2.4 Cell culture 
Cells of the atrial-derived cardiac cell line HL-1 (Claycomb et al., 1998) were plated in 
gelatin/fibronectin-coated culture vessels and maintained in Claycomb medium (JRH 
Biosciences) supplemented with 10% fetal bovine serum, 0.1 mM norepinephrine, 2 mM 
L-glutamine, 100 U/ml penicillin, 100 U/ml streptomycin, and 0.25 µg/ml amphotericin 
B.  Cells were passaged at 1:3 every two days and cells of the passages 70 to 80 were 
used for experiments.  For fluorescence microscopy, cells were plated on 25-mm-
diameter round glass coverslips (Fisher Scientific) or in the center of 14-mm-diameter 
glass bottom microwell dishes (MatTek).  For Western blotting, cells were plated in 6-
well-plates or 60-mm diameter dishes.   
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II-2.5 Transfections 
Cells, which had been plated the day before, were transfected with the indicated vectors 
using the transfection reagents Effectene (Qiagen) or LipofectamineTM 2000 (Invitrogen).  
The manufacturer’s protocols for adherent cells were optimized for HL-1 cells achieving 
on average ~40% and ~60% transfection efficiency, respectively, without detectable 
toxicity.   
II-2.5.1 Effectene transfection protocol     
 MatTek format 6-well format 60-mm format 
# of cells plated  35 000 150 000 300 000 
DNA 0.3 µg 0.9 µg 1.5 µg 
EC buffer 65 µl  195 µl 300 µl 
Enhancer 3.75 µl  10 µl 20 µl 
Effectene 2.5 µl 7.5 µl 13 µl 
Medium (per mix) 390 µl 600 µl 1.2 ml 
Medium (per dish) 1.0 ml 1.6 ml 3 ml 
 
The DNA was diluted in EC buffer and incubated for 5 min following addition of 
Enhancer.  Then, the non-liposomal lipid reagent Effectene was added and the mixture 
was incubated for an additional 10 min.  Fully supplemented (containing serum and 
antibiotics) Claycomb medium was added and the transfection complexes were 
immediately added to cells cultured in fully supplemented Claycomb medium.  Medium 
was exchanged after 16-24 h.  
II-2.5.2 Lipofectamine transfection protocol 
 MatTek format 6-well format 60-mm format 
# of cells plated 80 000 600 000 120 000 
DNA 2.4 µg 4 µg 8 µg 
   + OPTI-MEM 150 µl 250 µl 0.5 ml 
LipofectamineTM 2000 3 µl 5 µl 10 µl 
   + OPTI-MEM 150 µl 250 µl 0.5 ml 
Medium (per dish) 1.2 ml 2 ml 5 ml 
 
The DNA was diluted in serum-free OPTI-MEM (Invitrogen).  The cationic lipid reagent 
Lipofectamine 2000 was likewise diluted in serum-free OPTI-MEM and incubated for 5 
min at room temperature.  Following, DNA and Lipofectamine dilutions were combined 
and incubated for 20 min at room temperature.  Lipofectamine-DNA complexes were 
                                                                                                                MATERIALS & METHODS
          
II
 
 
 36 
added to cells cultured in antibiotic-free serum-containing Claycomb medium.  The 
medium was replaced after 5-8 h with fully supplemented Claycomb medium. 
II-2.6 High and low nutrient condition  
For high nutrient conditions, experiments were performed in fully supplemented 
Claycomb medium.  For low nutrient conditions, experiments were performed in Krebs-
Henseleit solution (KH, in mM: 110 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.25 MgSO4, 1.2 
CaCl2, 25 NaHCO3, 15 glucose, 20 HEPES, pH 7.4). 
II-2.7 Simulated ischemia/reperfusion (sI/R)   
For real-time fluorescence imaging, cells were plated on 25-mm-diameter round glass 
coverslips.  The coverslips were placed in an air-tight Leiden perfusion chamber 
(Harvard Apparatus; Holliston, MA, USA), mounted on the stage of a fluorescence 
microscope and subjected to 1-2 h of simulated ischemia by superfusion with ischemia-
mimetic solution (in mM: 125 NaCl, 8 KCl, 1.2 KH2PO4, 1.25 MgSO4, 1.2 CaCl2, 6.25 
NaHCO3, 5 Na-lactate, 20 HEPES, pH 6.6) equilibrated with 95% N2-5% CO2, followed 
by reperfusion with normoxic KH solution equilibrated with 95% O2-5% CO2.  
Alternatively, cells were plated in MatTek dishes and ischemia was introduced by 
a buffer exchange to ischemia-mimetic solution and placing of the dishes in hypoxic 
pouches (GasPakTM EZ, BD Biosciences). After 2 h of ischemia, reperfusion was 
initiated by a buffer exchange to normoxic KH solution and incubation at 95% room air-
5% CO2.  Controls incubated in normoxic KH solution were run in parallel for each 
condition. Under control conditions in KH solution cell viability was not compromised. 
II-2.8 Fluorescence microscopy 
II-2.8.1 Widefield fluorescence microscopy 
Cells were observed through a Nikon TE300 fluorescence microscope (Nikon; Tokyo, 
Japan) equipped with a 10x lens (0.3 N.A., Nikon), a 40x Plan Fluor and a 60x Plan Apo 
objective (1.4 N.A. and 1.3 N.A. oil immersion lenses; Nikon), a Z-motor (ProScanII, 
Prior Scientific; Rockland, MA, USA), a cooled CCD camera (Orca-ER, Hamamatsu; 
Hamamatsu, Japan) and automated excitation and emission filter wheels controlled by a 
LAMBDA 10-2 (Sutter Instrument; Novato, CA, USA) operated by MetaMorph 6.2r4 
(Universal Imaging; Buckinghamshire, UK).  UV, green, and red fluorescence was 
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excited through an excitation filter for DAPI (D350/50x), FITC (HQ480/40x), and Texas 
Red (D560/40x), respectively.  Fluorescent light was collected via a polychroic 
beamsplitter (61002bs) and emission filters for DAPI (D460/50m), FITC (HQ535/50m), 
and Texas Red (D630/60m).  DAPI, FITC, and Texas Red filters were from Chroma 
(Rockingham, VT, USA).  In addition, CFP fluorescence was excited through the 
excitation filter XF1071, collected via the dichroic beamsplitter XF2034 and the emission 
filter XF3075.  YFP fluorescence was excited through the excitation filter XF1068, 
collected via the dichroic beamsplitter XF2034 and the emission filter XF3074.  CFP and 
YFP filters were from Omega Optical (Brattleboro, VT, USA).   
II-2.8.2 Laser Scanning Confocal Microscopy (LSCM) 
LSCM was performed with a Bio-Rad Radiance 2100 laser scanning confocal 
microscope (Hercules, CA, USA) using a 60X Plan Apo objective (1.4 N.A oil 
immersion lens; Nikon), equipped with both a mixed gas Helium-Neon (543 nm) laser 
and an Argon (488 nm) laser, and operated through Bio-Rad LaserSharp 2000 software.  
Green and red fluorescence were directed to separate photomultipliers by a 560-nm long-
pass dichroic reflector through HQ530SP and HQ590/70 emission filters, respectively.  
The confocal pinholes were configured so as to obtain images of 0.7 µm in the axial 
dimension and step increments were 0.3 µm. 
II-2.9 Detection of ROS and ∆Ψm  
Intracellular ROS levels were assessed using chloromethyl-dichlorodihydrofluorescein 
diacetate (CM-DCFH2-DA), which is predominantly retained inside mitochondria due to 
covalent binding of the probe’s chloromethyl moiety to the abundant sulfhydryl groups in 
the mitochondrial matrix (Presley et al., 2003). ∆Ψm was assessed using 
tetramethylrhodamine methyl ester (TMRM) or Rhodamine123 (Rhod123), which 
electrophoretically accumulate in the matrix of actively respiring mitochondria and are 
released once ∆Ψm is impaired (Bernardi et al., 2001). For dye-loading, CM-DCFH2-DA 
(10 µM) was added to the cells prior to sI/R in KH buffer and allowed to load for 30 min 
at room temperature to ensure mitochondrial loading of CM-DCFH2-DA. TMRM (5 nM) 
was included in the ischemia-mimetic solution or, in normoxic control cells, the KH 
solution paralleling the experimental duration of 2 h ischemia simulation.  Cells 
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expressing either mCherry-Bax or mCherry-BaxT182A
 
were incubated 30 min with 50 nM 
Rhod123 at 37°C in HL-1 medium prior to imaging in dye-free KH solution. 
II-2.10 Assessment of mitochondrial morphology   
To visualize mitochondria independently of ∆Ψm, cells were transfected with a plasmid 
encoding mito-DsRed2 (Clontech) or mito-ECFP (II-2.3.3), in which the fluorescent 
proteins DsRed2 or ECFP are fused to the COX IV targeting sequence, thus targeting 
them to the mitochondrial inner membrane (Rizzuto, Brini et al. 1995).  
II-2.11 Quantification of cellular injury   
II-2.11.1 Redistribution of (mCherry-)GFP-Bax 
GFP-Bax (Wolter, Hsu et al. 1997) or mCherry-Bax (II-2.3.2) redistribution was used as 
a parameter to quantify irreversible cellular injury.  Cells were transfected with 
(mCherry-)GFP-Bax and allowed to express for 48 hours. Then, cells were subjected to 2 
h ischemia in hypoxic pouches followed by 5 h reperfusion and live cells were analyzed 
by fluorescence microscopy. Cells were classified as cells with (i) diffuse or (ii) punctate 
mitochondrial (mCherry-)GFP-Bax fluorescence.  Per condition, a total of approximately 
250-500 transfected cells were scored at 60x magnification in three independent 
experiments. 
II-2.11.2 Plasma membrane integrity 
To determine Bnip3-induced cell death, HL-1 cells were co-transfected with (a) pDsRed2 
and pcDNA3.1 or Bnip3, in combination with Beclin1 or Beclin1∆Bcl2BD, or (b) 
mCherry and pcDNA3.1 or Bnip3, in combination with mCherry-Atg5 or mCherry-
Atg5K130R, as indicated.  48 h after transfection, cells were stained with 0.1 µM of the 
DNA intercalating dye YoPro1 which enters both apoptotic and necrotic cells, but is 
excluded from healthy cells (Idziorek et al., 1995).  To quantify cell death, cells were 
inspected at 20x magnification and pDsRed2- or mCherry-positive cells were evaluated 
for YoPro1 staining.  Per condition, two replicate dishes were scored in three independent 
experiments.   
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II-2.12 Quantification of cellular autophagosome content  
Cellular contents of autophagosomal structures were quantified via fluorescence imaging 
of GFP-LC3 (Mizushima et al., 2004).  HL-1 cells were transfected with GFP-LC3 and 
48 h after transfection, cells were subjected to sI/R as indicated.  Cells were fixed with 
4% formaldehyde (Ted Pella; Irvine, CA, USA) in phosphate-buffered saline (PBS, pH 
7.4) for 15 min.  To quantify the autophagic response among a population of cells, cells 
were inspected at 60x magnification and classified as (i) cells with predominantly diffuse 
GFP-LC3 fluorescence or as (ii) cells with numerous punctate GFP-LC3 structures, 
representing autophagic vacuoles, AVs.  A minimum of 150 cells was scored in at least 
three independent experiments.  For quantification of the autophagic response of single 
cells, Z-stacks of GFP-LC3 fluorescence of 7-10 representative cells per condition in 
three separate experiments were acquired through the 60x oil immersion lens with 0.3 µm 
increments through the entire volume of the cell.  Z-stacks were thresholded and total 
number and volume of the autophagosome per cell was determined (AutoQuant).  
II-2.13 Determination of LC3-II degradation  
To analyze autophagic flux, GFP-LC3 expressing cells were subjected to the indicated 
experimental conditions with and without a cocktail of the cell-permeable lysosomal 
inhibitors bafilomycin A1 (100 nM, vacuolar H+-ATPase inhibitor) to inhibit lysosomal 
acidification (required for protease activity (Yoshimori et al., 1991)) and autophagosome-
lysosome fusion (Yamamoto et al.), and E64D (5 µg/mL, inhibitor of cysteine proteases, 
including cathepsin B), and pepstatin A methyl ester (5 µg/mL, cathepsin D inhibitor) to 
inhibit lysosomal protease activity.  Fluorescence microscopy of GFP-LC3 was used to 
determine cellular autophagosomal content as described above.   
II-2.14 Activity of the lysosomal compartment  
LysoTracker Red (LTR) is a cell-permeable acidotropic probe that selectively labels 
vacuoles with low internal pH and thus can be used to label functional lysosomes (Bucci, 
Thomsen et al.). Following sI/R and control experiments, cells were loaded with 50 nM 
LTR for 5 min in KH solution, the medium was then exchanged with dye-free KH 
solution, and cells were analyzed by fluorescence microscopy.  Activity and intracellular 
distribution of cathepsin B, a predominant lysosomal protease, was assessed using (z-
RR)2-MagicRed-Cathepsin B substrate (B-Bridge; Sunnyvale, CA, USA).  MagicRed 
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cathepsin B substrate (10 nM) was added to the cells during the last 30 min of an 
experiment.  Cells were rinsed once with PBS prior to analysis by fluorescence 
microscopy.   
II-2.15 Ca2+ imaging 
HL-1 cells were transfected with mito-ECFP and either WT-Bcl-2, mito-Bcl-2, or S/ER-
Bcl-2 at a ratio of 1:4 µg.  48 h after transfection, cells were incubated for 20 min in 2 
µM of the Ca2+-sensitive dye Fluo-4/AM at 37°C in KH solution.  Following, the dye-
containing solution was replaced with dye-free KH solution containing 100 µM 
norepinephrine, and cells were further incubated for a 30 min at 37°C prior to imaging.  
Mito-CFP transfected cells were visually located and 10 consecutive images (1/sec) of 
Fluo-4 fluorescence were acquired.  1 µM thapsigargin was then added, let to incubate 
for 1 min, and subsequently 10 consecutive images (1/sec) of Fluo-4 fluorescence were 
acquired.  The average change in Fluo-4 fluorescence (F) intensity (Finitial/(Ffinal-Finitial)) 
was determined from mean cellular image intensities using the ImageJ multi-ROI 
function. 
II-2.16 Image processing and analysis 
For high-resolution microscopy, Z-stacks of representative cells were acquired at 40x or 
60x magnification with 0.3 µm increments capturing total cellular volume.  Aquired 
widefield Z-stacks were routinely deconvolved using 10 iterations of a 3D blind 
deconvolution algorithm (AutoQuant, Media Cybernetics; Silver Spring, MD, USA) to 
maximize spatial resolution. Representative cells are shown as maximum projections of 
3D-deconvolved Z-stacks, unless stated otherwise.   
Image analysis and figure preparation was performed using the National Institutes 
of Health public domain software ImageJ (http://rsb.info.nih.gov/ij).  When required for 
optimal visualization, multi-color look-up-tables (LUT) were applied to grey-scale 
images.  3D images were reconstructed from Z-stacks using the volume rendering plugin 
for ImageJ (VolumeJ; (Abramoff and Viergever, 2002); 
http://www.isi.uu.nl/people/michael/vr.htm). 
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II-2.17 Immunoblotting   
Cells were harvested by scraping and centrifugation at 550 g for 5 min at 4°C and washed 
once with cold PBS (pH 7.4). To prepare whole cell lysates, cell pellets were redissolved 
in cold RIPA buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton-X 100, 0.1% 
SDS, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, and protease inhibitor cocktail (Roche)) 
and left on ice for 15 min. The cell extracts were centrifuged at 20 000 g for 5 min to 
remove cellular debris.  Protein concentrations were determined using Coomassie Plus 
Reagent (Pierce) and samples were diluted for equal loading per well.  After addition of 
sample buffer and reducing agent (Bio-Rad) samples were incubated at 95°C for 5 min 
and electrophoresed on 10% Bis-Tris SDS-PAGE gels (Bio-Rad) and transferred to 
nitrocellulose membranes (Bio-Rad) according to standard methods (Laemmli, 1970).  
Following, membranes were stained with Ponceau S (Pierce) to verify uniform loading 
and transfer.  For immunodetection the membranes were blocked in 5% dry milk in 
TBST (Tris-buffered saline (TBS)-Tween; 100 mM NaCl, 10 mM Tris, 0.05% Tween, 
pH 7.4) and then incubated with the primary antibody (II-1.1.1) in TBST/5% dry milk for 
2 h at room temperature (or overnight at 4°C).  After three washing steps with TBST for 
10 min the blot was incubated with the horseradish peroxidase-conjugated secondary 
antibody (II-1.1.2) in TBST/5% dry milk for 1 h at room temperature.  Subsequently, the 
membrane was washed three times with TBST and antibody-labeled proteins were 
detected using SuperSignal West Pico chemiluminscence substrate (Pierce).  Apparent 
molecular weights were estimated from the migration rates of Precision Plus Protein 
Standards (Bio-Rad).  Blots shown are representative of at least three independent 
experiments.   
II-2.18 Statistics   
The probability of significant differences between experimental groups was determined 
by the Student’s t-test. Values are expressed as mean±S.E.M. of at least three 
independent experiments unless stated otherwise.   
 
 
  
 
 
 
 
 
 
 
 
 
Chapter 3 
 
 
 
Proapoptotic Bcl-2 Family Members and Mitochondrial 
Dysfunction during Ischemia/Reperfusion Injury in HL-1 
Cardiac Myocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
Adapted from: Brady N.R.1, Hamacher-Brady A.1, and R.A. Gottlieb (2006). “Proapoptotic Bcl-2 
family members and mitochondrial dysfunction during ischemia/reperfusion injury: a study 
employing cardiac HL-1 cells and GFP-biosensors.” BBA - Bioenergetics, in press.  1Authors 
contributed equally. 
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The dynamics of Bax and Bid activation, in relation to mitochondrial dysfunction are 
unclear in the context of I/R injury in the heart.   The objective in this study was to 
evaluate alterations to mitochondrial function in a cell-based model of myocardial 
ischemia/reperfusion (I/R) injury.  Using reporter dyes, GFP-biosensors and fluorescence 
deconvolution microscopy we investigated mitochondrial function and morphology in 
relation to Bax and Bid activation in the HL-1 cardiac cell line.   
 
III-1 Simulated I/R in HL-1 cardiac myocytes induces mitochondrial 
dysfunction and PCD 
To simulate ischemia, which is characterized by a reduction in the supply of oxygen and 
nutrients, resulting in lactate accumulation and intracellular acidosis, cells were bathed in 
a hypoxic, glucose-free, lactate-containing  acidic KH solution (pH 6.6) containing 2-
deoxyglucose to inhibit glycolysis (Maddaford et al., 1999).  Following an ischemic 
period of 2 h, reperfusion was initiated by exchanging the ischemic solution with 
normoxic KH solution. Under control conditions, where cells were maintained in 
normoxic KH solution for the duration of the experiment, cell viability was not 
compromised. In response to sI/R, however, HL-1 cells reproducibly underwent cell 
death over a time-course of several hours, as determined by plasma membrane 
permeability to YoPro1 and propidium iodide (Bond et al., 1991; Idziorek et al., 1995) 
(data not shown).  
Mitochondrial dysfunction, characterized by the generation of ROS and loss of 
∆Ψm, is a critical feature of I/R injury (Gottlieb, 2003; Levraut et al., 2003).  Preservation 
of mitochondrial integrity is essential for energy homeostasis and survival of the cardiac 
myocyte, while compromised mitochondrial integrity ultimately leads to the conversion 
of mitochondria into executers of PCD. We investigated whether our model of sI/R 
activated classic parameters of mitochondrial dysfunction.  90 min after reperfusion, HL-
1 cells displayed decreased ∆Ψm, as indicated by decreased TMRM fluorescence, as well 
as enhanced mitochondrial ROS generation, as indicated by increased mitochondrial-
concentrated CM-DCF fluorescence (Fig. 6). Notably, sI/R-activated ROS production 
and ∆Ψm collapse occurred heterogeneously within the population of HL-1 cells.  The 
HL-1 cell line responds to 2 h simulated ischemia and 90 min reperfusion rather than the 
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many hours of simulated ischemia required for neonatal myocytes or H9c2 cells.  In this 
respect, it more closely resembles adult cardiomyocytes which initiate similar responses 
after 30 min simulated ischemia and 90 min reperfusion.  The production of ROS and 
mitochondrial depolarization also recapitulate well characterized events in myocardial 
I/R injury. 
 
TMRM (∆Ψ)
Control 90’ Reperfusion
CM-DCF (ROS)
Control 90’ Reperfusion
 
 
FIG. 6.  sI/R in HL-1 cardiac myocytes leads to mitochondrial dysfunction.  HL-1 cells were 
loaded with 10 µM CM-DCFH2-DA and subjected to 2 h ischemia in the presence of 5 nM TMRM. 
Following, reperfusion was introduced by a buffer exchange to dye-free KH solution. At 90 min of 
reperfusion, TMRM (upper panels) and CM-DCF (lower panels) fluorescence were compared to 
normoxic control cells, which had been identically treated with dyes, to assess ∆Ψm and ROS 
levels, respectively. Representative images were acquired at 20x magnification under the exact 
same conditions to ensure comparability. Multicolor look up tables (LUT) were applied to grey 
scale images to visualize the range of fluorescence intensities with black representing lowest 
pixel values and white representing highest pixel values. Scale bars, 50 µm.   
 
 
III-2 Mitochondrial dysfunction and fragmentation 
The modulation of mitochondrial morphology is an important parameter of mitochondrial 
function.  Recent studies have shown that during PCD induced by staurosporine 
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(Karbowski et al., 2002), metabolic inhibition (Lyamzaev et al., 2004), or hydrogen 
peroxide
 
(Skulachev et al., 2004), fragmentation of the mitochondrial network is a 
consistent feature.  
  Using mitochondrial-targeted fluorescent markers for mitochondria, either mito-
DsRed2 or mito-ECFP, we assessed mitochondrial morphology during sI/R-induced 
injury using high resolution imaging. Prior to the ischemic insult, mito-DsRed2-labeled 
mitochondria were observed as elongated, branched organelles, whereas mitochondrial 
fragmentation occurred during ischemia and persisted during reperfusion (Fig. 7).  Cells 
incubated under control conditions (in KH solution) remained filamentous for more than 
24 h (data not shown).  These results indicate that a process of dramatic mitochondrial 
remodeling is initiated during simulated ischemia. 
 
Mito-DsRed2
Before sI/R
20’ ischemia
60’ reperfusion
 
FIG. 7.  sI/R causes the disruption of the 
mitochondrial network.  HL-1 cells were 
subjected to sI/R in the Leiden perfusion 
chamber mounted to the stage of the 
fluorescence microscope and mitochondrial 
dynamics were monitored by 4D-imaging of 
mito-DsRed2 with 20 min intervals between 
frames. During normoxic conditions prior to 
ischemia, mitochondria were branched and 
elongated (upper panel). sI/R induced 
fragmentation of the mitochondrial network 
(lower panels).  
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III-2.1 sI/R-induced mitochondrial fragmentation is mediated by Drp1  
To determine if mitochondrial fragmentation occurring during sI/R was due to specific 
activity of known protein mediators of mitochondrial fission, and not an unspecific event, 
cells were transiently transfected with vectors encoding either Drp1, which promotes 
mitochondrial fission, or a GTPase-dead dominant negative of Drp1 (Drp1K38E) which 
blocks mitochondrial fission (Smirnova et al., 1998).  Mitochondrial morphology was 
examined using mito-DsRed2 as a mitochondrial marker (Fig. 8).  Under control 
conditions Drp1 increased the number of cells exhibiting the fragmented phenotype.  
Drp1K38E, as previously described, inhibited fragmentation, resulting in supra-networks 
and perinuclear clustering (Smirnova et al., 1998).     
Following ischemia, mitochondria of control and Drp1 overexpressing cells 
underwent pronounced fragmentation.  Fragmentation was significantly reduced by 
expression of Drp1K38E.  Notably, fragmented mitochondria in Drp1 overexpressing cells 
remained distributed throughout the cell, as opposed to control cells where mitochondrial 
fragments clustered in perinuclear regions.  Perinuclear clustering of mitochondria has 
been described previously in PCD and attributed to activity of the mitochondrial fission 
machinery, or impaired kinesin-dependent transport of mitochondria (Li et al., 1998; 
Frieden et al., 2004).  
 
III-3 Bax activation in sI/R 
One key feature of sI/R-induced cell death is the participation of the pro-apoptotic Bcl-2 
protein Bax in the mitochondrial death pathway (Wolter et al., 1997).  Under normal 
conditions Bax is found homogeneously distributed throughout the cell.  In neonatal 
cardiac myocytes, Bax translocates to the mitochondria in response to staurosporine and 
prolonged chemical hypoxia (Capano and Crompton, 2002).  
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FIG. 8. Drp1 mediates the disruption of the mitochondrial network.  HL-1 cells were 
transfected with mito-DsRed2 to visualize mitochondrial morphology and incubated in KH solution 
or subjected to sI/R.  At 30 min reperfusion, mitochondrial morphology was examined in live cells 
using a 60x lens.  (A)  Shown are maximum projections of representative images.  During 
normoxic conditions prior to ischemia, mitochondria were branched and elongated. sI/R induced 
fragmentation of the mitochondrial network.  Drp1 overexpression resulted in increased 
fragmentation of the mitochondrial network under control conditions (KH solution).  Drp1K38E 
expression reduced sI/R activated mitochondrial fission.  (B) Quantification of changes to 
mitochondrial morphology, as a function of Drp1, Drp1K38E expression and sI/R (*p<0.001; 
**p<0.05).  
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III-3.1 Bax translocation and clustering 
Using constructs encoding human Baxα fused to either EGFP (GFP-Bax (Wolter et al., 
1997) or monomeric red fluorescing mCherry (Shaner et al., 2004), (mCherry-Bax), we 
investigated Bax translocation and clustering on mitochondria in response to sI/R.  Under 
normal conditions GFP-Bax was homogeneously distributed throughout the cytosol (Fig. 
9).  During the 2 h ischemic treatment, GFP-Bax detectably translocated in only a few 
cells (~15%, data not shown).  The majority of GFP-Bax translocation to the 
mitochondria occurred during reperfusion.   GFP-Bax initially circumscribed the outer 
mitochondrial membrane and then, several hours into reperfusion, formed the typical 
punctate GFP-Bax foci , or clusters (Nechushtan et al., 2001; Lim et al., 2002), at or on 
fragmented mitochondria (Fig. 9).   
sI
/R
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Mito-DsRed2 GFP-Bax merge
 
FIG. 9.  sI/R-induced Bax translocation to mitochondria.  HL-1 cells were transfected with 
mito-DsRed2 to visualize mitochondria and GFP to follow changes in subcellular localization of 
Bax during sI/R. In normoxic control cells GFP-Bax exhibits diffuse cytosolic and nuclear 
fluorescence distributed equally throughout the cell (upper panels).  Starting in ischemia and 
extending into the reperfusion period, Bax translocates to the mitochondria, where it coats them 
homogeneously (data not shown).  By the time cells have completed 2 h ischemia and 5 h 
reperfusion, GFP-Bax is found as clusters surrounding individual swollen mitochondria (lower 
panels). Scale bars, 10 µm.  Identical results were obtained with mCherry-Bax.   
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III-3.2 Bax translocation and clustering, mitochondrial fragmentation, and ∆Ψm 
To further explore the two phases of Bax activation (translocation and clustering) we 
transiently expressed a C-terminal threonine-to-alanine point mutant of Bax (T182A) 
fused to mCherry (mCherry-BaxT182A). BaxT182A has been recently shown to 
spontaneously translocate to mitochondria and in some cell types can trigger apoptosis 
(Precht et al., 2005). The translocation of Bax to mitochondria is a prerequisite for 
mitochondrial outer membrane permeabilization for cytochrome c release as well as for 
the MPTP (Shimizu et al., 1999; Saito et al., 2000)  
In HL-1 cells, the majority of mCherry-BaxT182A was associated with the mitochondria 
even under basal conditions (Fig. 10A).  Interestingly, in the absence of sI/R, cells 
transfected with either mCherry-Bax or mCherry-BaxT182A
 
exhibited polarized, 
filamentous mitochondria, indicating intact mitochondrial function (Fig. 10B).  
Moreover, for up to 4 days following transfection, BaxT182A was not sufficient to induce 
apoptosis in HL-1 cells.  We therefore asked whether the mitochondrial localization of 
Bax sensitized cells to sI/R injury.  Bax-mCherry clustering was quantified at time points 
2.5 h and 5 h of reperfusion.  At 2.5 h of reperfusion, there was no statistically significant 
difference between mCherry-Bax and mCherry-BaxT182A clustering.  However, at 5 h of 
reperfusion, mCherry-BaxT182A clustering was significantly higher than for mCherry-Bax 
(Fig. 10C).  These results indicate that in HL-1 cells Bax translocation itself is not 
sufficient to induce mitochondrial fragmentation or depolarization, but that it may 
sensitize the mitochondria to injury or shorten the interval to complete apoptosis.  Thus, 
Bax translocation may be regarded as a priming event.  Bax clustering on the other hand 
can be considered as an index of irreversible injury as it was followed by plasma 
membrane permeabilization as determined by YoPro1 labeling (results not shown).  
MAPK (mitogen-activated protein kinase) p38 is an established participant in I/R 
activated PCD in the heart (Baines et al., 2005)   Moreover, treatment with p38 inhibitors 
can block nitric oxide-induced Bax activation (Ghatan et al., 2000).  To determine the 
effect of p38 on Bax translocation and clustering in our model of sI/R, we added the p38 
inhibitor SB203580 at reperfusion.  Inhibition of p38 significantly blunted mCherry-Bax 
translocation and clustering.  To determine if p38 was required just for translocation or if 
it was also required for clustering, we evaluated the effect of SB203580 on mCherry-
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BaxT182A (Fig. 10C).  As previously observed, mCherry-BaxT182A spontaneously 
associated with mitochondria; however, the addition of SB203580 at reperfusion 
prevented clustering.  Taken together, these results indicate a role for p38 in both steps in 
Bax activation.   
In addition, we noted that while >90% of mitochondria were fragmented at the 
end of ischemia, a morphology that persisted beyond 5 h reperfusion, cells treated with 
SB203580 exhibited filamentous mitochondria at 5 h reperfusion, indicating that the 
filamentous mitochondrial network had re-formed (Fig. 10D).   This suggests that p38 
may play an active role in regulating mitochondrial structure during I/R injury. 
 
 
FIG. 10.  Bax translocation to mitochondria independent of mitochondrial dysfunction.  (A)  
Cells were co-transfected with mCherry-Bax constructs and mito-ECFP and cells were imaged in 
KH solution.  Whereas mCherry-Bax(wt) was found to be homogeneously distributed throughout 
the cell, mCherry-BaxT182A was found to coat the mitochondrial networks of the cell.  (B) ∆Ψm was 
determined using Rhodamine 123 (Rhod123, 50 nM).  Cells expressing mCherry-Bax(wt) or 
mCherry-BaxT182A
 
exhibited similar levels of filamentous, polarized mitochondria.  (C)  Bax 
mitochondrial localization and effect of p38 inhibition on Bax activation.  At 2.5 h reperfusion the 
extent of clustering of mCherry-BaxT182A
 
was similar to mCherry-Bax(wt).  At 5 h reperfusion 
mCherry-BaxT138A formed significantly more clusters than mCherry-Bax(wt) (p<0.01).  SB203580 
(10 µM) significantly decreased the percentage of cells with Bax clustering in both mCherry-Bax 
and mCherry-BaxT182A expressing cells (p<0.01).  (D)  SB203580 effect on mitochondrial 
morphology.  At 5 h reperfusion, decreased mCherry-Bax(wt) and or mCherry-BaxT182A
 
clustering 
correlated with recovery of mitochondrial networks as revealed by imaging of mito-ECFP.  
mCherry-Bax(wt) was homogeneously distributed following SB203580 treatment at reperfusion.   
*
*
**
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Mitochondrial depolarization occurred following fragmentation but prior to Bax 
clustering.  Mitochondrial depolarization is often a result of MPTP opening.  To assess 
whether Bax clustering caused or was a result of MPTP opening, we treated HL-1 cells 
with CsA (1 µM).  This intervention significantly reduced sI/R-induced GFP-Bax 
clustering   (Fig. 11), indicating that MPTP opening was upstream of Bax clustering.   
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FIG. 11.  MPTP is upstream of GFP-Bax activation.   GFP-Bax expressing cells were subjected 
to sI/R with or without 1 µM CsA.  At 5 h of reperfusion, cells were classified as displaying diffuse 
cytosolic or punctate mitochondrial GFP-Bax localization. The percentage of cells with punctate 
GFP-Bax distribution per total cells scored is represented as the mean±S.E.M. of three 
independent experiments, each performed in duplicate.  CsA significantly reduced redistribution 
and clustering of GFP-Bax at the mitochondria (*p<0.05).  
 
 
III-4 GFP-Bax clustering as a parameter of sI/R-induced injury  
Using mitochondrial clustering of GFP-Bax as an index to monitor activation of PCD 
(Fig. 12A) we found that sI/R induced PCD in a hypoxia/reoxygenation-dependent 
manner (Fig. 12B).  
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FIG. 12.  sI/R-specific GFP-Bax clustering.  GFP-Bax transfected HL-1 cells were incubated in 
either KH solution or ischemia-mimetic solution for 2 h in normoxic (sI/R Normox) or hypoxic 
(sI/R) conditions followed by 5 h reperfusion in normoxic KH solution.  (A) Z-stacks of 
representative cells were acquired at 60x magnification with 0.3 µm increments. Shown are the 
maximum projections of total cellular GFP-Bax fluorescence.  (B) Cells were then classified as 
displaying diffuse cytosolic or punctate mitochondrial GFP-Bax localization. Represented is the 
percentage of cells with punctate GFP-Bax distribution per total cells scored (*p<0.05).   
 
 
Overexpression of both Bcl-2 and Bcl-xL, known protectors against cardiac I/R injury 
(Brocheriou et al., 2000; Imahashi et al., 2004; Huang et al., 2005), significantly reduced 
sI/R-induced GFP-Bax clustering, further demonstrating suitability of the experimental 
model (Fig. 13A, B).   Interestingly, both wild-type (WT-)Bcl-2 and mitochondrial-
targeted (mito-)Bcl-2 significantly protected against sI/R-induced GFP-Bax clustering, 
while S/ER-targeted (S/ER-)Bcl-2 did not significantly affect GFP-Bax clustering (Fig. 
13C). 
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Fig. 13. Anti-apoptotic Bcl-2 and Bcl-xL oppose sI/R-induced GFP-Bax clustering.  (A) GFP-
Bax transfected cells were co-transfected with Bcl-2 or Bcl-xL and overexpression of Bcl-2/-xL was 
verified by immunodetection of cell lysates.  (B) GFP-Bax clustering was assessed under both 
control and sI/R conditions as under B (*p<0.05).  (C)   GFP-Bax clustering was assessed in 
control cells and cells co-expressing WT-Bcl-2, mito-Bcl-2, and S/ER-Bcl-2 (*p<0.01; **p<0.05). 
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FIG. 14. Fissioned mitochondria afford protection from sI/R injury in HL-1 cells and Bcl-xL 
protects independently of mitochondrial fission.   (A)  HL-1 cells were co-transfected with 
GFP-Bax and either empty vector (control), Drp1, or Drp1K38E.  At 5 h following sI/R, GFP-Bax 
activity (defined as punctate mitochondrial GFP-Bax localization) was quantified (*p<0.05).  (B) 
Cells were co-transfected with mito-DsRed2 and Bcl-xL and subjected to sI/R.  Shown are the 
maximum projections of representative cells under control (normoxic KH) or sI/R (at 30 min 
reperfusion) conditions.  (C) Cells were co-transfected with GFP-Bax and empty vector or Bcl-xL 
and GFP-Bax clustering was quantified as described above.      
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III-5 Drp1-mediated mitochondrial fragmentation protects against sI/R  
We next determined the significance of mitochondrial morphological states (fragmented 
vs. fused) in mediating the injury response to simulated I/R as determined via GFP-Bax 
clustering.  Drp1 significantly reduced sI/R-activated GFP-Bax clustering (Fig. 14A).  
Drp1K38E had no significant effect on GFP-Bax activity in response to sI/R.  These results 
indicate that ischemia-induced mitochondrial fission mediated by Drp-1 affords 
protection from sI/R injury.   
In order to understand the above results in the context of PCD, we then 
overexpressed the anti-apoptotic protein Bcl-xL and examined the effect on mitochondrial 
fragmentation.  Bcl-xL, although protecting against GFP-Bax clustering (Fig. 13B), did 
not block mitochondrial fragmentation (Fig. 14B, C), indicating that Bcl-xL does not 
achieve mitochondrial protection through effects on mitochondrial fragmentation. We 
infer that fragmentation precedes and is independent of mitochondrial pro-apoptotic 
alterations. 
 
III-6 Bid activation in sI/R monitored by a GFP biosensor   
Bid is another pro-apoptotic Bcl-2 protein whose activation is thought to be a causative 
event during myocardial I/R injury (Chen et al., 2002). To explore the kinetics of sI/R-
induced Bid activation in a time and spatially resolved manner, we constructed a GFP-
based biosensor, in which full-length Bid is flanked by YFP at the N-terminus and CFP at 
the C-terminus (YFP-Bid-CFP).  This was chosen in order to enable tracking of both the 
N- and C-terminal fragments of Bid.  
Under control conditions, both YFP and CFP fluorescence were distributed 
homogeneously throughout the cell (Fig. 14A) consistent with the cytosolic distribution 
of Bid in healthy cells.  In cells which had been subjected to simulated ischemia followed 
by prolonged hours of reperfusion (+6 h), however, YFP-Bid displayed mainly a diffuse 
cytosolic staining pattern while C-terminal Bid-CFP (containing the BH3 domain) was 
found at distinct subcellular regions (Fig. 15A).  Dual imaging of mito-DsRed2 and tBid-
CFP identified mitochondria as the subcellular targets of Bid (Fig. 15B).   
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FIG. 15.  YFP-Bid-CFP sensor to monitor Bid activation.  (A) Cells were transfected with YFP-
Bid-CFP and analyzed by 3D fluorescence imaging under control conditions and after 2 h 
ischemia and 6 h reperfusion.  Under control conditions both CFP and YFP signals of Bid exhibit 
diffuse fluorescence.  Following 6 h of reperfusion, Bid-CFP (C-terminal fragment) exhibits a 
punctate distribution resembling mitochondria, while YFP-Bid (N-terminal fragment) is diffusely 
distributed.  (B) After sI/R, Bid-CFP co-localizes with mito-DsRed2 visually confirming the 
mitochondrial localization of activated tBid-CFP.  
 
 
III-6.1 sI/R-induced cardiac myocyte Bid cleavage is mediated by caspase 8  
Bid can be cleaved by various proteases such as caspase 8 (Li et al., 1998), calpain (Chen 
et al., 2001; Mandic et al., 2002) cathepsin proteases (Stoka et al., 2001), and granzyme 
B (Heibein et al., 2000; Sutton et al., 2000). While calpain has been reported to play a 
role in I/R-induced Bid cleavage in the perfused whole heart model (Chen et al., 2001), 
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Bid cleavage has been attributed to varying proteases depending on the death stimulus 
and cell type  (e.g., caspase 8 in cardiomyocytes vs. caspase 9 in endothelial cells in 
response to sI/R the isolated heart (Scarabelli et al., 2002). 
To determine whether caspase 8 was the responsible protease in sI/R-induced Bid 
cleavage in HL-1 cells, we inserted a point mutation within the caspase 8 cleavage site of 
Bid, generating Bid∆casp8, and subcloned it into the Bid biosensor. TNF-α activates 
PCD involving caspase 8 dependent cleavage of Bid (Li et al., 1998). Treatment of HL-1 
cells transfected with either Bid-sensor or Bid∆casp8-sensor with TNF-α resulted in the 
cleavage of Bid-sensor but not Bid∆casp8-sensor, indicating successful mutation of the 
caspase 8 cleavage site (Fig. 16A).  Cells expressing the Bid∆casp8-sensor were 
subjected to 2 h ischemia and 6 h reperfusion.  The Bid∆casp8 cleavage product was not 
detected although the cleavage product could be detected in cells expressing the wild type 
Bid-sensor (Fig. 16A). Likewise, inhibition of caspases with 50 µM zVAD-fmk inhibited 
sI/R-induced cleavage of ectopically expressed Bid-sensor as well as endogenous Bid, 
while the presence of 10 µM ALLN, an inhibitor of calpain and cathepsins B and L, did 
not affect Bid cleavage (Fig. 16B).  These results indicate that caspase 8 is responsible for 
Bid cleavage after sI/R of HL-1 cardiac myocytes. 
Co
n
tro
l
TN
F-
α
Co
n
tro
l
TN
F-
α
sI
/R
WT M WT M
sI
/R
YFP-Bid-CFP
tBid-CFP
A sI
/R
sI
/R
 
+
 
AL
LN
sI
/R
 
+
 
zV
AD
-
fm
k
tBid-CFP
Actin
FL-Bid
B
 
FIG. 16.  Bid cleavage during sI/R is mediated by caspase 8.  (A) HL-1 cells were transfected 
with either Bid-sensor (WT) or Bid∆casp8-sensor (M) and treated with TNF-α (100 ng/ml) for 24 
h. Proteins of whole cell lysates were separated by SDS-PAGE, transferred to nitrocellulose, and 
probed with anti-FP antibody to detect WT and M Bid-sensor (78 kDa) and cleavage product tBid-
CFP (42 kDa). (B) Bid-sensor expressing cells were subjected to 2 h ischemia followed by 6 h 
reperfusion in the presence of the protease inhibitors ALLN (10 µM) or zVAD-fmk (50 µM). 
Western blots of whole cell lysates were probed with anti-FP, anti-Bid, and anti-actin antibodies. 
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FIG. 17.  Sequential activation of Bax and Bid in response to sI/R.  (A) HL-1 cells were co-
transfected with mCherry-Bax and YFP-Bid-CFP.  CFP and mCherry signals were detected under 
control conditions (2+5 h KH solution) and after 2 h simulated ischemia and 5 h reperfusion.  (B) 
To determine whether tBid and Bax colocalize at mitochondria, HL-1 cells transfected with Bid-
sensor and mCherry-Bax were subjected to 2 h ischemia followed by 6 h reperfusion and 
analyzed by fluorescence microscopy.  Z-stack was 3D-rendered using the VolumeJ plugin for 
ImageJ.  3D rendering reveals the distinct pattern of distribution of mCherry-Bax (clusters) and 
tBid-CFP (homogeneous mitochondrial pattern). 
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III-7 Spatio-temporally resolved interplay of Bid and Bax at the 
mitochondria 
During the preceding experiments, we noted that Bid truncation and translocation to the 
mitochondria occurred at a later time point than mitochondrial Bax translocation and 
clustering.  In order to resolve the spatio-temporal interplay of Bid and Bax at the 
mitochondria, we transfected cells with both mCherry-Bax and YFP-Bid-CFP.  Under 
control conditions both mCherry-Bax and YFP-Bid-CFP were distributed homogeneously 
throughout the cell.  However, after 2 h ischemia and 5 h of reperfusion, mCherry-Bax 
was detected at the mitochondria, mainly in the absence of YFP-Bid-CFP redistribution, 
which could be detected more frequently at later times (Fig. 17A).  These results are 
consistent with the notion that Bax translocation and activation at the mitochondria 
occurs prior to massive Bid activation.  Although tBid is thought to function in concert 
with Bax (Lim et al., 2002), we found that Bid did not localize to the Bax clusters but 
instead displayed a homogeneous mitochondrial distribution (Fig. 17B).   
 
 
  
 
 
 
 
 
 
 
 
 
Chapter 4 
 
 
 
Bcl-2 Regulation of Sarco-/Endoplasmic Reticulum 
Calcium Stores Mediates the Autophagic Response to 
Nutrient Deprivation in HL-1 Cardiac Myocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
Adapted from: Brady N.R., Hamacher-Brady A., and R.A. Gottlieb. “Bcl-2 regulation of 
sarco/endoplasmic reticulum calcium stores mediates the autophagic response to nutrient 
deprivation in the HL-1 cardiac myocyte.” Submitted. 
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Recent findings evidence a link between the apoptotic and autophagic pathways through 
the interaction of the anti-apoptotic proteins Bcl-2 and Bcl-xL with Beclin1 (Liang et al., 
1998; Saeki et al., 2000; Shimizu et al., 2004; Pattingre et al., 2005).  However, the 
nature of the interaction, either in promoting or blocking autophagy remains 
controversial.  In part this is due to incorrect use of tools available for detecting the 
autophagic response: currently, a demonstration of increased presence of either 
autophagic vacuoles (AVs) or protein markers thereof, is the standard means for 
detecting changes in autophagic activity.   
However, autophagy involves the delivery of the autophagosomes and their 
contents to lysosomes which contain the degradative enzymes needed to complete the 
catabolic processes of autophagy (Klionsky and Emr, 2000).  Therefore, an increased 
presence of AVs may either reflect (i) enhanced formation of AVs, (ii) impaired fusion of 
AVs with lysosomes to generate autophagolysosomes, or (iii) a combination of both.  
Moreover, the AVs may be removed by lysosomal degradation at a rate that exceeds our 
imaging capabilities; i.e., the transit is so rapid and/or the AVs so small that only a few 
AVs can be detected at any given time.  Accordingly, a low number of AVs may be due 
to either low or high autophagic activity.  
Here we implement a highly-sensitive, macroautophagy-specific assay which 
allows for the distinction between enhanced AV production and suppressed AV 
degradation.   Using this assay we investigated the control of Beclin1 and Bcl-2 on 
nutrient deprivation-activated autophagy. 
 
IV-1 Inhibiting lysosomal activity to quantify autophagic flux 
During the initiation of autophagy, cytosolic LC3 (LC3-I) is cleaved and lipidated to 
form LC3-II (Kabeya et al., 2004; Tanida et al., 2005).  LC3-II is then recruited to the 
autophagosomal membrane (Mizushima et al., 2001).  Thus, punctate GFP-LC3-labeled 
structures represent AVs.  Importantly, overexpression of (GFP-)LC3 does not affect 
autophagic activity, and transgenic mice expressing GFP-LC3 display no detectable 
abnormalities (Kirisako et al., 1999; Mizushima et al., 2004).   
 In this study we utilized the extent of GFP-LC3-labeled AV formation during a 
set amount of time as a specific index of macroautophagic activity.  Lysosomal 
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degradation of AVs was blocked using a cocktail consisting of the cell-permeable 
pepstatin A methyl ester (5 µg/µl, inhibitor of cathepsin D), (2S,3S)-trans-epoxysuccinyl-
L-leucylamido-3-methylbutane ethyl ester (E64d; 5 µg/µl, inhibitor of cathepsin B) and 
bafilomycin A1 (Baf A1, 50 µM;  inhibitor of v-ATPase).  To verify the inhibition of 
cathepsin activity we utilized the fluorescent MagicRed Cathepsin B substrate 
(Lamparska-Przybysz et al., 2005).  Under normal conditions MagicRed fluorescence is 
localized to individual organelles representing the lysosomes due to processing of the 
substrate to its fluorescent form by the lysosomal protease cathepsin B (Fig. 18A).  In 
cells treated with the inhibitor cocktail, fluorescence intensity was decreased due to 
decreased MagicRed processing by cathepsin B.  Similarly, lysosomal acidification 
which is required for protease activity (Yoshimori et al., 1991) and AV-lysosome fusion 
(Yamamoto et al., 1998), was inhibited as assayed by LysoTracker Red (Fig. 18B). 
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FIG. 18.  Inhibition of lysosomal activity with the inhibitor cocktail.  (A) Inhibition of cathepsin 
B activity by lysosomal inhibitors.  Activity and intracellular distribution of cathepsin B, a 
predominant lysosomal protease, was assessed using MagicRed-Cathepsin B substrate.  HL-1 
cells were treated with lysosomal inhibitors (Baf A1, pepstatin A methyl ester, and e64D) for 2 h 
with MagicRed present during the last 30 min of the experiment.  (B)  Inhibition of v-ATPase 
activity by Baf A1.  Following 2 h incubation in KH + Baf A1, cells were loaded with 50 nM 
LysoTracker Red (LTR) for 5 min.  The solution was then exchanged with dye-free KH solution, 
and cells were analyzed by fluorescence microscopy.  (A+B) Shown are the maximum projections 
of deconvolved Z-stacks of representative cells acquired at 40x magnification.      
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IV-2 Quantifying autophagy in HL-1 cardiac myocytes  
We first characterized the basal level of autophagy in fully supplemented medium 
(Claycomb et al., 1998).  GFP-LC3 expressing HL-1 cells were treated with the 
lysosomal inhibitor cocktail for a period of 3.5 h and the percentage of cells 
demonstrating a robust intracellular accumulation of GFP-LC3-labeled AVs (active 
autophagy) was determined by fluorescence imaging.  Two populations were readily 
apparent: under full medium conditions in the absence of the inhibitor cocktail the 
majority of the cells contained few or no AVs (Fig. 19A).  In the presence of lysosomal 
inhibitors, only a small, statistically insignificant increase in the percentage of cells 
exhibiting high AV content was observed, evidencing low autophagic activity under high 
nutrient conditions. The results, represented as bar graphs, thus indicate the percentage of 
cells showing numerous AVs at steady-state (absence of inhibitors; representing either 
increased AV formation or slow degradation) and under inhibited degradation of AVs 
(cumulative AV formation over a fixed period of time).  The difference in cells with high 
AV content in the presence or absence of inhibitors (number in graphs) represents the 
percentage of cells with high autophagic flux (Fig. 19B).   
IV-2.1 Pharmacologic activation of autophagy  
We next sought to gauge the accuracy of our method to determine autophagic flux by 
evaluating the effect of agents known to perturb the autophagic pathway.  Rapamycin can 
stimulate autophagy even under high nutrient conditions (Noda and Ohsumi, 1998).  
GFP-LC3-expressing HL-1 cells were treated with the lysosomal inhibitor cocktail in full 
medium, without and with rapamycin.  In the absence of lysosomal inhibitors, the 
percentage of cells with high AV content increased only slightly in response to 
rapamycin (Fig. 19A).  Lysosomal inhibition in rapamycin-treated cells, however, 
resulted in a profound further increase in the percentage of cells with high AV content, 
revealing the autophagy-inducing potential of rapamycin (Fig. 19B).  Furthermore, our 
results demonstrate that the rapamycin-induced AV formation in full medium exceeds the 
capacity for AV degradation, as steady-state levels of AVs increased even though flux 
greatly increased.   
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FIG. 19. Basal and rapamycin-activated 
autophagic activity in full medium.  (A) 
GFP-LC3 transfected HL-1 cells were 
treated with 1 µM rapamycin for 30 min in 
full medium (FM).  Z-stacks of 
representative cells were acquired at 60x 
magnification and subsequently processed 
by 3D blind deconvolution (AutoQuant). 
Shown are the maximum projections of total 
cellular GFP-LC3 fluorescence.  (B) The 
percentage of cells with high numbers of 
AVs without (steady-state AVs) and with 
(cumulative AVs) lysosomal inhibitors was 
quantified (*p<0.05; **p<0.01; ***p<0.001). 
 
 
IV-2.2 Autophagic response to nutrient deprivation  
Autophagy is strongly upregulated in response to nutrient deprivation (Kim and 
Klionsky, 2000). GFP-LC3-expressing HL-1 cells were incubated in glucose-containing 
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Krebs-Henseleit (KH) solution, which deprives the cells of amino acids and serum, 
without and with the lysosomal inhibitors (Fig. 20A, B).  Similar to the results in full 
medium, low steady-state levels of AVs were detected in KH alone, yet lysosomal 
inhibition revealed robust levels of autophagic flux in almost all cells, with ~90% of cells 
displaying high AV levels.  A remainder of ~10% was inhibitor-insensitive.  These 
results indicate that, as expected, autophagic flux was substantially upregulated in 
response to a low nutrient environment.  
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FIG. 20.  Autophagic flux under nutrient deprivation.  (A) Shown are maximum projections of 
Z-stacks taken of GFP-LC3 fluorescence in cells incubated in KH for 2 h without and with 
lysosomal inhibitor cocktail.  Without lysosomal inhibition cells typically displayed low steady-state 
AV contents (left panel).  However, in the presence of the inhibitor cocktail cells accumulated 
numerous AVs revealing high autophagic flux (right panel). (B)  The percentage of cells with high 
numbers of AVs without (steady-state AVs) and with (cumulative AVs) lysosomal inhibitors was 
quantified (*p<0.001). 
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IV-2.3 Molecular perturbation of the autophagic pathway  
During formation of the pre-autophagosomal structure, the C-terminal glycine of Atg12 
forms a bond with Atg5 lysine 130.  Replacing Atg5 lysine 130 with arginine (Atg5K130R) 
renders Atg5 unable to accept Atg12, and thus blocks AV formation, including LC3 
recruitment (Mizushima et al., 2001).  In order to enable molecular perturbation of the 
autophagic pathway, we generated and characterized fusion proteins of the monomeric 
red fluorescent protein mCherry (Shaner et al., 2004) and Atg5 or the dominant negative 
mutant of Atg5, Atg5K130R.  Autophagic flux was determined under full medium and KH 
solution conditions in HL-1 cells co-transfected with GFP-LC3 and either mCherry, 
mCherry-Atg5 or mCherry-Atg5K130R (Fig. 21A).  Expression of mCherry-Atg5 did not 
significantly influence autophagic flux in either high or low nutrient conditions when 
compared to control (mCherry-expressing) cells.  However, expression of mCherry-
Atg5K130R significantly reduced both steady-state and lysosomal inhibitor-sensitive 
accumulation of AVs in low nutrient conditions.  This trend, although insignificant, was 
also observed under high nutrient conditions.  Moreover, high resolution imaging 
indicated that AV formation was interrupted by mCherry-AtgK130R (Fig. 21B).   In 
response to nutrient starvation, GFP-LC3-labeled punctae were smaller in mCherry-
AtgK130R cells than in control or mCherry-Atg5 cells, indicative of failed pre-
autophagosome maturation (Mizushima et al., 2001).  
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FIG. 21.  Atg5 control of autophagosome formation.  HL-1 cells were co-transfected with GFP-
LC3 and either mCherry (empty vector control), mCherry-Atg5 or mCherry-Atg5K130R.  Cells were 
incubated in KH solution, with or without lysosomal inhibitors for 3.5 h, at which time the cells 
were formaldehyde-fixed.  (A) Autophagic flux was quantified via scoring of mCherry-positive 
cells with numerous GFP-LC3 vacuoles without (steady-state AVs) and with (cumulative AVs) 
lysosomal inhibitors.  Represented is the percentage of cells with numerous GFP-LC3 vacuoles 
per total cells scored (*p<0.05; **p<0.001 (flux: Vector vs. Atg5K130R in KH)).  (B) Representative 
images of the autophagic response are shown. 
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Together, these results demonstrate that, contrary to current assumptions, 
autophagic activity and AV content are not necessarily correlated, either positively or 
negatively. Low levels of autophagy (full medium), high levels of autophagy (nutrient 
deprivation) and impaired autophagy (mCherry-Atg5K130R), are all reflected in low 
steady-state presence of GFP-LC3-labeled AVs.  However, the use of lysosomal 
inhibitors revealed substantial differences in actual autophagic flux and thus is necessary 
in order to quantify autophagic activity. 
 Interestingly, the maximal percentage of cells responding to nutrient deprivation 
or rapamycin was ~90%, indicating that ~10% of cells lack the capacity for AV 
generation. Similarly, ~10% of cells displayed high steady-state levels of AVs.  AV 
presence in this subpopulation may indicate disrupted autophagic flux.  Therefore, ~80% 
of HL-1 cells have the capacity to mount an autophagic response.   
 
IV-2.4 Beclin1 control of the autophagic response to nutrient deprivation is 
dependent on a functional Bcl-2/-xL binding domain 
Having established a novel sensitive method to quantify the autophagic response in a 
population of cells, in response to both acute activation (rapamycin) and genetic 
disruption (Atg5K130R), we investigated the control of Beclin1 and its binding partners, 
Bcl-2, on autophagic activity.   
Beclin1 was the first mammalian protein described to mediate autophagy (Liang 
et al., 1999).  Beclin1 interacts with the class III PI3-K Vps34, regulating the formation 
of the lipid second messenger phosphatidylinositol 3-phosphate (PI3-P) which is required 
for activating the autophagic pathway (Kihara et al., 2001).  Beclin1 contains a Bcl-2-
binding domain which has been shown to interact with anti-apoptotic Bcl-2 and Bcl-xL, 
but not pro-apoptotic Bcl-2 family members (Liang et al., 1998).  However, the nature of 
the relationship between Beclin1 and Bcl-2 remains unclear.  Recent work has implicated 
Bcl-2 in the suppression of starvation-induced autophagy (Pattingre et al., 2005), yet 
others have shown that Bcl-2 positively regulates autophagic cell death activated by 
etoposide (Shimizu et al., 2004).  
Here we sought to determine the effect of Beclin1 and a mutant form of Beclin1 
lacking the Bcl-2 binding domain (Beclin1∆Bcl2BD) on autophagic activity, under high 
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and low nutrient conditions.  Under high nutrient conditions, steady-state and cumulative 
autophagy were similar in control cells and Beclin1-transfected cells (Fig. 22A).  In KH 
solution, both control and Beclin1-overexpressing cell populations responded maximally 
to nutrient deprivation.  Beclin1∆Bcl2BD expression significantly reduced the percentage 
of cells with autophagic flux in low nutrient conditions, indicating that Beclin1-mediated 
autophagy required the presence of Bcl-2/-xL for maximal autophagic response.   
Consistent with a failed response to trigger AV formation, Beclin1∆Bcl2BD expression 
resulted in the formation of small GFP-LC3 ‘speckles’, similar to that observed in cells 
expressing Atg5K130R (Fig. 22B).   
 
 
IV-3 Bcl-2 suppression of the autophagic response to nutrient deprivation 
is dependent on its subcellular localization  
Our ability to quantify autophagic flux (versus the commonly reported AV content) 
revealed the surprising finding that Beclin1∆Bcl2BD suppressed autophagy.  
Beclin1∆Bcl2BD, as well as other Beclin1 mutants lacking Bcl-2 interaction, increased 
steady-state AV levels in cancer cells and have been shown to activate cell death during 
nutrient deprivation, presumably due to overactive autophagy.  Furthermore, Bcl-2 was 
found to suppress steady-state AV levels presumably through its interaction with the 
Beclin1 Bcl-2 binding domain (Pattingre et al., 2005).   
To unravel the reasons for this discrepancy, we investigated the effect of Bcl-2 
overexpression on the autophagic response to nutrient deprivation (Fig. 23).  Although 
we found that Beclin1∆Bcl2BD expression greatly reduced the autophagic response, we 
detected a minor but statistically significant suppressive effect on autophagy by 
overexpression of wild-type (WT-) Bcl-2.  Endogenous Bcl-2 is found in the cytosol, at 
the mitochondria, and at the S/ER (Lithgow et al., 1994).  Forced localization of Bcl-2 to 
the S/ER  was shown to be responsible for the suppression of AV formation in response 
to nutrient deprivation (Pattingre et al., 2005).  We found that similar to the findings with 
WT-Bcl-2, mitochondrial- (mito-)targeted Bcl-2 only slightly suppressed the autophagic 
response.  However, S/ER-targeted Bcl-2 potently decreased the percentage of cells 
exhibiting autophagic activity in response to nutrient deprivation by about ~50%.   
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FIG. 22. Beclin1 regulation of the autophagic response.  HL-1 cells co-transfected with GFP-
LC3 and either a plasmid encoding Beclin1, Beclin1∆Bcl2BD or empty vector (control).  Cells 
were incubated in either the high-nutrient full medium (FM) or low nutrient KH solution.  Cells 
were incubated either without or with the lysosomal inhibitor cocktail for 3.5 h and formaldehyde-
fixed.  (A) Autophagic flux was determined via fluorescent imaging of GFP-LC3-II without (steady-
state AVs) and with (cumulative AVs) lysosomal inhibitors.  Represented is the percentage of 
cells with numerous GFP-LC3 vacuoles per total cells scored (*p<0.01 (flux: Vector vs. Beclin1 
∆Bcl2BD)).  (B) Maximum projections of Z-stacks of representative cells in each condition are 
shown. 
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FIG. 23. Bcl-2 control of autophagic activity.  HL-1 cells were transfected with GFP-LC3 and 
either empty vector, mito-Bcl-2, wild type Bcl-2, or S/ER-Bcl-2 constructs.  Cells were incubated 
for 3.5 h in KH solution, without and with lysosomal inhibitors, at which time they were fixed by 
formaldehyde (4%).  The percentage of cells displaying high levels of AVs was quantified under 
all conditions (*p<0.05; **p<0.001 (cumulative AVs vs. Vector)). 
 
 
IV-4 Bcl-2 overexpression inhibits autophagy due to depletion of 
sequestered S/ER Ca2+ stores  
The strong suppressive effect on autophagy exerted by Beclin1∆Bcl2BD, the minimal 
suppressive effect of wild-type Bcl-2, together with the profound suppressive effect of 
S/ER-targeted Bcl-2 were not compatible with Bcl-2 functioning simply as a direct 
suppressor of Beclin1 activity.  These conflicting results suggested the presence of an 
additional mechanism controlling autophagic activity.  At the S/ER, Bcl-2 is involved in 
the regulation of Ca2+ homeostasis.  Bcl-2 increases the permeability of the S/ER to Ca2+ 
(Foyouzi-Youssefi et al., 2000) through its interaction with  sarco/endoplasmic reticulum 
Ca2+ ATPase (SERCA), which is responsible for pumping Ca2+ from the cytosol back 
into the S/ER (Dremina et al., 2004).  Intriguingly, S/ER Ca2+ stores are required for the 
activation of autophagy (Gordon et al., 1993) as well as downstream lysosomal function 
(Hoyer-Hansen et al., 2005).  We hypothesized that Bcl-2 targeted to the S/ER inhibits 
autophagy in part due to modulation of the S/ER Ca2+ content. 
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 We first sought to determine whether overexpression of Bcl-2 significantly 
reduced Ca2+ content in the HL-1 cardiac cell.  S/ER Ca2+ homeostasis is maintained by a 
concerted action of release by ryanodine receptor and re-uptake by SERCA.  
Thapsigargin (TG), a selective SERCA inhibitor (Thastrup et al., 1990), can be used to 
deplete S/ER  Ca2+ stores, by blocking re-uptake (Thastrup et al., 1990).  S/ER Ca2+ 
content was inferred by measuring the increase in cytosolic Ca2+ after TG treatment using 
fluorescent Ca2+ indicator Fluo-4 (Fig. 24A, B).  TG-mediated depletion of S/ER Ca2+ 
was similar between WT-Bcl-2 and control cells, but was significantly reduced in cells 
expressing S/ER-Bcl-2.  These results demonstrate that the capacity for S/ER Ca2+ 
release, an index of S/ER Ca2+ levels, is reduced by S/ER-Bcl-2 in the HL-1 cardiac 
myocyte. 
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FIG. 24.  Bcl-2 reduces S/ER Ca2+ content.  HL-1 cells were co-transfected with mito-CFP and 
either WT-Bcl-2 or S/ER-Bcl-2.  Cells were incubated with 2 µM Fluo-4 and solution was replaced 
with dye-free KH solution, containing norepinephrine (100 µM) to stimulate Ca2+ release.  10 
images were collected prior to the addition of 1 µM thapsigargin (TG), at 1 image/sec. (A) 
Representative images.  (B) The average percent change in Fluo-4 fluorescence was calculated 
(*p<0.01; **p<0.001). 
 
 
IV-5 Positive regulation of autophagy by S/ER Ca2+ 
Consistent with previous reports (Dremina et al., 2004; Palmer et al., 2004), we found 
that in HL-1 cardiac myocytes, S/ER-targeted Bcl-2 depleted Ca2+ content in the S/ER.  
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We then sought to determine whether low levels of intracellular Ca2+ influence the 
activation of autophagy by nutrient deprivation.  BAPTA-AM (25 µM), a membrane 
permeable Ca2+ chelator (Tsien, 1980), was applied to HL-1 cells, and autophagic flux 
was quantified.  BAPTA-AM treatment resulted in complete inhibition of autophagic 
activity (Fig. 25A).  Moreover, BAPTA-AM decreased autophagy in the presence of 
rapamycin (1 µM; results not shown). 
To determine whether S/ER Ca2+ content affected autophagic activity, we 
depleted S/ER Ca2+ with TG.  In control, WT-Bcl-2, mito-Bcl-2, and S/ER-Bcl-2 cells, 
TG (1 µM) significantly suppressed nutrient deprivation-induced autophagic activity by 
70-80%.  Furthermore, in cells expressing S/ER-Bcl-2, TG reduced autophagic activity to 
zero (cumulative AVs + TG equaled S/ER-Bcl-2 steady-state AVs) (Fig. 25B).   
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FIG. 25.  Role of S/ER Ca2+ stores on nutrient deprivation induced autophagy.  HL-1 cells 
were transfected with GFP-LC3.  Cells were incubated in the absence or presence of either (A) 
BAPTA-AM (25 µM) or (B) TG (1 µM) for 3.5 h in KH solution, without or with lysosomal inhibitors, 
at which time they were fixed with formaldehyde (4%).  The percentage of cells displaying high 
levels of AVs was quantified ((A) *p<0.01; (B) *p<0.001 (vs. respective cumulative AVs w/o TG)). 
.   
 
 
  
 
 
 
 
 
 
 
 
 
Chapter 5 
 
 
 
Enhancing Macroautophagy Protects Against 
Ischemia/Reperfusion Injury in HL-1 Cardiac Myocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
Adapted from: Hamacher-Brady A, Brady NR, and Gottlieb RA. “Enhancing macroautophagy 
protects against ischemia/reperfusion injury in cardiac myocytes.” Submitted. 
 
                                                                
RESULTS: Autophagy protects
 
against
 
sI/R
          
V
 
 
81 
Cardiac myocytes undergo PCD as a I/R, resulting in reduced heart function.  One feature 
of I/R injury is the increased prevalence of autophagosomes.  However, to date it is not 
known whether autophagy functions as a protective pathway, contributes to PCD, or is a 
non-relevant event during myocardial I/R injury.  Autophagy may be a protective 
response to I/R injury, as increased presence of autophagosomes has been documented in 
response to sub-lethal ischemia in the perfused heart (Decker and Wildenthal, 1980).  
Moreover, it was recently reported that enhanced levels of Beclin1 in the heart correlated 
with the onset of protection in an in vivo model of myocardial stunning (Yan et al., 
2005).   
 
V-1 Cellular autophagosomal content is increased during the early phase 
of sI/R injury 
We used HL-1 cells to explore the role of autophagy during sI/R injury.  To determine if 
autophagic activity is modulated in response to sI/R, we first characterized changes in 
cellular autophagosomal content using high-resolution 3D-imaging of GFP-LC3.  We 
transfected HL-1 cardiac myocytes with GFP-LC3 and compared the abundance of AVs 
in cells subjected to sI/R to normoxic control cells.  Under normoxic conditions in KH 
solution, GFP-LC3 was diffusely distributed throughout the cell, with very few detectable 
AVs (Fig. 26A, upper panel).  Cells subjected to sI/R, however, displayed increased 
numbers of AVs (Fig. 26A, bottom panel).  In addition, in control cells the few pre-
existing AVs were randomly distributed, while AVs in cells subjected to sI/R were 
typically more clustered at the center of the cell.  This distinctive distribution contrasts 
with the autophagic response to starvation in hepatocytes, where no such clustering was 
observed (Kochl et al., 2006).  
To quantify the increase in GFP-LC3-labeled AVs, the percentage of cells 
displaying numerous punctate GFP-LC3 structures was determined.  Only a small 
fraction of cells displayed punctate GFP-LC3 fluorescence when incubated in fully 
supplemented medium or KH solution (Fig. 26B).  In cells subjected to sI/R, however, the 
number of cells with numerous AVs was significantly increased (Fig. 26B).  Quantitative 
analysis performed on Z-stacks of GFP-LC3 fluorescence revealed that sI/R significantly 
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increased the number of AVs per cell and, likewise, the total autophagosomal volume 
(Fig. 26C).  
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FIG. 26.  Analysis of cellular autophagosomal content during sI/R.  GFP-LC3 expressing cells 
were subjected to 2 h ischemia and 1.5 h reperfusion. The extent of autophagy was assessed by 
the intracellular distribution of GFP-LC3.  (A) Z-stacks of representative cells were acquired at 
60x magnification with 0.3 µm increments to capture the total autophagosomal population of a 
cell. Shown are the maximum projections of total cellular GFP-LC3 fluorescence in the XY, XZ 
and YZ planes. (B) Cellular AV content in a population of cells was quantified and represented as 
the percentage of cells with numerous GFP-LC3 vacuoles at 1.5 h reperfusion (*p<0.05).  FM, full 
medium.  (C) Quantification of intracellular autophagy of single cells was performed via 3D 
analysis of representative Z-stacks. Shown are the average number of autophagosomes per cell 
(left panel) and the average autophagosomal volume per cell (right panel).  sI/R significantly 
increased levels of autophagy in single cells (*p<0.01). 
                                                                
RESULTS: Autophagy protects
 
against
 
sI/R
          
V
 
 
83 
V-2 Changes in autophagic activity during ischemia an reperfusion 
We subsequently addressed the effect of sI/R on actual autophagic activity.  Our results 
above (V-1) demonstrate that cellular AV content was increased early in the reperfusion 
period.  However, a central finding of Chapter II was that steady-state levels of AVs do 
not reflect autophagic flux.  Thus, the increased presence of AVs observed during sI/R 
may either be a sign of (i) enhanced formation of AVs, (ii) impaired fusion of AVs with 
lysosomes to generate autophagolysosomes, or (iii) a combination of both.  To 
characterize autophagic activity in sI/R we therefore determined two relevant parameters 
of autophagosome-lysosome fusion: the index of LC3-II degradation (autophagic flux) 
and downstream lysosomal activity. 
V-2.1 Flux of LC3-II degradation during sI/R 
Using our previously established (Chapter II) approach based on the inhibition of 
downstream lysosomal degradation of AVs and their cargo, we determined whether the 
increase in cellular AVs during sI/R was indicative of increased or impaired autophagy.  
Cells were subjected to various experimental conditions and treated with a cocktail of 
lysosomal inhibitors to inhibit autophagolysosome formation (with bafilomycin A1) and 
lysosomal protease activity (with E64D and pepstatin A).  By analyzing the lysosomal 
inhibitor-mediated increase in GFP-LC3-II (AV) accumulation within a cell population 
we were able to obtain a quantitative index of the flux of AV formation and degradation.  
Bar graphs depict the percentage of cells exhibiting high AV levels in the absence and 
presence of lysosomal inhibitors, per condition.  The difference between the two bars (see 
values in graphs) is a measure of the percentage of cells demonstrating high autophagic 
activity, or flux.  
As reported in Chapter IV, in KH solution AV content was dramatically increased 
in the presence of inhibitors (IV-2.2).  Thus, under control conditions in KH solution, 
which lacks the serum and amino acid component of full medium, autophagy was 
strongly active.  sI/R augmented the number of cells with increased numbers of AVs (Fig. 
27A).  Under lysosomal inhibition the number of cells with high AV content was 
increased only slightly more, indicating that the previously described steady-state 
increase in cellular AV content in sI/R (Fig. 26 and 27A) is a reflection of an 
accumulation of AVs, presumably due to impairment in the autophagic pathway at a 
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point(s) following AV formation and before AV degradation.  As the level of AV 
accumulation was substantially smaller than the inhibitor-mediated response seen in KH 
solution for the same period of time, it can be concluded that autophagy is also impaired 
at the level of AV formation.   
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FIG. 27.  Flux of LC3-II degradation during sI/R.  (A) Inhibitor-sensitive autophagy at 1.5 h 
reperfusion was quantified by determining the percentage of cells with numerous GFP-LC3-
labeled AVs in each condition without (steady-state AVs) and with (cumulative AVs) lysosomal 
inhibitors present during reperfusion (cumulative AVs: *p<0.001 (KH vs. ISCH); **p<0.01 (KH vs. 
ISCH Normox)).  sI/R ‘Normox’, ischemia-mimetic solution in presence of oxygen.  (B) GFP-LC3-
expressing cells were fixed immediately following 2 h ischemia without and with presence of 
lysosomal inhibitors and autophagic flux was determined as described above (*p<0.01, steady-
state AVs (KH vs. sI/R); **p<0.05, cumulative AVs (KH vs. sI/R)). Lysosomal inhibitors were 
present throughout ischemia.  ISCH, ischemia; ISCH ‘normoxic’, ischemia-mimetic solution in 
presence of oxygen.   
 
 
Most AVs were formed during the reperfusion period, as cells fixed immediately 
after the ischemic period were essentially devoid of AVs, either with or without 
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lysosomal inhibitors, indicating a complete blockage of autophagy during the ischemic 
period (Fig. 27B).  Interestingly, hypoxia was a necessary component of the insult, as 
cells incubated in ischemia-mimetic solution alone, under normoxic conditions, exhibited 
only a minor reduction of autophagic flux which recovered completely upon reperfusion 
(Fig. 27A). 
V-2.2 Lysosomal activity during sI/R 
One possible explanation for the observed accumulation of AVs during sI/R was a non-
functional lysosomal compartment.  To investigate downstream lysosomal activity, HL-1 
cells were incubated in LysoTracker Red (LTR), which labels the highly acidic lysosomal 
vacuoles and thus reports activity of the vacuolar H+-ATPase (v-ATPase).  Before and 
after sI/R, we observed similar patterns of LTR fluorescence, indicating that, consistent 
with its importance in cell survival during I/R (Karwatowska-Prokopczuk et al., 1998), 
activity of the v-ATPase is maintained during the reperfusion period (Fig. 28A).   
Furthermore, we determined the activity and subcellular localization of cathepsin 
B, a predominant lysosomal protease, using a MagicRed substrate which fluoresces when 
cleaved by cathepsin B (Lamparska-Przybysz et al., 2005).  We did not detect a decrease 
in cathepsin B activity following sI/R, as MagicRed fluorescence was still punctate 
(lysosomal) and displayed an intensity comparable to the normoxic control (Fig. 28B).  
Moreover, we found that cathepsin B activity was not detected in the cytosol, indicating 
that cathepsin B is not released from the lysosomes following sI/R.  Together, these 
results indicate a functional lysosomal compartment during our experiments.   
 
FIG. 28.  (Next page) Assessment of lysosomal activity and participation in pro-death 
signaling. Representative images were aquired at 40x magnification under the exact same 
conditions to ensure comparability.  Multicolour look-up-tables were applied to grey scale images 
to visualize the range of fluorescence intensities with black representing lowest pixel values and 
white representing highest pixel values.  (A) Cells were subjected to the experimental conditions 
and then stained with 50 nM LTR.  Shown are maximum projections of total cellular LTR 
fluorescence in control cells (KH), cells subjected to 2 h ischemia followed by 1.5 h reperfusion 
(sI/R), and cells incubated in bafilomycin A1-containing KH solution (KH + Baf A1) to exemplify 
LTR staining during compromised vacuolar H+-ATPase activity.  (B) Cells were loaded with 
MagicRed cathepsin B substrate during the last 30 min of the experiment.  Shown are maximum 
projections of MagicRed stacks in control cells (KH), cells subjected to 2 h ischemia followed by 
1.5 h reperfusion (sI/R), and cells incubated in lysosomal inhibitor-containing KH solution (KH + i) 
to illustrate MagicRed staining under cathepsin B inhibition.  Similar results were obtained with 
LTR and MagicRed after 5 h reperfusion (data not shown).    
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V-3 Unraveling the role of autophagy in sI/R injury 
The above results demonstrate that formation of AVs is suppressed during ischemia, and 
that autophagic flux only partially recovers during reperfusion.  As such, to determine 
whether autophagy represents a protective response or a component of injury, we altered 
the autophagic pathway using pharmacological and molecular perturbations at the levels 
of induction and/or formation of AVs.   
 
V-3.1 Pharmacological perturbation of autophagy induction influences sI/R 
injury 
Phosphatidylinositol 3-kinases (PI3-K) exert opposing actions on the autophagic 
pathway, with class I PI3-K inhibiting and class III PI3-K stimulating autophagy (Petiot 
et al., 2000).  The PI3-K inhibitors 3-methyladenine (3-MA) and wortmannin (Arcaro 
and Wymann, 1993; Blommaart et al., 1997) are used as inhibitors of autophagy at the 
sequestration step due to their inhibition of class III PI3-K (Seglen and Gordon, 1982; 
Seglen and Bohley, 1992).  Conversely, the inhibition of autophagy by class I PI3-K is 
mediated through its downstream action on mammalian target of rapamycin (mTOR) 
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which negatively controls autophagy.  Inhibition of mTOR with the immunosuppressant 
rapamycin results in the induction of autophagy (Blommaart et al., 1995; Noda and 
Ohsumi, 1998; Ravikumar et al., 2006).  
Cells were treated with either 10 mM 3-MA or 100 nM wortmannin, to inhibit 
autophagy, or with 1 µM rapamycin, to enhance autophagy.  To verify the effect on 
autophagic flux, GFP-LC3 expressing cells were incubated with the indicated inhibitors 
and autophagic flux was evaluated in KH solution.  Both 3-MA and wortmannin 
completely abolished autophagic flux in KH solution (Fig. 29A).  During sI/R this was 
reflected in a complete lack of AV accumulation in cells treated with 3-MA and 
wortmannin (Fig. 29B). Treatment with rapamycin on the other hand increased autophagy 
in KH solution at the level of AV formation (Fig. 29A). It can be concluded that 
rapamycin-induced AV formation exceeds the capacity for AV degradation, since 
although a maximal percentage of cells showed active autophagy as revealed by 
lysosomal inhibition, the percentage of cells with high steady-state AVs increased 
significantly.  During sI/R, rapamycin-treated cells still displayed numerous AVs (Fig. 
29B).  Determination of autophagic activity during sI/R revealed that rapamycin did not 
rescue autophagy during ischemia, but increased autophagic flux at 1.5 h reperfusion as 
fewer cells displayed steady-state accumulation of AVs (Fig. 29C). 
The effect of pharmacological interference with the activation of autophagy on 
sI/R-induced cellular injury was evaluated based on mitochondrial clustering of GFP-Bax 
(Fig. 30A).  Under normoxic control conditions, over the duration of the experiment both 
3-MA and wortmannin slightly increased basal levels of GFP-Bax clustering.  Incubation 
with 3-MA and wortmannin prior to and during sI/R resulted in a significant aggravation 
of cellular injury.   
Similarly, disruption of lysosome function increased sI/R injury.  Under normoxic 
control conditions lysosomal inhibition did not affect cell viability for up to 7 hours, as 
assessed by GFP-Bax clustering (Fig. 30B).  However, lysosomal inhibition significantly 
increased GFP-Bax clustering following sI/R, indicating that lysosomal proteases do not 
exert pro-apoptotic functions during sI/R but rather participate in the maintenance of cell 
survival.  In contrast, cells treated with rapamycin were significantly protected against 
sI/R injury, suggesting that autophagy may serve a pro-survival role during sI/R injury.  
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FIG. 29.  Pharmacologic interference with autophagy induction. Cells were pre-treated with 
the indicated inhibitors for 1 h in Claycomb medium prior to incubation in experimental conditions. 
Inhibitors were also present in both ischemic and reperfusion buffers.  (A) GFP-LC3 expressing 
cells were pre-treated with rapamycin (Rm, 1 µM), 3-MA (10 mM), or wortmannin (Wm, 100 nM) 
for 1 h in Claycomb medium and then incubated in KH solution with and without lysosomal 
inhibitors for 2 h. Rm, 3-MA, and Wm were also present during incubation in KH solution.  The 
presence of punctate GFP-LC3-positive AVs was then assessed per incubation condition 
(*p<0.001).  (B) Representative images of cells treated with the indicated inhibitors and subjected 
to sI/R are shown. (C) GFP-LC3 expressing cells were subjected to 2 h ischemia followed by 1.5 
h reperfusion with and without rapamycin.  Autophagic flux was then determined as described 
above (*p<0.05 (sI/R vs. sI/R + Rm flux).   
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FIG. 30.  Effect of pharmacological interference upstream of AV formation on sI/R injury.  
(A) GFP-Bax expressing cells were pre-treated with the indicated inhibitors for 1 h in Claycomb 
medium prior to incubation in experimental conditions (Wm, wortmannin; Rm, rapamycin). 
Inhibitors were also present in both ischemic and reperfusion buffers. At 5 h of reperfusion, GFP-
Bax expressing cells were classified as displaying diffuse cytosolic or punctate mitochondrial 
GFP-Bax localization.  Represented is the percentage of cells with punctate GFP-Bax distribution 
per total cells scored (†p<0.05 vs. normoxic control; *p<0.05 and **p<0.001, vs. sI/R control).  (B) 
GFP-Bax expressing cells were subjected to sI/R in the presence of the lysosomal inhibitor 
cocktail.  At 5 h of reperfusion cells were classified as displaying diffuse cytosolic or punctate 
mitochondrial GFP-Bax localization. Represented is the percentage of cells with punctate GFP-
Bax distribution per total cells scored (*p<0.05).   
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V-3.2 Beclin1 protects from sI/R-activated injury and increases autophagic flux 
The above results implicate autophagy as a protective response to I/R injury.  However, 
the pharmacological reagents employed are known to also exert effects unrelated to 
autophagy (Caro et al., 1988; Brunn et al., 1996; Xue et al., 1999).  We therefore sought 
to confirm these findings by targeting specific proteins in the autophagic pathway.  
Beclin1, which is endogenously expressed in HL-1 cells (Fig. 31A), is a necessary 
participant in AV formation and also believed to take part in the trafficking of lysosomal 
proteins (Liang et al., 1999; Kihara et al., 2001).  We examined the effect of 
overexpression of Beclin1 on sI/R-induced cellular injury.  Similar to the protective 
effect of rapamycin, cells which had been transiently transfected with Beclin1 were 
significantly protected against sI/R-induced GFP-Bax clustering (Fig. 31B). 
We subsequently reduced Beclin1 expression using the Block-iT miR RNAi 
vector which bicistronically encodes for GFP as an expression marker. We found that 96 
hours of expression were necessary in order to achieve a significant knock-down of 
Beclin1 (Fig. 31C).  Beclin1 silencing aggravated cellular injury after sI/R (Fig. 31D, E), 
revealing that autophagic activity following sI/R, although somewhat impaired, is a 
crucial component of the cell’s survival response. 
 
 
 
 
 
FIG. 31.  (Next page) Beclin 1 overexpression protects against sI/R injury.  (A) Total Beclin1 
expression levels were compared between whole cell lysates of control cells and cells transiently 
transfected with flag-Beclin1 (61 kDa) or flag-Beclin1∆Bcl2BD (52 kDa) for 48 h. 
Immunodetection of total Beclin1 demonstrated successful overexpression of constructs.  (B) 
Cells were co-transfected with GFP-Bax and empty vector, flag-Beclin1, or flag-Beclin1∆Bcl2BD.  
At 5 h reperfusion, cellular injury was assessed by scoring cells with mitochondrial translocated 
GFP-Bax. Represented is the percentage of cells with punctate GFP-Bax distribution per total 
cells scored (*p<0.01).  (C) Cells were transfected with a vector encoding RNAi against either 
Beclin1 or LacZ.  Whole cell lysates were prepared after 96 h of expression (at which time 
transfection efficiency was ~30%) and used for immunoblot detection of protein downregulation.  
(D) For assessment of cellular injury, cells were co-transfected with mCherry-Bax and the RNAi 
vectors as indicated.  Co-expression of mCherry-Bax and RNAi after 96 h was confirmed with the 
help of GFP which is bicistronically included in the RNAi vectors.  (E)   96 h after transfection, 
cells were subjected to sI/R and GFP-positive cells with mitochondrial mCherry-Bax were scored 
and quantified as described above (*p<0.05).   
 
                                                                
RESULTS: Autophagy protects
 
against
 
sI/R
          
V
 
 
91 
0
10
20
30
40
50
60
70
Vector Beclin1 Beclin1
∆Bcl2BD
%
 
ce
lls
 
w
ith
 
pu
n
ct
a
te
 
GF
P-
Ba
x 
.
KH sI/R
0
10
20
30
40
50
LacZ RNAi Beclin1 RNAi%
 
ce
lls
 
w
ith
 
pu
n
ct
a
te
 
m
Ch
e
rr
y-
Ba
x 
. KH sI/R
A B
Beclin1
Beclin1∆Bcl2BD
Actin
Be
cli
n
1
∆
Bc
l2
BD
Co
n
tro
l
Be
cl
in
1
Co
n
tro
l
Actin
Beclin1
C D
GFP-RNAi mCherry-Bax
E
Be
cli
n
1 
RN
Ai
 
 
La
cZ
RN
Ai
Actin
Beclin1
*
*
 
 
                                                                
RESULTS: Autophagy protects
 
against
 
sI/R
          
V
 
 
92 
To determine if protection conferred by Beclin1 overexpression correlated with 
increased autophagic flux, LC3 processing was quantified in cells expressing Beclin1 
following sI/R.  Fluorescence analysis of GFP-LC3 co-transfected cells revealed a 
significant increase in autophagic flux after sI/R, as the percentage of cells with steady-
state accumulation of AVs was decreased (Fig. 32A).     
The interaction between Beclin1 and the class III PI3-K, Vps34, is a prerequisite 
for the induction of autophagy (Kihara et al., 2001), through the generation of 
phosphatidylinositol 3-phosphate (PI3-P) which functions as a second messenger to 
activate autophagy (Petiot et al., 2000).  To obtain insight into the effect of Beclin1 on 
the initiation of AV formation, we utilized GFP-2xFYVE, a sensor for the intracellular 
presence and distribution PI3-P.  The binding pocket of FYVE is specific for PI3-P 
(Vieira et al., 2001), and upon generation of PI3-P, GFP-2xFYVE concentrates at sites of 
production, allowing for a qualitative measure of PI3-P.  Under control conditions (KH 
solution) and at 1.5 h reperfusion, vesicular accumulation of GFP-2xFYVE was detected.  
This labeling was dependent on PI3-K activity, as treatment with wortmannin resulted in 
a homogenous distribution of GFP-2xFYVE.  In KH solution and during reperfusion, 
both control cells and cells overexpressing Beclin1 exhibited large clusters of GFP-
2xFYVE-labeled vesicles, indicating a robust generation of PI3-P (Fig. 32D).   
 
 
V-3.3 Beclin1 protection against sI/R injury requires a functional Bcl-2 binding 
domain 
Beclin1 contains a Bcl-2 binding domain which has been shown to interact with the anti-
apoptotic Bcl-2 family members Bcl-2 and Bcl-xL (Liang et al., 1998; Pattingre et al., 
2005).  In Chapter IV we found that the autophagic response to starvation requires a 
functional Beclin1 Bcl2 binding domain (IV-2.4).  To determine whether the protection 
conferred by Beclin1 following sI/R was regulated by the Bcl-2 family, we made use of a 
Beclin1 deletion mutant, Beclin1∆Bcl2BD, which lacks the Bcl-2 binding domain (Liang 
et al., 1998) (Fig. 31A), but still can  function in autophagy induction (Pattingre et al., 
2005; Shibata et al., 2006).  Beclin1∆Bcl2BD reduced autophagic activity during the 
reperfusion period as reflected in a decreased percentage of cells with steady-state 
accumulation of AVs as well as a complete absence of autophagic flux (Fig. 32A).  
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Unlike overexpression of Beclin1, Beclin1∆Bcl2BD expression did not confer protection 
against sI/R injury (Fig. 31B), confirming a cytoprotective role for autophagy. 
Beclin1∆Bcl2BD may interfere with endogenous Beclin1 interaction with the PI3-K, 
Vps34, as PI3P-induced GFP-2xFYVE clustering was decreased under control 
conditions, and at 1.5 h reperfusion (Fig. 32B). 
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FIG. 32.  Beclin1-mediated protection in sI/R correlates with its effect on autophagy.  (A) 
Cells were co-transfected with GFP-LC3 and empty vector, Beclin1, or Beclin1∆Bcl2BD.  At 1.5 h 
reperfusion, autophagic flux was determined via fluorescent imaging of GFP-LC3-II without 
(steady-state AVs) and with (cumulative AVs) lysosomal inhibitors.  Represented is the 
percentage of cells with numerous GFP-LC3 vacuoles per total cells scored (*p<0.01; **p<0.05; 
flux Vector vs. Beclin1: p<0.05).  (B) Cells were co-transfected with GFP-2xFYVE and empty 
vector, Beclin1, or Beclin1∆Bcl2BD and incubated in KH or subjected to 2 h ischemia followed by 
1.5 h reperfusion.  Shown are representative cells of each condition.     
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V-3.4 Inhibition of Atg5 aggravates injury and counteracts protection conferred 
by Beclin1 
We next sought to determine whether the protective effect exerted by Beclin1 was 
specific to autophagy, or rather the result of a perturbation in the ratio of pro- and anti-
apoptotic Bcl-2 family members, via binding of Beclin1 to Bcl-2 and/or Bcl-xL.  To do so 
we targeted Atg5, a necessary component of the autophagic machinery downstream of 
Beclin1 activity (Mizushima et al., 2001).  We utilized mCherry-Atg5 and the dominant 
negative mCherry-Atg5K130R which were characterized in Chapter IV (IV-2.3).   
Autophagic flux at 1.5 h following sI/R was virtually the same for cells 
expressing mCherry-Atg5 and mCherry alone, suggesting that Atg5 is not a rate-limiting 
factor in the autophagic response to sI/R.  Conversely, mCherry-Atg5K130R significantly 
reduced autophagy during sI/R (Fig. 33A).  To assess the consequence of reducing 
autophagy via expression of mCherry-Atg5K130R, HL-1 cells were co-transfected with 
GFP-Bax and either mCherry-Atg5, mCherry-Atg5K130R, or mCherry alone, and subjected 
to sI/R (Fig. 33B).  Consistent with the lack of an effect on autophagic flux, mCherry-
Atg5 expression did not affect sI/R-induced GFP-Bax activation.  Similar to the results 
obtained through silencing of Beclin1, mCherry-Atg5K130R expression resulted in 
increased GFP-Bax clustering, indicating that residual autophagic activity represents an 
underlying protective response to sI/R.   
Finally, to determine if Beclin1-mediated protection was due to its effect on 
autophagy, we blocked autophagy with mCherry-Atg5K130R in Beclin1 overexpressing 
cells.  Strikingly, protection resulting from Beclin1 expression was lost when co-
expressing mCherry-Atg5K130R, indicating that Beclin1 protection is entirely linked to its 
role in increasing autophagy (Fig. 33C).   
 
                                                                
RESULTS: Autophagy protects
 
against
 
sI/R
          
V
 
 
95 
0
10
20
30
40
50
60
Vector Atg5 Atg5(K130R)%
 
ce
lls
 
w
ith
 
pu
n
ct
a
te
 
G
FP
-
Ba
x 
. KH sI/R
0
10
20
30
40
50
60
70
80
Vector Beclin1 Beclin1 +
Atg5(K130R)
%
 
ce
lls
 
w
ith
 
pu
n
ct
a
te
 
GF
P-
Ba
x 
.
KH sI/R
Figure 33. Hamacher
C
A
*
*
**
B
0
10
20
30
40
50
sI/R + Vector sI/R + Atg5 sI/R +
Atg5(K130R)
%
 
ce
lls
 
w
ith
 
n
u
m
e
ro
u
s 
G
FP
-
LC
3 
va
cu
o
le
s
Steady-state AVs Cumulative AVs
11.1 9.9
3.4
*
 
FIG. 33.  Inhibition of Atg5 increases sI/R injury and abolishes protection through Beclin1.  
Cells were transfected with either (A) GFP-LC3 or (B) GFP-Bax together with mCherry-Atg5, 
mCherry-Atg5K130R, or mCherry alone (Control) and allowed to express for 48 h.  Co-expression 
of GFP and mCherry was found to be >95%.  (A) Autophagic flux at 1.5 h reperfusion was 
determined via scoring of mCherry-positive cells with numerous GFP-LC3 vacuoles without 
(steady-state AVs) and with (cumulative AVs) lysosomal inhibitors.  Represented is the 
percentage of cells with numerous GFP-LC3 vacuoles per total cells scored (*p<0.01).  (B) Cells 
were subjected to simulated ischemia followed by 5 h reperfusion, and cellular injury was 
assessed by scoring mCherry-positive cells with mitochondrial-translocated GFP-Bax.  
Represented is the percentage of cells with punctate GFP-Bax distribution per total cells scored 
(*p<0.01).  (C) Cells were co-transfected with GFP-Bax and Beclin1 plus mCherry, Beclin1 plus 
mCherry-Atg5K130R and subjected to sI/R 48 h after transfection.  mCherry-positive cells with 
mitochondrial GFP-Bax were scored and quantified as described above (*p<0.001; **p<0.05).   
 
 
  
 
 
 
 
 
 
 
 
 
Chapter 6 
 
 
 
Mitophagy as Part of the Autophagic Survival Response 
during Simulated Ischemia/Reperfusion Injury in HL-1 
Cardiac Myocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
___________________________________________________________________ 
Adapted from: Hamacher-Brady A., Brady N.R., Logue S.E., Sayen M.R., Jinno M., 
Kirshenbaum L.A., Gottlieb R.A., and A.B. Gustafsson (2006). “Response to myocardial 
ischemia/reperfusion injury involves autophagy and Bnip3.” Cell Death Differ., in press. 
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The central importance of mitochondria in determining cell viability following I/R has 
been increasingly recognized in recent years.  Preservation of mitochondrial integrity is 
essential for the survival of the cardiac myocyte as it guarantees the maintenance of the 
cell’s energetic homeostasis, while compromised mitochondrial integrity ultimately leads 
to the conversion of mitochondria into executers of programmed cell death.  In Chapter 
III we observed that mitochondrial networks of HL-1 cells fragmented during sI/R.  
Reformation of the mitochondrial network correlated with cell viability, whereas 
fragmented mitochondria eventually became targets of pro-apoptotic Bax.  Autophagy is 
a mechanism capable of removing organelles such as mitochondria (mitophagy) and, as 
described in Chapter V, autophagy is a powerful protective pathway against I/R injury.   
As mitochondrial dysfunction is a key component in I/R injury and ultimately 
decides cell fate, we hypothesized that autophagy may help maintaining cell viability via 
the selective scavenging of pro-apoptotic mitochondria. As such, autophagy would allow 
a cardiac myocyte to remain viable up to a threshold, which would be a balance between 
the removal of dysfunctional mitochondria and the ability of the remaining mitochondria 
to meet the energetic demands of the cell.  We speculated that in sI/R dysfunctional 
mitochondria would be removed via autophagy.   Using sI/R of the cardiac HL-1 cell line 
as an in vitro model of I/R injury to the heart and overexpression of Bnip3 as a surrogate 
for I/R-induced mitochondrial damage we investigated the relationship between 
mitochondrial dysfunction and autophagy.   
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VI-1 Fragmented mitochondria are targets of autophagy during 
reperfusion  
sI/R-activated mitochondrial fragmentation (Chapter III) coincides spatially with the 
accumulation of AVs occurring at reperfusion (Chapter V), as both fragmented 
mitochondria (Fig. 8A) and AVs (Fig. 26A) were predominantly present in perinuclear 
regions.       
Dysfunctional mitochondria can be removed from the cell via autophagy (Elmore 
et al., 2001; Lemasters, 2005; Priault et al., 2005).  Studies employing electron 
microscopy have previously shown that mitophagy occurs in the heart. In the perfused 
rabbit heart model, Decker and Wildenthal demonstrated that autophagic sequestration of 
mitochondria was a prominent event during the reperfusion phase following a mild 
hypoxic insult (Decker et al., 1980; Decker and Wildenthal, 1980).  To investigate if 
mitochondria were sequestered by autophagosomes in our model of sI/R, we performed 
3D imaging of HL-1 cells co-transfected with mito-DsRed2 and GFP-LC3 in order to 
detect mitochondrial autophagy with high spatial resolution.  
Merged Z-stacks of mito-DsRed2 and GFP-LC3 fluorescence taken of live cells 
after sI/R indicated the colocalization of mitochondria and AVs, as seen in the 3-plane 
view of Fig. 34A.  Detailed image analysis revealed that small mitochondrial fragments 
were in fact present within the GFP-LC3 labeled structures, i.e. undergoing mitophagy 
(Fig. 34B).  Since autophagy is likely to fulfill functions in addition to the removal of 
mitochondria, it is to be expected that not all autophagosomes contain mitochondria. 
Furthermore, during the execution of mitophagy, once delivered to the lysosome, mito-
DsRed2 fluorescence is quenched at low pH and degraded by lysosomal proteases.  
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FIG. 34.  sI/R leads to autophagic sequestration of fragmented mitochondria.  HL-1 cells 
were co-transfected with mito-DsRed2 and GFP-LC3 to simultaneously visualize mitochondria 
and autophagosomes and subjected to 2 h ischemia in hypoxic pouches followed by reperfusion 
in normoxic KH solution.  Live cells were then analyzed by fluorescence microscopy. (A) Shown 
is the 3-plane view of a 3D deconvolved Z-stack acquired at 60x magnification with 0.3 µm 
increments at 90 min reperfusion. (B) 3D reconstructions of merged GFP-LC3 and mito-DsRed2 
fluorescence were produced with ImageJ of a subcellular region with apparent colocalization of 
mito-DsRed2 and GFP-LC3 (arrow in (a)). Scale bar, 1 µm. 
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VI-2 Bnip3 overexpression as a surrogate for sI/R-induced mitochondrial 
dysfunction  
We hypothesize that mitophagy could constitute a cytoprotective mechanism during sI/R 
via the selective scavenging of dysfunctional mitochondria.  To test this hypothesis, we 
employed overexpression of Bnip3 as a model for sI/R-activated mitochondrial 
dysfunction.   
Bnip3 is a pro-apoptotic member of the Bcl-2 family and is known to exert its 
pro-apoptotic function by compromising mitochondrial integrity (Vande Velde et al., 
2000).  Overexpression of Bnip3 has been shown to induce cell death related to MPTP 
activation, increased ROS production and autophagic activity (Chen et al., 1997; Daido et 
al., 2004; Kanzawa et al., 2005).  As such, Bnip3 may be an important point of crosstalk 
between the apoptotic and autophagic pathways.  We speculated that Bnip3-induced 
mitochondrial dysfunction was connected to its autophagy-inducing properties, rendering 
it a suitable model to mimic and study the relationship between sI/R-induced 
mitochondrial dysfunction and autophagy in isolation from other molecular events 
occurring during sI/R. 
Bnip3 is expressed at high levels in the adult myocardium and contributes to I/R-
induced mitochondrial dysfunction in the ex vivo heart (Hamacher-Brady et al., 2006).  
First, we verified that similarly Bnip3 contributes to sI/R injury in HL-1 cells using RNAi 
knockdown of Bnip3 (Fig. 35A).  Cells transfected with RNAi directed against Bnip3 
were significantly protected against sI/R-induced GFP-Bax activation (Fig. 35B), 
demonstrating that Bnip3 is a mediator of injury in our in vitro model of sI/R. 
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FIG. 35.  Bnip3 mediates sI/R injury in the HL-1 cardiac myocyte.  (A) Cells were transfected 
with RNAi directed against LacZ, as a control, or Bnip3. 48 h after transfection, cell lysates were 
analyzed for Bnip3 content via Western blotting.  (B) Cells were co-transfected with GFP-Bax and 
RNAi against LacZ or Bnip3. After 48 h of expression, cells were subjected to sI/R and GFP-Bax 
clustering was analyzed (*p<0.01).       
 
 
Furthermore, overexpression of Bnip3 resulted in cell death over extended periods 
of time, detectable over 24-72 h (Fig. 36), indicating that overexpression of Bnip3 is 
sufficient to exert its pro-apoptotic function.   
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FIG. 36.  Bnip3 overexpression activates 
cell death in HL-1 cardiac myocytes.  
Cells were transfected with either empty 
vector (Control) or Bnip3 and cell death was 
monitored using YoPro1 as a vital exclusion 
dye.  Similar results were obtained in three 
independent experiments.   
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VI-3 Bnip3 induces autophagy in cardiac HL-1 cells 
A unique feature of Bnip3 is its C-terminal transmembrane (TM) domain which is 
required for its pro-apoptotic function, including its targeting to the mitochondria (Chen 
et al., 1997; Yasuda et al., 1998).  Bnip3∆TM, which lacks this transmembrane domain, 
has been shown to act as a dominant negative, blocking Bnip3-induced cell death 
(Kubasiak et al., 2002; Regula et al., 2002; Kothari et al., 2003).  Accordingly, we used 
Bnip3∆TM expression to investigate the effects of Bnip3 on mitochondria.   
To investigate the link between I/R-induced autophagy and Bnip3 activation, HL-
1 cells were transiently transfected with wild type Bnip3 or Bnip3∆TM.   The level of 
autophagy was assessed under normoxic conditions in full medium.  As shown in Fig. 
37A and B, overexpression of Bnip3 caused a significant increase in the steady-state 
levels of AVs compared to control cells.  In contrast, Bnip3∆TM-transfected cells did not 
show a significant increase in AV levels.  As demonstrated in Chapters IV and V, 
increased basal levels of AVs do not sufficiently report autophagic activity.  To 
investigate if the Bnip3-induced increased number of AVs reflected increased autophagic 
flux or an accumulation of AVs due to compromised downstream degradation, we 
employed inhibition of lysosomal activity.  As introduced in Chapter IV, the difference 
between the accumulation of GFP-LC3-labeled AVs under steady-state conditions and 
conditions of lysosomal inhibition serves as a quantitative index of autophagic activity.  
We found that Bnip3 increased both AV formation and autophagic flux (Fig. 37C). 
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FIG. 37.  Bnip3 overexpression increases autophagic flux in full medium.  (A) HL-1 cells 
were co-transfected with GFP-LC3 and empty vector (Control), Bnip3, or Bnip3∆TM.  After 48 h, 
the extent of autophagy was assessed by analyzing staining patterns of GFP-LC3.  (B) 
Quantification of autophagy in transfected cells. Overexpression of Bnip3 in cardiac myocytes 
significantly increased the abundance of AVs (*p<0.05).  (C) HL-1 cells were co-transfected with 
GFP-LC3 and empty vector (Control) or Bnip3.  48 h following transfection, cells were incubated 
with the lysosomal inhibitor cocktail for 7 h in full medium.  Quantification of autophagic flux 
demonstrates that lysosomal inhibitors dramatically increased the abundance of AVs, and that 
Bnip3 increased autophagic flux (p<0.01).  
 
 
In addition, we stained Bnip3-transfected cells with LysoTracker Red (LTR) to 
monitor activity of the lysosomal compartment.  We found co-localization of GFP-LC3 
and LTR, indicating fusion between autophagosomes and lysosomes (Fig. 38).  No 
differences were observed in total LTR staining between control and Bnip3-
overexpressing cells (data not shown).  Notably, LTR staining was dispersed throughout 
the cell in control cells, but was more concentrated to regions of high autophagosomal 
content in Bnip3 overexpressing cells.    
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FIG. 38.  Fusion between AVs and 
lysosomes seems functional in Bnip3-
overexpressing cells.  48 h following co-
transfection with GFP-LC3 and Bnip3, HL-1 
cells were loaded with 50 nM LTR.  Co-
localization of LysoTracker Red (LTR) and 
GFP-LC3 demonstrates formation of 
autophagolysosomes. LTR staining was 
prominent in the area containing 
autophagosomes. Scale bar, 10 µm. 
 
VI-4 Bnip3 causes autophagy of mitochondrial fragments 
Several studies have reported that Bnip3 overexpression causes mitochondrial 
dysfunction.  Closer examination of mitochondria in Bnip3-transfected cells revealed a 
widespread fragmentation of the mitochondrial network, whereas cells transfected with 
vector or Bnip3∆TM had typical filamentous mitochondria (Fig. 39).   
 
Control Bnip3 Bnip3∆TM
 
FIG. 39. Bnip3 overexpression results in fragmentation of the mitochondrial network.  Cells 
were co-transfected with mito-DsRed2 and vector (Control), Bnip3, or Bnip3∆TM and images 
were acquired of live cells 48 h after transfection. Shown are maximum projections of 
representative images.      
 
 
Above we described that in sI/R fragmented mitochondria were targets of 
autophagy (Fig. 34).  To investigate if autophagic removal of mitochondria was caused 
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by sI/R-induced mitochondrial damage, we investigated whether Bnip3 overexpression 
would likewise lead to mitophagy.  To detect mitophagy we employed laser scanning 
confocal microscopy of cells expressing mito-DsRed2-labeled mitochondria and GFP-
LC3-labeled autophagosomes.  Analysis of generated Z-stacks revealed extensive 
mitophagy in Bnip3-cotransfected HL-1 cells, where many GFP-LC3 labeled 
autophagosomes co-localized with fragmented mitochondria (Fig. 40A).  3D surface 
rendering of confocal Z-stacks revealed different stages of engulfment of individual 
mitochondria (Fig. 40B).  We did not observe instances of mitophagy in control or 
Bnip3∆TM transfected cells (data not shown).   
 
VI-5 Autophagy is a protective response against Bnip3-induced cell death 
In Chapter V we showed that enhancing autophagy protects against sI/R injury.  We 
hypothesized that this protection was partly due to the sequestration of dysfunctional 
mitochondria since mitophagy was a prominent feature of the autophagic response to sI/R 
(Fig. 34).  Bnip3 is involved in I/R-induced mitochondrial dysfunction (Hamacher-Brady 
et al., 2006) and we found that overexpression of Bnip3 leads to mitophagy (Fig. 40).  
Thus, we investigated whether autophagy protects against Bnip3-induced cell injury.   
We found that overexpression of autophagy protein Beclin1 protected against 
Bnip3-mediated cell death in HL-1 cells (Fig. 41A). Conversely, co-expression of 
Beclin1∆Bcl2BD aggravated Bnip3-induced cell death, further indicating the importance 
of physiologically regulated Beclin1.  Similarly, overexpression of Atg5 significantly 
reduced Bnip3-mediated cell death (Fig. 41B).  In contrast, the dominant negative 
Atg5K130R increased Bnip3-mediated cell death.   
Together, these results indicate that autophagy protects against Bnip3-mediated 
mitochondrial dysfunction in sI/R via the selective scavenging of malfunctioning 
mitochondria.   
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FIG. 40.  Bnip3 overexpression activates mitophagy.  HL-1 cells were co-transfected with mito-
DsRed2, GFP-LC3and Bnip3.  48h following transfection GFP-LC3 distribution and mito-DsRed2-
labeled mitochondria were detected by 3D confocal imaging.  (A) Mitochondria appeared 
fragmented and were observed within autophagosomes.  Scale bar, 3 µm.  (B) Surface volume 
rendering reveals the mitophagic process in 3D showing different stages of mitochondrial 
engulfment in Bnip3 overexpressing cells:  (i) mitochondrion undergoing sequestration (A, open 
arrow), and (ii) engulfed mitochondrion (A, closed arrow).  
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FIG. 41.  Modulation of autophagy affects Bnip3-mediated cell death. (A) Cells were co-
transfected with DsRed2 as a transfection marker and Bnip3 together with pcDNA3.1, Beclin1, or 
Beclin1∆Bcl2BD. At 48 h after transfection, cell death of DsRed2-positive cells was assessed 
using YoPro1 as a vital exclusion dye (*p<0.01; **p<0.05).  (B) Cells were transfected with Bnip3 
and mCherry, mCherry-Atg5 or mCherry-Atg5K130R and cell death was assessed 48 h after 
transfection using YoPro1 (*p<0.05). 
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I/R injury results in cell death of cardiac myocytes, a terminally differentiated cell type of 
finite number, and consequently reduced myocardial function.  Although the relative 
contributions of necrosis and apoptosis (PCD type I) are still subject to much debate, both 
are established as modes of cell death contributing to I/R injury (Kajstura et al., 1996).  
Apoptosis is a highly-regulated genetic program that allows for intervention and thus, 
rescue of cells.  As such, there is much interest and need in elucidating the participants 
and mechanisms involved in the regulation of cardiac myocyte apoptosis in order to 
develop pharmaceutical compounds to treat heart disease.  
In recent years, autophagy has come to the forefront of scientific attention, due to 
the characterization of its molecular mechanism in yeast and the identification of 
mammalian homologues of autophagic proteins (Klionsky and Emr, 2000).  It has 
emerged that autophagy is a crucial process for maintaining cell homeostasis and 
disruption to the pathway can be a contributing factor to many diseases.  Decreased 
autophagy may be causative in the development of  cancer (Yue et al., 2003) and 
neurodegenerative conditions including Alzheimer’s (Nixon et al., 2005) and Parkinson’s 
diseases (Webb et al., 2003; Ravikumar et al., 2004; Shibata et al., 2006).  Furthermore, 
excessive autophagy is recognized as a form of PCD linked to, but distinct from 
apoptosis (Codogno and Meijer, 2005).   
A growing number of studies report the prevalence of autophagosomes 
(autophagic vesicles, AVs) in cardiac disease.  However, the literature to date consists 
mainly of correlative studies which infer the role of autophagy as either detrimental or 
beneficial: autophagic cell death (PCD type II) has been implicated in myocardial 
dysfunction (Hein et al., 2003; Akazawa et al., 2004; Saijo et al., 2004) , however, during 
ischemic injury autophagy may be a protective response  (Decker and Wildenthal, 1980; 
Yan et al., 2005).   
Thus, the main objective of this thesis was to investigate the role of autophagy in 
I/R-induced activation of cell death pathways.  This was accomplished by (1) the 
establishment of a cardiac myocyte cell culture model allowing for the quantification of 
apoptotic signaling during I/R injury, and (2) developing a sensitive method for detecting 
and quantifying changes in autophagic activity.  Subsequently, (3) the cause-and-effect 
relationship between I/R-activated mitochondrial death signaling (apoptosis) and 
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autophagy was examined.  Finally, (4) based on the obtained results we investigated the 
autophagic removal of mitochondria (mitophagy) as a potential mechanism of protection. 
 
VII-1 Chapter I:  HL-1 cell culture model of myocardial I/R injury allowing for 
the spatio-temporal investigation of apoptosis-related signaling 
pathways 
Prerequisite for the investigation of apoptotic signaling in myocardial I/R was the 
development and characterization of a cell culture-based model thereof.  Prior to this 
body of work no such model existed that closely reflected the in vivo situation: 
commonly used myocyte cell lines (H9c2, C2C12) and cultured neonatal cardiac 
myocytes  require prolonged (from 8 to 24 h) hypoxia or simulated ischemia to activate 
death signaling pathways (Dougherty et al., 2002; Hollander et al., 2003; Hou and Hsu, 
2005).  Alternatively, oxidizing agents (e.g. hydrogen peroxide) or initiators of apoptosis 
(e.g. staurosporine) are employed as surrogates to explore I/R injury (Capano and 
Crompton, 2002; Akao et al., 2003), which do not necessarily recapitulate the events of 
I/R injury.  We sought to establish an acute model which closely resembles the in vivo 
signaling pathways during I/R injury to the heart, using the recently established cardiac 
HL-1 cell line which has been described as a successful model for studying many aspects 
of cardiac cell physiology (White et al., 2004).  As HL-1 cells are readily transfectable, 
as opposed to the adult cardiac cell which cannot be transfected using conventional 
means, we consider the HL-1 cell a unique system for investigating in a single cell 
resolution the pro-death and pro-survival pathways during I/R injury. 
We found that HL-1 cells reproducibly underwent PCD in response to an acute (2 
h) ischemic insult via pathways resembling in vivo myocardial I/R injury:  we 
demonstrate that in HL-1 cells sI/R leads to mitochondrial dysfunction, reflected by a 
collapse of ∆Ψm and increased mitochondrial ROS production, hallmarks of the I/R 
response by adult cardiac myocytes (Honda et al., 2005).  In addition, sI/R injury 
culminates in a redistribution of pro-apoptotic Bax and Bid, and finally cell death, 
revealing a carefully orchestrated cell death program (Fig. 42).    
                                                                                                   
DISCUSSION
          
VII
 
 
115 
 Of note is that our model of sI/R conferred a rather mild insult, as the cell death 
program was executed over a time-course of several hours and therefore allowed us to 
study a heterogeneous cell population that, like the injured myocardium in vivo, 
comprised (i) cells which had suffered irreversible damage and underwent cell death and 
(ii) cells which had undergone sub-lethal stress and were able to recover eventually. 
VII-1.1  Mitochondrial dysfunction is an early event in sI/R injury to HL-1 cardiac 
myocytes   
A high ∆Ψm is an excellent indicator for functional mitochondria, which are considered a 
crucial parameter of cardiac cell viability (Di Lisa and Bernardi, 1998).  Mitochondria 
account for 30% of cardiac myocyte volume (Page et al., 1971) and supply the majority 
of ATP needed for contraction and maintenance of ionic homeostasis.  Apart from 
disrupting cellular ATP supply, uncoupling of oxidative phosphorylation, reflected in the 
loss ∆Ψm, can lead to increased leak of ROS from the electron transport chain (Vanden 
Hoek et al., 1997).  ROS production is a causative factor in I/R injury (Vanden Hoek et 
al., 1998; Levraut et al., 2003).  We found that in the first 90 min of reperfusion, sI/R-
induced mitochondrial dysfunction was apparent, reflected by loss of ∆Ψm and increased 
ROS generation.   
VII-1.2  Pro-apoptotic Bax activity 
By combining 4D imaging of GFP-biosensors and Western blotting, we were able to 
characterize the dynamics of pro-apoptotic Bcl-2 family members Bax and Bid, which 
are necessary components of the machinery mediating I/R-activated PCD in the heart 
(Peng et al., 2001; Hochhauser et al., 2003).  GFP-based Bax fusion proteins were used 
to quantify sI/R-induced Bax translocation and clustering on mitochondria in relation to 
mitochondrial remodeling and depolarization at the level of the single cell.   
In response to sI/R, Bax translocation occurred in two phases, a priming phase in 
which Bax coated the mitochondria homogeneously, and an activation phase in which 
Bax formed discrete clusters on the mitochondria. The coating phase occurred during 
ischemia and early reperfusion, whereas clustering occurred hours later.  Both phases 
were sensitive to the p38 inhibitor SB203580, and thus are likely to be mediated by p38 
activity.  This is consistent with the recent report by Capano and Crompton (Capano and 
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Crompton, 2002), who showed that Bax translocation and coating of mitochondria during 
ischemia was dependent on p38.   
 Bypassing the translocation phase via expression of mCherry-BaxT182A, which 
results in spontaneous Bax translocation to mitochondria, resulted in accelerated 
clustering during reperfusion.  However, forced Bax translocation alone was not 
sufficient to induce mitochondrial dysfunction, indicating that downstream events are 
critical in the activation of PCD.  Although previous studies have suggested that the loss 
of ∆Ψm occurs following Bax and Bid translocation (Scorrano et al., 2002), our data 
indicate that in this model, MPTP activation is upstream of Bax clustering.  The loss of 
∆Ψm is not necessarily indicative of MPTP activity.  However, as CsA inhibited Bax 
clustering, our results support the notion that sI/R-induced MPTP activation was an 
upstream event for the death signal cascades (De Giorgi et al., 2002; Precht et al., 2005).  
Importantly, hypoxia/reoxygenation was found to be a necessary component of sI/R, as 
incubation of HL-1 cells in normoxic ischemia-mimetic solution (metabolic inhibition 
without hypoxia) did not result in Bax activation.   
VII-1.3 Bid activation and translocation 
CFP-Bid-YFP was employed to track both the N- and C-terminal fragments of Bid.  A 
surprising finding was that Bid activation, via caspase 8, occurred downstream of Bax 
clustering.  This appears to contradict previous studies which have shown that Bax and 
Bid act in concert to release pro-apoptotic proteins from the mitochondria (Eskes et al., 
2000).  However, Bid may function to stimulate or amplify the cell death program by 
sequestering Bcl-2/-xL, thereby facilitating the pro-apoptotic actions of Bax (Yi et al., 
2003).   Another possibility for the relationship between Bid and Bax is that at sub-
detection levels tBid potentiates Bax clustering, and the second (obvious) phase of Bid 
activity involves massive destruction to the mitochondria, ensuring the point of no return.  
It is also possible that in this model, Bid is simply a bystander that undergoes processing 
at the time of general caspase activation.  Further work will be needed to establish the 
role of Bid in this system.  
Our findings that Bid cleavage is caspase 8-dependent in HL-1 cells is at variance 
with previous studies of our lab in isolated perfused hearts which showed that Bid 
cleavage was mediated by calpain (Chen et al., 2001), but is consistent with another study 
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(Scarabelli et al., 2002).  Calpain activation after global ischemia in the ex vivo heart has 
been attributed to excessive preload (input pressure at the left atrium) (Feng et al., 2001), 
which would be absent from this cell-based model. 
VII-1.4 Bcl-2 and Bax activation: role of subcellular localization 
Having used the GFP-based Bid and Bax biosensors to characterize the spatial and 
temporal dynamics of pro-apoptotic Bcl-2 family member signaling, we subsequently 
investigated the role of anti-apoptotic Bcl-2 and Bcl-xL.  Both Bcl-2 and Bcl-xL, which 
are potent protective proteins in myocardial I/R injury in vivo (Brocheriou et al., 2000; 
Huang et al., 2005 Schneider 2004), significantly reduced mitochondrial clustering of 
GFP-Bax.  Bcl-2 and Bcl-xL oppose apoptotic signals from the mitochondria, through 
stabilizing the mitochondrial outer membrane (Susin et al., 1996), and at the S/ER, by 
decreasing pro-apoptotic Ca2+ levels (Chami et al., 2004).  We found that Bcl-2 targeted 
to the mitochondria strongly reduced Bax activation, whereas Bcl-2 targeted to the S/ER 
did not afford protection.  Thus, in sI/R injury to the HL-1 cardiac myocyte, 
mitochondrial dysfunction is the major factor activating pro-death signaling.  
Furthermore, these results indicate that apoptotic Ca2+ signaling may not play a dominant 
role in I/R injury.  In agreement with out findings, mitochondrial Ca2+-overload was 
recently shown to be a secondary event following ROS-induced MPTP opening (Kim et 
al., 2006). 
It is interesting to note that the physiological implications of S/ER-targeted Bcl-2 
in the cardiac myocyte are unclear.  Conditions which trigger S/ER-Bcl-2 translocation 
have not been shown and it is not known if this is a normally occurring physiological 
response.  Although enforced Ca2+ release from S/ER stores, by either Bcl-2 or Bcl-xL, 
minimizes the Ca2+ signaling component of apoptosis (Chami et al., 2004), it is not 
known if S/ER targeted-Bcl-2 affects the ability of the cardiac myocyte to contract.  It is 
likely that the decrease of S/ER Ca2+ stores would be harmful to the heart by reducing its 
capacity to do work.   
VII-1.5 sI/R-induced mitochondrial fragmentation  
Mitochondria vary in regards to their morphology.  They can exist as largely 
interconnected networks or as independent units (Collins et al., 2002).  Interestingly, we 
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found that sI/R led to the fragmentation of the previously branched and elongated HL-1 
mitochondria into spherical shaped organelles.  Fragmentation of mitochondrial networks 
occurs in many instances of PCD (Karbowski et al., 2002; Lyamzaev et al., 2004; 
Skulachev et al., 2004), and protein mediators of mitochondrial morphology have been 
linked to PCD (Karbowski et al., 2002; Lee et al., 2004).  For instance mitofusin2 
(Mfn2), which participates in mitochondrial fusion (Santel and Fuller, 2001), has been 
shown to stabilize the MPTP and block Bax translocation (Neuspiel et al., 2005), whereas 
dynamin-related protein 1 (Drp1), which promotes mitochondrial fission (Smirnova et al., 
2001), has been shown to participate in Bax-mediated cytochrome c release (Frank et al., 
2001; Lee et al., 2004; Jagasia et al., 2005).  Conversely, Drp1 mediated fragmentation of 
mitochondrial networks has also been shown to be protective by limiting 
intramitochondrial propagation of pro-apoptotic calcium signaling (Szabadkai et al., 
2004).   
We found that ischemia resulted in fragmentation of the usually elongated and 
branched HL-1 mitochondrial population.  Unexpectedly, mitochondrial fragmentation 
occurred during ischemia, before loss of ∆Ψm and Bax translocation (Fig. 42), indicating 
that endogenous Drp1 activation occurs well before becoming engaged with the PCD 
pathway.  This differs from a report (Karbowski et al., 2002), by Youle’s group which 
described Bax translocation before fragmentation in Hela and Cos-7 cells.  Interestingly, 
at 5 h of reperfusion, SB203580-treated cells displayed elongated mitochondria, 
demonstrating that in the absence of Bax and p38 signaling, recovery of mitochondrial 
filamentous morphology was possible, supporting the notion of a relationship between 
Bax and the morphology machinery (Karbowski et al., 2002; Neuspiel et al., 2005) 
We found that by enforcing the fragmented morphology via overexpression of 
Drp1, HL-1 cells were protected from sI/R injury, as monitored by GFP-Bax clustering at 
the mitochondria.  Likewise, overexpression of Bcl-xL protected against sI/R injury 
without preventing sI/R-induced mitochondrial fragmentation.  Together, these results 
indicate that in HL-1 cells mitochondrial fragmentation is a reflection of the sI/R insult 
which counteracts the initiation of the apoptotic signaling cascade.  We hypothesize that 
the protection conferred by Drp1 is in part due to increased spacing between neighboring 
mitochondria, thereby maintaining localized ATP delivery needed for contraction as well 
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as ionic homeostasis, whilst limiting mitochondrion-to-mitochondrion transmission of 
ROS production through ROS-induced ROS release which mediates sI/R injury (Brady et 
al., 2004). 
VII-1.6  Conclusions 
The use of multicolor live-cell imaging enabled us to investigate the spatio-temporal 
behavior of Bax and Bid during sI/R, allowing unprecedented inquiry into the 
relationship between sI/R-induced pro-apoptotic signaling and mitochondrial dysfunction 
pathways. 
Furthermore, we conclude that the dynamics of GFP-Bax clustering at the 
mitochondria are an informative parameter of irreversible apoptotic injury to the HL-1 
cardiac myocyte, enabling us to investigate processes which enhance or inhibit the 
tendency of a cell to undergo apoptosis. 
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FIG. 42. Time-line of events during sI/R in HL-1 cells.  The scheme is an approximate 
representation reflecting the observed sequence of events during sI/R. Importantly, no causative 
relations are depicted. Bax translocation can start during ischemia, however is mostly detectable 
during reperfusion. Mitochondrial networks can be re-built during reperfusion in the presence of 
SB203580. 
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VII-2 Chapter IV:  Investigating autophagy in HL-1 cardiac myocytes 
Autophagy is emerging as both an important process for cell physiology, as well as a 
putative cytoprotective mechanism in the heart  (Kuma et al., 2004; Yan et al., 2005) 
(Depre et al., 2004).  The characterization of a GFP-LC3 fusion protein is a driving force 
in the autophagy field as it functions as  a unique and specific indicator for AVs in live 
cells (Kabeya et al., 2000).  Currently, a demonstration of either punctate GFP-LC3-II 
labeled AVs by fluorescence imaging, or LC3-II detection by Western blotting, are the 
standard means for detecting changes in autophagic activity.  However, it is important to 
note that lysosomal degradation of LC3-II varies according to cell type (Mizushima et al., 
2004), and LC3 forms I and II are differentially recognized by the LC3 antibodies 
(Kabeya et al., 2004), rendering it difficult to quantify LC3 processing via 
immunodetection.  Moreover, increased levels of AVs can represent impairment in the 
fusion with lysosomes rather than an upregulation in autophagic activity (Trost et al., 
1998).  Thus, one crucial objective of Chapter IV was to establish a technique for the 
quantitative assessment of autophagy.   
VII-2.1 Determination of autophagic flux 
It is well known that autophagic activity is upregulated in low nutrient conditions (e.g. 
amino acid and/or serum deprivation) when compared to high nutrient conditions (e.g. 
fully supplemented culture medium) (Kim and Klionsky, 2000).  Furthermore, the 
immunosuppressant rapamycin induces autophagy even under high nutrient conditions 
(Noda and Ohsumi, 1998), and the dominant negative Atg5K130R can be used to impair 
autophagy at the level of AV formation (Mizushima et al., 2001).  Hence, we chose those 
settings to develop and gauge a technique for the quantitative assessment of autophagy.  
To quantify autophagy in our experimental system, we inhibited lysosomal degradation 
and analyzed the accumulation of GFP-LC3-positive AVs during a given amount of time 
by fluorescence microscopy.  Our results dispute the widely held assumption that cellular 
AV (LC3-II) levels correlate with autophagic activity: we show that low AV levels can 
reflect either high lysosomal turnover of AVs or low autophagic activity.   Cells with low 
autophagic activity (full medium), high autophagic activity (nutrient deprivation), and 
impaired autophagy (expressing mCherry-Atg5K130R) all exhibit virtually identical low 
steady-state levels of GFP-LC3-labeled AVs.  Moreover, high AV levels can reflect either 
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enhanced AV formation (rapamycin) or blocked downstream degradation of AVs 
(lysosomal inhibition).  Thus, the determination of steady-state AV content is not an 
adequate qualitative or quantitative index of autophagy.  The differences in autophagic 
flux are only revealed when lysosomal trafficking is blocked.  Consequently, the 
difference in GFP-LC3 labeled AV content in the presence and absence of lysosomal 
inhibitors is the most informative gauge of the autophagic pathway.  Moreover, unlike 
commonly used assays measuring degradation of long-lived proteins, the technique we 
employed is specific to quantify macroautophagy.  Such a distinction is relevant, as 
chaperone-mediated autophagy (Paglin et al., 2005), which targets cytosolic proteins,  is 
strongly stimulated by ketone bodies which form during starvation (Finn and Dice, 2005) 
and oxidative stress (Kiffin et al., 2004).  In fact, recent findings indicate that CMA and 
macroautophagy may have compensating functions (Massey et al., 2006).  
VII-2.2 Regulation of Beclin1-mediated autophagy 
We then sought to apply our technique for the quantification of autophagic flux to 
elucidate the control over the Beclin1-mediated autophagic response exerted by its 
putative interacting partner Bcl-2.    
VII-2.2.1 Endogenous Bcl-2 promotes Beclin1-mediated autophagy during nutrient 
deprivation 
The nature of the interaction between Beclin1 and Bcl-2/-xL on autophagic activity is 
unclear. We found that Beclin1∆Bcl2BD reduced autophagy, indicating that Bcl-2 is a 
necessary participant for maximal Beclin1-mediated autophagic activity in the HL-1 
cardiac myocyte.  In line with this finding, it was shown in MEFs that Bcl-2 and Bcl-xL 
promote Atg5-Atg12 conjugation in response to etoposide (Shimizu et al., 2004).  On the 
other hand, Bcl-2 has been shown to suppress autophagy under certain conditions: 
Beclin1∆Bcl2BD functioned similar to wild-type Beclin1 to promote clearance of toxic 
huntingtin aggregates in neurons (Shibata et al., 2006) and Beclin1 lacking, or mutated 
in, the Bcl-2 binding domain caused a massive accumulation of AVs and induced cell 
death in both full medium and under starvation conditions (Pattingre et al., 2005).    
Pattingre et al. further demonstrated that AV content was negatively correlated with the 
amount of Bcl-2 that interacted with Beclin1, and that Bcl-2 binding of Beclin1 interferes 
with the Beclin1-Vps34 interaction which signals autophagy.  In support of this model 
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the authors showed that high levels of Bcl-2 and Beclin1 co-immunoprecipitated under 
high nutrient conditions, and, conversely Bcl-2 did not co-immunoprecipitate with 
Beclin1 under low nutrient conditions (Pattingre et al., 2005).  However,  Zeng et al. 
showed that endogenous Bcl-2 did not interact with Beclin1 in U-251 cells under full 
medium conditions; only through overexpression of Bcl-2 was this interaction detected 
(Zeng et al., 2006).  Moreover, Kihara et al. found that under full medium conditions in 
HeLa cells all of Beclin1 is bound to the class III PI 3-kinase Vps34 (Kihara et al., 2001).   
These diverging reports strongly suggest that rheostatic control of autophagy by Beclin1-
Bcl-2 interaction is not a universal mechanism.   
VII-2.2.2 S/ER-localized Bcl-2 depletes S/ER Ca2+-content, thereby inhibiting autophagy 
High S/ER Ca2+ stores are required for autophagy (Gordon et al.).  We found that S/ER-
Bcl-2 both suppressed autophagic activity similar to the previous report (Pattingre et al., 
2005) and reduced S/ER Ca2+ content, as previously shown (Dremina et al., 2004; Palmer 
et al., 2004).  Moreover, we directly demonstrated the Ca2+ requirement for autophagic 
activity: intracellular chelation of Ca2+ by BAPTA and depletion of S/ER Ca2+ stores by 
SERCA inhibitor thapsigargin both significantly suppressed autophagy.  Although 
overexpression of wild-type Bcl-2 slightly suppressed autophagy, this may reflect the 
amount of Bcl-2 protein localized to the S/ER, which was considerably less than when 
expressing S/ER-targeted Bcl-2 (results not shown).  We speculate that the specialized 
S/ER of the HL-1 cardiomyocyte, which contains high SERCA levels, is able to 
overcome some degree of Bcl-2 leak and maintain S/ER Ca2+-content in response to low 
levels of Bcl-2 (Palmer et al., 2004), yet would be impaired by supra-physiologic levels 
of Bcl-2 at the S/ER (Dremina et al., 2004).  It remains unknown if S/ER Ca2+ positively 
regulates autophagy, or if high cytosolic Ca2+ suppresses autophagy.  One possibility is 
that the C2 domain of Vps34 may respond to Ca2+ fluxes to signal the recruitment of the 
autophagic machinery to the Golgi membrane (Rizo and Sudhof, 1998).   
The findings that  overexpression of Bcl-2 leads to S/ER Ca2+ depletion and 
suppression of autophagy may be significant in our understanding of the autophagic 
processes in the heart.  The cardiomyocyte requires an efficient supply and delivery of 
ATP from the mitochondria to perform work and maintain ionic homeostasis.  Ca2+ 
couples mitochondrial ATP production to demand (I-3.2.3).  We provided evidence that 
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Ca2+ homeostasis further is coupled to the vital process of autophagy.  Autophagy is 
emerging as an important process involved in programmed cell death as well as 
cytoprotection.  We propose that the inability to mount an autophagic response due to 
depleted S/ER Ca2+ is relevant for paradigms of both cellular protection and cell death. 
VII-2.3 Conclusions: Chapter IV  
We established a technique for the quantitative assessment of macroautophagy based on 
the inhibition of lysosomal degradation of AVs.  By analyzing the percentage of cells 
with numerous AVs without (steady-state AVs) and with (cumulative AVs) lysosomal 
inhibition, we can discriminate between (a) the percentage of cells with disrupted 
autophagic flux (steady-state AVs), and (b) the percentage of cells with active autophagic 
flux (cumulative AVs minus steady-state AVs).  Using our novel technique to 
systematically determine autophagic flux, we were able to reveal a two-tiered relationship 
between autophagic activity and Bcl-2:  under normal conditions Bcl-2 is a necessary 
participant in autophagy via its interaction with Beclin1, yet under conditions in which 
Bcl-2 is artificially concentrated at the S/ER, the consequent depletion of lumenal Ca2+ 
results in an overriding inhibition of autophagy. 
 
VII-3 Chapter V:  Autophagy in sI/R 
In Chapter III we established a reproducible model for quantifying sI/R-activated 
apoptosis.  In Chapter IV we developed tools for perturbing and quantifying the 
autophagic pathway with unprecedented precision.  We subsequently sought to 
investigate the role of autophagy during sI/R injury.   
VII-3.1 Autophagic flux during sI/R 
Similarly to ex vivo reports of increased AV content during myocardial I/R injury 
(Decker et al., 1980; Decker and Wildenthal, 1980), we found that sI/R led to the steady-
state accumulation of AVs in HL-1 cardiac myocytes.  However, as described in Chapter 
IV, AV content does not correlate with autophagic activity: high steady-state AV content 
can be indicative of the cell’s inability to degrade formed AVs, due to either excessive 
AV formation, or a disruption of downstream degradation.  Utilizing the technique we 
developed for determining autophagic flux (Chapter IV), we found that the accumulation 
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of GFP-LC3-labeled AVs during sI/R is complex, resulting from simultaneous alterations 
in the induction and formation of AVs, their transit to and fusion with lysosomes, and 
their ultimate degradation within the autophagolysosomes (Fig. 43).  During ischemia, 
the formation of AVs was blocked.  Rapamycin treatment was unable to increase 
autophagy during the ischemic period, whereas autophagic flux was robust in cells 
incubated with the ischemic solution under normoxic conditions.  As the conjugation 
steps performed by E1-like Atg7 during the formation of the AV require ATP (Ichimura 
et al., 2000), it is likely that energetic constraints of hypoxia preclude autophagy during 
the ischemic period.      
Reperfusion led to an increase in the formation, and, to a lesser extent, 
degradation, of AVs.  However, the autophagic response, i.e. the percentage of cells with 
high cumulative AVs, was smaller than that seen in KH solution.  Thus, it is likely that 
autophagy is impaired at the level of induction.  This interpretation is supported by our 
finding that Atg5 overexpression did not increase autophagic activity, indicating that the 
autophagic machinery downstream of Beclin1-dependent induction was functional and 
not a rate-limiting factor.     
The steady-state accumulation of AVs in a significant percentage of sI/R-treated 
cells indicates a second disruption to the autophagic pathway downstream of AV 
formation.  One potential mechanism would be lysosomal dysfunction.  During the onset 
of some forms of PCD lysosomal proteases can be released into the cytosol where they 
trigger apoptosis via cleavage of Bid and perhaps other targets (Stoka et al., 2001; 
Cirman et al., 2004).  Furthermore, decreased activity of the predominant lysosomal 
protease cathepsin B has been reported in neuronal apoptosis (Uchiyama, 2001).  
However, our experiments did not reveal a disruption of lysosomal function at the level 
of the v-ATPase or cathepsin B activity indicating that autophagic flux was impaired 
upstream of lysosomes.  Consistent with this result, cathepsin inhibition had no effect on 
sI/R-activated Bid cleavage (III-6.1).  Thus, the observed accumulation of AVs during 
sI/R likely reflects impaired delivery to (Webb et al., 2004), or fusion with (Gutierrez et 
al., 2004) the lysosomes.  Additional support for this explanation is derived from the fact 
that we found little colocalization of GFP-LC3-labeled AVs and LTR-stained lysosomes 
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after sI/R (data not shown). However, this technique did not allow for quantitative 
analysis. 
VII-3.2 Enhancing autophagic flux protects against sI/R injury 
Enhanced autophagic flux (through rapamycin treatment or Beclin1 overexpression) 
reduced sI/R-induced apoptosis.  Conversely, pharmacologic inhibition of autophagy 
with wortmannin or 3-MA, RNAi knockdown of Beclin1 and overexpression of the 
dominant negative Atg5K130R all sensitized cardiac cells to apoptosis.  To the best of our 
knowledge, the work presented here demonstrates for the first time that autophagy 
constitutes an underlying protective response against I/R injury in heart cells.   
Interestingly, protection correlated with enhanced autophagic flux. Both 
rapamycin and Beclin1-overexpression increased autophagic flux by decreasing the 
percentage of cells with steady-state accumulation of AVs, yet without changing the total 
percentage of cells demonstrating active autophagy.  In addition to their role in the 
initiation of AV formation, Beclin1 and/or Vps34 have been shown to play a role in 
sorting of lysosomal proteins (Kihara et al., 2001; Row et al., 2001; Obara et al., 2006).  
Rab7, a member of the family of Rab GTPases which regulate transport and 
tethering/docking of vesicles (Waters and Pfeffer, 1999), mediates the fusion of AVs with 
lysosomes (Gutierrez et al., 2004; Jager et al., 2004).  Rab7 also interacts with Beclin1 
interacting partner Vps34, (Stein et al., 2003),  and it has been suggested that the 
localization of Rab7 to AVs is negatively regulated by mTOR (Gutierrez et al., 2004).  
We propose that the protection conferred by rapamycin and Beclin1-overexpression is 
linked to rescued autophagolysosome formation.  Further studies will be needed to 
support this hypothesis.  
VII-3.3 Protection, Bcl-2, and autophagy 
Cellular survival following I/R depends in large part on the interactions between anti-
apoptotic (e.g. Bcl-2, Bcl-xL) and pro-apoptotic (e.g. Bid, Bax) Bcl-2 family members.  
Bcl-2 and Bcl-xL are known to protect against I/R injury (Brocheriou et al., 2000; Huang 
et al., 2005), and were likewise protective in our model (III-4).  We attributed the 
protective effect of Bcl-2 to its action at the mitochondria.  Moreover, Bcl-2 localized to 
the S/ER was found to reduce autophagy due to reduced S/ER Ca2+-content (IV-4).  
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Interestingly, S/ER Bcl-2 did not reduce nor sensitize to sI/R activation of Bax, even 
though S/ER Bcl-2 dramatically inhibited the autophagic response to nutrient deprivation.  
It is possible that the lower levels of autophagy present during sI/R are less susceptible to 
reduced S/ER Ca2+-content.  Alternatively, S/ER Bcl-2 might not further reduce S/ER 
Ca2+-content during sI/R, which is already low due to decreased decreased availability of 
ATP during I/R.   
Both Bcl-2 and Bcl-xL interact with Beclin1 (Liang et al., 1998).  Importantly, the 
ability of Atg5K130R to block the Beclin1-mediated cytoprotection demonstrated that the 
protective effect of Beclin1 is due to its enhancement of autophagy rather than a 
perturbation of Bcl-2/-xL homeostasis.   
Expression of Beclin1 Bcl-2 binding domain mutants has been reported to 
increase AV formation and autophagic cell death (Pattingre et al., 2005).    However, our 
results using lysosomal inhibitors to quantify autophagic flux clearly indicate that 
expression of Beclin1∆Bcl2BD decreased autophagy during both nutrient deprivation 
(IV-2.4) and sI/R, and furthermore, unlike wild-type Beclin1, did not confer protection 
against sI/R.  Moreover, expression of either wild-type Bcl-2 or Bcl-xL had no detectable 
effect on the autophagic response (data not shown), yet significantly protected against 
sI/R injury.  The suppressive effect of Beclin1∆Bcl2BD on autophagy indicates that an 
interaction between Beclin1 and Bcl-2/-xL is required for full autophagic activity, arguing 
for the possibility of coinciding pro-survival activities of both Bcl-2/-xL and autophagy. 
In fact, increased expression of both Bcl-2 and Beclin1 have been correlated with 
protection during myocardial stunning (Depre et al., 2004; Yan et al., 2005). 
VII-3.4 Conclusions: Chapter V  
We found that the accumulation of AVs in sI/R injury is indicative of impaired 
autophagic flux rather than excessive autophagy.  Residual levels of autophagy, although 
not maximal, are part of a cellular pro-survival program as inhibition of autophagy via 3-
MA, wortmannin, and Atg5K130R aggravated sI/R-induced apoptosis.  Moreover, 
enhancing autophagic flux via rapamycin or overexpression of Beclin1 protected against 
sI/R-induced apoptosis.  Bcl-2 supports Beclin1-mediated autophagy as a deletion of the 
Beclin1 Bcl-2 binding domain decreased autophagic flux in sI/R and abolished 
protection. 
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FIG. 43.  Autophagy in HL-1 cardiac myocytes.   The main steps of the autophagic mechanism 
are (1) induction, (2) AV formation, (3) sequestration of cytoplasmic material, and (4) degradation 
of the AVs and cargo by lysosomal proteases (see Fig. 3, 5).  Nutrient (amino acid, AA; serum) 
deprivation strongly activated autophagic flux.  During ischemia, autophagy was inhibited at the 
level of autophagosome formation.  Upon reperfusion, autophagy partially recovered, with 
submaximal induction and impaired degradation.  Enhancing autophagic flux was protective 
against sI/R injury.  Interestingly, Beclin1 enhanced autophagic flux by increasing lysosomal 
degradation of AVs, supporting a suggested role in lysosomal protein sorting. 
 
 
VII-4 Chapter VI:  Nature of protection exerted by autophagy: role of 
mitophagy 
In Chapter III we determined that sI/R in HL-1 cardiac myocytes leads to mitochondrial 
stress, reflected by loss of ∆Ψm, increased ROS generation, and fragmentation of 
mitochondria. In addition, sI/R injury culminates in Bax redistribution and cell death, 
revealing the execution of the mitochondrial apoptotic pathway.  In Chapter V we 
determined that autophagy constitutes an underlying protective response against 
mitochondrial apoptotic I/R injury in cardiac myocytes.  Based on our findings we 
refined our original hypothesis, and in Chapter VI sought to test whether the protection 
exerted by autophagy is in part due to the degradation of malfunctioning mitochondria. 
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VII-4.1 Autophagic scavenging of mitochondria (mitophagy) during sI/R 
High-resolution fluorescence microscopy of mito-DsRed2-labeled mitochondria and 
GFP-LC3-labeled AVs revealed autophagic sequestration of mitochondrial fragments 
early in the reperfusion period.  Mitophagy has been reported to occur in the in vivo 
heart: Electron microscopy studies detected mitophagy in the perfused rabbit heart model 
following a mild hypoxic insult (Decker et al., 1980; Decker and Wildenthal, 1980).   
Destabilized mitochondria can be removed through the process of mitophagy: 
mitochondria are sequestered by autophagosomes, which then deliver the mitochondria to 
the lysosomes where they are degraded.  Mitophagy is a normal cell function to replace 
‘old’ mitochondria, and in the heart mitochondrial turnover has been clocked at 6-10 days 
(Moreau et al., 2005). Tight control of the cell’s mitochondrial population is necessary, as 
mitochondria are important sources of ROS (Boveris et al., 1972) due to their high 
oxidative capacity consequent to meeting the extreme energetic demands of the cardiac 
myocyte.  Mitochondria are also ROS-excitable organelles, amplifying internal or 
external ROS signals at the electron transport chain (Huser et al., 1998; Leach et al., 
2001; Brady et al., 2004), a phenomenon termed ROS-induced ROS release (Zorov et al., 
2000). As such, mitochondria are not only a target of oxidative damage but also the most 
important source of oxidative stress to neighboring components of the cell, resulting in 
high levels of oxidative damage to proteins, lipids and mtDNA. This ‘vicious cycle’ is 
thought to contribute to I/R injury ((Juhaszova et al., 2004) and aging (Lakatta and 
Sollott, 2002).  Mitophagy may function during myocardial I/R injury as a means to 
eliminate mitochondria which are destructive (e.g. generating ROS, releasing pro-
apoptotic molecules), thus modulating the threshold for PCD.   
VII-4.2 Bnip3 and activation of the sI/R apoptotic pathway 
We recently determined that Bnip3 is a major contributor to I/R injury in the ex vivo heart 
via disruption of mitochondrial integrity, leading to enhanced superoxide production and 
the release of pro-apoptotic factors such as cytochrome c and AIF (Hamacher-Brady et 
al., 2006).  In our HL-1 cardiac myocytes model, overexpression of Bnip3 was used to 
mimic I/R-induced mitochondrial dysfunction in a setting in which primary causative 
factors of ischemia are not in place, i.e. in nutrient and oxygen rich conditions.  
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Consistent with a role in I/R-induced mitochondrial dysfunction and cell death in the ex 
vivo heart, RNAi knockdown of Bnip3 decreased sI/R-mediated Bax activation. 
VII-4.2.1 Bnip3, mitochondrial fragmentation, and autophagy 
Similar to sI/R, Bnip3 caused extensive fragmentation of the mitochondrial network, 
which correlated with an upregulation of autophagy.  We identified fragmented 
mitochondria inside the autophagosomes, suggesting that autophagy serves as a 
protective response to remove damaged mitochondria that may be harmful to the cell. We 
found that mitophagy targeted previously fragmented mitochondria and that sI/R-induced 
mitochondrial fragmentation was mediated by Drp1 (III-2.1).  As enforced fragmentation 
prior to sI/R via overexpression of Drp1 was protective against sI/R (III-5), we 
hypothesize that Drp1-mediated mitochondrial fragmentation is a prerequisite for the 
scavenging of damaged mitochondria via mitophagy.  A recent report by Arnoult et al. on 
Drp1 and mitochondrial elimination during PCD adds new evidence to this hypothesis 
(Arnoult et al., 2005).   
VII-4.2.2 Autophagy protects against Bnip3 apoptotic signaling 
We determined that the increase in autophagic activity was a protective response against 
Bnip3-mediated cell death.  Similar to the findings in sI/R, Beclin1 overexpression 
protected against, while Atg5K130R aggravated, Bnip3-induced cell death. However, 
opposed to the findings in sI/R, Beclin1∆Bcl2BD massively aggravated and Atg5 
overexpression protected against Bnip3-induced cell death.  These data indicate that 
Bnip3-induced death is counteracted by on both signaling (Beclin1) and machinery level 
(Atg5) functional autophagy. 
Together, these results further support the notion that mitophagy during 
reperfusion is specific to sI/R signaling pathways and that autophagy is a cytoprotective 
mechanism that is capable of reducing sI/R-induced damage.  Furthermore, Bnip3 exerts 
its toxicity by causing mitochondrial dysfunction indicating that autophagy protects 
against sI/R injury by removing pro-apoptotic mitochondria.      
VII-4.2.3 Signal for mitophagy? 
It is not known whether Bnip3 activates the autophagic machinery directly or whether 
autophagy is induced as a consequence of mitochondrial damage caused by Bnip3. 
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Several studies have reported that overexpression of Bnip3 induces cell death through 
MPTP opening (Vande Velde et al., 2000).  Previous work has shown that the MPTP 
serves as an upstream signal for mitochondrial autophagy (Elmore et al., 2001). The 
MPTP has also been reported to play a role in I/R injury (Borutaite et al., 2003; 
Hausenloy et al., 2003; Weiss et al., 2003), as well as in our of model of sI/R (III-3.2).  
Activation of the MPTP causes collapse of ∆Ψm, the driving force for ATP synthesis, 
leading us to speculate that a change in ATP:AMP may be a signaling mechanism for 
autophagy. AMPK, which functions as a sensor for the intracellular energetic state, is 
strongly and immediately upregulated by uncoupling of oxidative phosphorylation 
(Soltoff, 2004) and can inactivate p70S6 kinase, the downstream mediator of mTOR 
(Tokunaga et al., 2004).  As mTOR has been reported to be localized in part to 
mitochondria (Desai et al., 2002), an mTOR-AMPK interaction may govern local 
selective removal of mitochondria.    
VII-4.3 Conclusions 
In summary, our results suggest that mitophagy is a crucial mechanism that allows the 
cell to eliminate the most harmful mitochondria, thus modulating the threshold for the 
onset of PCD.  We propose that by removing a more susceptible subpopulation of pro-
apoptotic mitochondria responsible for local ROS generation and release of pro-apoptotic 
factors the cell can prevent the recruitment of the entire mitochondrial population to the 
execution of the cell death program (Lemasters et al., 1998; Skulachev, 2000).   
 
VII-5 Perspectives: Significance in the heart 
The body of work presented in this thesis demonstrates for the first time that autophagy 
constitutes an underlying protective response against I/R injury in heart cells. Future 
experiments are needed to determine whether autophagy, and specifically mitophagy, 
represents a means to reduce cardiac I/R injury in vivo.   
Clearly, establishing the mechanisms which promote the anti-apoptotic effects of 
autophagy, and minimize autophagic cell death may represent a potentially powerful tool 
against I/R-activated cardiac myocyte cell death.  Although cell models are useful for 
identifying participants and their roles in the control of autophagy over cell death, ex vivo 
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and in vivo models of autophagy must be developed to determine the relevance in the 
heart.  PI3-K inhibitors do not discriminate between different classes of PI3-K.  Long-
term administration of 3-MA toxic in heart cells (Terman et al., 2003) and furthermore, 
wortmannin has been shown to inhibit class I PI3-K/Akt-dependent pro-survival 
pathways in myocardial I/R injury (Tsang et al., 2004).  Likewise, rapamycin, which has 
been shown to be protective in neurons (Ravikumar et al., 2006), may not be acceptable 
to treat the heart as it inhibits Hif-1-alpha and thus would block Hif1alpha-mediated 
protective responses (Cai et al., 2003).  Thus, classic means to perturb the autophagic 
pathway are not ideal for studies in the heart.   
TAT-mediated protein transduction which has proven useful for introducing 
protective proteins to the heart, in vivo and ex vivo (Gustafsson et al., 2002; Inagaki et al., 
2003) will likely be a useful tool to dissect the role of autophagy in the heart.  Our lab has 
shown that proteins fused to the protein transduction domain of HIV TAT, an 
amphiphatic 11 amino acid sequence can be transduced across the plasma membrane in 
large quantities in the heart.  TAT-fusion proteins used to introduce ARC and Bnip3∆TM 
provided significant protection against I/R injury and improved cardiac function.  Based 
on the results of this thesis, Beclin1, Atg5 and Atg5K130R are interesting candidates for 
TAT studies.   
Our method of systematically distinguishing AV content from autophagic activity, 
i.e. the flux of AV formation and degradation, using lysosomal inhibition has the 
potential to redefine previous reports concerning autophagy in the heart and other 
models.  The combination of lysosomal inhibitors and TAT-fusion proteins in the ex vivo 
heart of transgenic GFP-LC3 mice (Kirisako et al., 1999; Mizushima et al., 2004) is 
likely to give powerful insights into the role of autophagy in the heart.  
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VIII Summary 
Apoptotic cell death of cardiac myocytes contributes to cardiovascular disease.  Increased 
levels of autophagosomes have been reported during myocardial ischemia/reperfusion 
(I/R) injury, however, whether autophagy functions as a protective or lethal response is 
unclear.  The overall goal of this thesis was to elucidate the nature of the relationship 
between I/R-activated mitochondrial (apoptotic) death pathways and autophagy.  
Apoptotic and autophagic signaling pathways were systematically perturbed to determine 
cause and effect relationships.  High-resolution fluorescence imaging was employed to 
quantify spatial and temporal events in the single cell.   
In Chapter III, we developed a cell culture-based model of simulated I/R (sI/R) 
injury which closely matches the in vivo situation, using the HL-1 cardiac myocyte cell 
line, specific fluorescent dyes, GFP-fusion proteins, and multidimensional fluorescence 
deconvolution microscopy.  During ischemia, which was simulated using a hypoxic, 
glucose-free, acidic solution, mitochondrial networks fragmented.  Bax translocation 
from the cytosol to mitochondria was initiated during ischemia and continued during 
reperfusion.  However, subsequent clustering (activation) of Bax at mitochondria 
occurred late into reperfusion.  Enforced mitochondrial fragmentation by expression of 
Drp1 reduced Bax clustering, indicating that fragmentation was a protective response.  
Bid processing was caspase 8 dependent, and Bid translocation to mitochondria occurred 
after Bax translocation and clustering, and shortly before cell death.  Clustering of Bax 
was prevented by anti-apoptotic Bcl-2 and Bcl-xL, cyclosporine A, an inhibitor of the 
mitochondrial permeability transition pore, and also by SB203580, an inhibitor of p38 
MAPK.  Surprisingly, mitochondrial fragmentation could be reversed by the addition of 
the p38 inhibitor SB203580 at reperfusion, implicating p38 MAPK in the mitochondrial 
remodeling response to I/R that facilitates Bax recruitment to mitochondria.   
Apoptotic and autophagic pathways are linked through the interaction of anti-
apoptotic Bcl-2 proteins with the autophagy protein Beclin1.  However, the nature of the 
interaction, either in promoting or blocking autophagy remains unclear.  In Chapter IV 
we developed a highly-sensitive, macroautophagy-specific methodology: to quantify 
nutrient-deprivation-activated autophagic flux by comparing levels of GFP-LC3 labeled 
autophagosomes under steady-state conditions and in the presence of lysosomal 
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inhibitors.  Expression of Beclin1 lacking the Bcl-2 binding domain (Beclin1∆Bcl2BD) 
significantly reduced autophagic flux, indicating that Beclin1-mediated autophagy 
requires an interaction with Bcl-2.  In apparent contrast, overexpression of Bcl-2 slightly 
suppressed autophagic flux; this effect was enhanced by targeting Bcl-2 to the 
sarco/endoplasmic reticulum (S/ER).  The suppressive effect on autophagy by S/ER-
targeted Bcl-2 may be in part due to the depletion of S/ER calcium stores: intracellular 
scavenging of calcium by BAPTA-AM and treatment with thapsigargin, an inhibitor of 
the S/ER calcium ATPase (SERCA; pumps calcium from the cytosol into the S/ER), 
significantly reduced autophagic activity.  These findings demonstrate that Bcl-2 
regulates the autophagic response at the level of S/ER calcium content rather than via 
direct interaction with Beclin1.  Moreover, calcium homeostasis was identified as an 
essential component of the autophagic response to nutrient deprivation. 
Subsequently, in Chapter V, the dynamics and role of autophagy during sI/R were 
investigated.  Autophagic flux was null during the ischemic period, and increased at 
reperfusion, but not to the same degree as under normoxic conditions.  We found that 
sI/R impaired both formation and downstream lysosomal degradation of 
autophagosomes.  Both rapamycin and overexpression of Beclin1 enhanced autophagic 
flux following sI/R and significantly reduced activation of Bax, while 3-MA, 
wortmannin, and RNAi knockdown of Beclin1 increased Bax activation.  Expression of 
Beclin1∆Bcl2BD resulted in decreased autophagic flux and did not protect against Bax-
activation and the expression of a dominant negative mutant of Atg5, a component of the 
autophagosomal machinery downstream of Beclin1, increased Bax activation.  These 
results demonstrate that autophagic flux is impaired at the level of both induction and 
degradation.  Residual levels of autophagy, even though not maximal, functioned to 
preserve cell viability following sI/R and enhancing autophagy constituted a powerful 
and previously uncharacterized protective mechanism against I/R injury to the heart cell.  
In Chapter VI, using high-resolution imaging we found that during sI/R 
fragmented mitochondria were frequently sequestered by autophagosomes (mitophagy).  
To investigate the connection between sI/R-induced mitochondrial dysfunction and 
autophagy we focused on Bnip3, a mitochondrial pro-apoptotic Bcl-2 family member 
which mediates I/R-induced mitochondrial dysfunction in the heart and has been shown 
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to activate autophagy.  RNAi knockdown identified Bnip3 as an important mediator of 
sI/R injury in HL-1 cells.  Overexpression of Bnip3, to simulate a specific and necessary 
event in I/R-activated mitochondrial dysfunction, induced fragmentation of the 
mitochondrial network and cell death in the absence of sI/R.  Moreover, Bnip3 
expression enhanced both steady-state levels of AVs and autophagic flux.  Many of the 
Bnip3-induced autophagosomes contained fragmented mitochondria.  Overexpression of 
both Beclin1 and Atg5 protected against Bnip3-mediated cell death, while blocking 
autophagy with dominant negative mutants of Beclin1 or Atg5 enhanced cell death.  
These findings indicate that the autophagic pathway opposes the mitochondrial apoptotic 
pathway, in that autophagy of dysfunctional mitochondria counteracts Bnip3-mediated 
mitochondrial death signaling.  We hypothesize that, likewise, autophagy protects against 
myocardial I/R injury via the removal of damaged mitochondria.  
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X-1 Figure index 
 
FIG. 1. Comprehensive schema of signaling pathways implicated in apoptosis (PCD type   
             I) of cardiac myocytes.                 9 
FIG. 2.  Bcl-2 homology domains.               13 
FIG. 3.  Macroautophagy is a three-step process.             16 
FIG. 4.  Two ubiquitin-like conjugation systems during autophagosome formation.       18 
FIG. 5.  Molecular mechanism and regulation of autophagy.           21 
 
FIG. 6.  sI/R in HL-1 cardiac myocytes leads to mitochondrial dysfunction.         46 
FIG. 7.  sI/R causes the disruption of the mitochondrial network.           47 
FIG. 8. Drp1 mediates the disruption of the mitochondrial network.          49 
FIG. 9.  sI/R-induced Bax translocation to mitochondria.            50 
FIG. 10.  Bax translocation to mitochondria independent of mitochondrial dysfunction.52  
FIG. 11.  MPTP is upstream of GFP-Bax activation.             53 
FIG. 12.  sI/R-specific GFP-Bax clustering.              54 
FIG. 13. Anti-apoptotic Bcl-2 and Bcl-xL oppose sI/R-induced GFP-Bax clustering.     55 
FIG. 14. Fissioned mitochondria afford protection from sI/R injury in HL-1 cells and Bcl- 
               xL protects independently of mitochondrial fission.           56 
FIG. 15.  YFP-Bid-CFP sensor to monitor Bid activation.               58 
FIG. 16.  Bid cleavage during sI/R is mediated by caspase 8.           59 
FIG. 17.  Sequential activation of Bax and Bid in response to sI/R.           60 
 
FIG. 18.  Inhibition of lysosomal activity with the inhibitor cocktail.          66 
FIG. 19. Basal and rapamycin-activated autophagic activity in full medium.         68 
FIG. 20.  Autophagic flux under nutrient deprivation.            69 
FIG. 21.  Atg5 control of autophagosome formation.            71 
FIG. 22. Beclin1 regulation of the autophagic response.            74 
FIG. 23. Bcl-2 control of autophagic activity.             75 
FIG. 24.  Bcl-2 reduces S/ER Ca2+ content.              76 
FIG. 25.  Role of S/ER Ca2+ stores on nutrient deprivation induced autophagy.         77 
 
FIG. 26.  Analysis of cellular autophagosomal content during sI/R.           82 
FIG. 27.  Flux of LC3-II degradation during sI/R.             84 
FIG. 28.  Assessment of lysosomal activity and participation in pro-death signaling.      85 
FIG. 29.  Pharmacologic interference with autophagy induction.           88 
FIG. 30.  Effect of pharmacological interference upstream of AV formation on sI/R   
               injury.                 89 
FIG. 31.  Beclin 1 overexpression protects against sI/R injury.           90 
FIG. 32.  Beclin1-mediated protection in sI/R correlates with its effect on autophagy.   93 
FIG. 33.  Inhibition of Atg5 increases sI/R injury and abolishes protection through   
               Beclin1                 95 
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FIG. 34.  sI/R leads to autophagic sequestration of fragmented mitochondria.       101 
FIG. 35.  Bnip3 mediates sI/R injury in the HL-1 cardiac myocyte.         103 
FIG. 36.  Bnip3 overexpression activates cell death in HL-1 cardiac myocytes.       103 
FIG. 37.  Bnip3 overexpression increases autophagic flux in full medium.        105 
FIG. 38.  Fusion between AVs and lysosomes seems functional in Bnip3-overexpressing  
     cells.               106 
FIG. 39. Bnip3 overexpression results in fragmentation of the mitochondrial network.106 
FIG. 40.  Bnip3 overexpression activates mitophagy.          108 
FIG. 41.  Modulation of autophagy affects Bnip3-mediated cell death.        109 
 
FIG. 42.  Time-line of events during sI/R in HL-1 cells           119 
FIG. 43.  Autophagy in HL-1 cardiac myocytes                                   127    
 
X-2 Oligonucleotides 
 
Construct Oligo Comment Sequence1 
pmCherry-
C1 
Forw. AgeI  GTAACCGGTATGGTGAGCAAGGGCGAG 
 Rev. BglII GTAAGATCTCTTG TACAGCTCGTCCATGC  
mCherry-
Bax(WT) 
Forw. BglII  
 GTAAGATCTATGGACGGGTCCGGGGAG 
 Rev. EcoRI GTAGAATTCTCAGCCCACT TCTTCCAGATGGTG  
mCherry-
BaxT182A 
Forw. T182A GGGAGTGCTCGCCGCCTCACTCACCATCTGG 
 Rev.  CCAGATGGTGAGTGAGGCGGCGAGCACTCCC 
YFP-Bid-
CFP 
Forw. YFP(AgeI) GTAACCGGTATGGTGAGCAAGGGCGAGG 
 Rev. YFP(XhoI) GTACTCGAGCTTGTACAGCTCGTCCATGC 
 Forw. Bid(XhoI) GTACTCGAGATGGACTGTGAGGTCAACAACG 
 Rev. Bid(SphI) GTAGCATGCGTCCATCCCATTTCTGGC 
 Forw. CFP(SphI) GTAGCATGCATGGTGAGCAAGGGCGAGG 
 Rev. CFP(NotI) GCAGCGGCCGCTTACTTGTACAGCTCGTCC 
Bid∆casp8 Forw. D60E GAGCTGCAGACTGAGGGCAACCGCAGCAGC 
 Rev.  GCTGCTGCGGTTGCCCTCAGTCTGCAGCTC 
Atg5 Forw. XhoI GTACTCGAGGGATGACAGATGACAAAGATGTG 
 Rev. BamHI GTAGGATCCATCTGTTGGCTGGGGGAC 
Atg5K130R Forw. K130R GTCGTGTATGAGAGAAGCTGATG 
 Rev.  CATCAGCTTCTCTCATACACGAC 
Bnip3 
miRNA 
‘78’ Target TCCAGCCTCCGTCTCTATTTA 
  Complement TAAATAGAGACGGAGGCTGGA 
Beclin1 ‘a’ Target TGAAACTTCAGACCCATCTTA 
miRNA  Complement TAAGATGGGTCTGAAGTTTCA 
 ‘b’ Target TAATGGAGCTGTGAGTTCCTG 
  Complement CAGGAACTCACAGCTCCATTA 
1Sequences are shown 5-prime to 3-prime with restriction sites underlined.  Oligo, 
oligonucleotide; Forw., forward; Rev., reverse 
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X-3 Amino acid code 
 
Single letter code Abbreviation Amino acid 
G Gly Glycine 
P Pro Proline 
A Ala Alanine 
V Val Valine 
L Leu Leucine 
I Ile Isoleucine 
M Met Methionine 
C Cys Cysteine 
F Phe Phenylalanine 
Y Tyr Tyrosine 
W Trp Tryptophan 
H His Histidine 
K Lys Lysine 
R Arg Arginine 
Q Gln Glutamine 
N Asn Asparagine 
E Glu Glutamic acid 
D Asp Aspartic acid 
S Ser Serine 
T Thr Threonine 
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X-4 Fluorescent dyes  
 
Fluorescent dye2 Abbreviation Excitation/Emission 
Maxima (nm) 
Concentration Phenomenon/ 
specificity 
Carboxymethyl-
dihydrochlorofluorescein 
diacetate 
CM-H2DCF-
DA 500 /530  10 µM ROS 
Fluo-4 Fluo-4 491 /518 2 µM Ca2+ 
LysoTracker Red LTR 577 /590  50 nM Acidic vesicles 
(z-RR)2-MagicRed-
Cathepsin B substrate MagicRed 550 /610  10 nM Cathepsin B 
Rhodamine 123 Rhod123 485 /530 50 nM ∆Ψm 
Tetramethylrhodamine 
methyl ester TMRM 556 /576  100 nM  ∆Ψm 
Yo-Pro-1 iodide YoPro1 491 /509  100 nM Plasmamembrane integrity 
2Listed are the fluorescent dyes used in this thesis. 
 
 
 
X-5 Fluorescent protein variants 
 
Fluorescent protein 
variant3 
Abbreviation Excitation/ 
Emission 
Maxima (nm) 
Comments Originator 
Green fluorescent protein GFP 488 /509 variant ‘EGFP’ Clontech 
Cyan fluorescent protein CFP 433 (452) /475 
(505) 
variant ‘ECFP’ Clontech 
ECFPS72A/Y145A/H148D Cerulean 433 /475 brighter, >lifetime Dr. D. Piston 
DsRed2 DsRed2 558 /583 forms dimers Clontech 
mCherry mCherry 587 /610 monomeric  Dr. R. Tsien 
Yellow fluorescent protein YFP 516/ 529 variant ‘EYFP’ Clontech 
EYFP F64L/M153T/V163A/S175G Venus 515 /528 pH & Cl- insensitive  Dr. A. Miyawaki 
3Listed are the fluorescent protein variants used in this thesis.  ‘E’ in ‘EGFP’, ‘ECFP’, and ‘EYFP’: 
enhanced.   
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X-6 Vector maps 
 
X-6.1   pECFP-mito 
 
 
 
 
X-6.2   p_mCherry-C1 
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X-6.3   p_mCherry-Bax 
 
 
 
 
X-6.4   mCherry-Atg5 
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X-6.5   YFP-Bid-CFP 
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